Annual Report (Form 10-K), fiscal year 1994

ITEM 1. BUSINESS
Eastman Kodak Company (the Company) is engaged primarily in developing, manufacturing, and marketing consumer and commercial imaging products.
In conjunction with the Company's announced intention to refocus its attention on its consumer and commercial imaging businesses, the Company has changed its segments for financial reporting purposes, effective with the second quarter of 1994. The Consumer Imaging business unit, which was previously reported in the former Imaging segment, is now reported as a separate segment. The new Commercial Imaging segment includes the other business units from the former Imaging segment, the business units from the former Information segment, Digital and Applied Imaging operations and the Health Sciences business unit, which was previously included in the Health segment. Data for prior periods have been restated to conform with the 1994 presentation.
Kodak's sales, earnings and identifiable assets by industry segment for the past three years are shown in Segment Information on page 46. - - ------------------------------------------------------------------------------
CONSUMER IMAGING SEGMENT
Sales of the consumer imaging segment, including intersegment sales, for the past three years were:
(in millions) 1994 1993 1992
$5,919 $5,292 $5,414
The products of the consumer imaging segment are used for capturing, recording or displaying a consumer originated image. For example, traditional amateur photography requires, at a minimum, a camera, film, and photofinishing. Photofinishing requires equipment and supplies, including chemicals and paper for prints.
Kodak manufactures and markets various components of imaging systems. For amateur photography, Kodak supplies films, photographic papers, processing services, photographic chemicals, cameras and projectors. Recent imaging products developed by Kodak include new generations of films, cameras, photographic papers and single-use cameras.
Marketing and Competition. Kodak's consumer imaging products and services are distributed worldwide through a variety of channels. Individual products are often used in substantial quantities in more than one market. Most sales of the consumer imaging segment are made through dealers. Independent retail outlets handling Kodak amateur products total many thousands. In a few areas abroad, Kodak products are marketed by independent national distributors.
Kodak's advertising programs actively promote its products and services in its various markets, and its principal trademarks, trade dress, and corporate symbol are widely used and recognized.
Kodak's consumer imaging products and services compete with similar products and services of others. Competition in traditional imaging markets is strong throughout the world. Many large and small companies offer similar products and services that compete with Kodak's business. Kodak's products are continually improved to meet the changing needs and preferences of its customers.
Raw Materials. The raw materials used by the consumer imaging segment are many and varied and generally available. Silver is one of the essential materials in photographic film and paper manufacturing. Digital electronics are becoming more integral in product offerings.
- - ------------------------------------------------------------------------------
COMMERCIAL IMAGING SEGMENT
Sales of the commercial imaging segment for the past three years were:
(in millions) 1994 1993 1992
$7,646 $7,382 $7,592
The commercial imaging segment consists of businesses that serve the imaging and information needs of commercial customers. Products in this segment are used to capture, store, process and display images and information in a variety of forms.
Kodak products for the commercial imaging segment include films, photographic papers, photographic plates, chemicals, processing equipment and audiovisual equipment, as well as copiers, graphic arts films, microfilm products, applications software, printers and other business equipment and service agreements to support these products. These products serve professional photofinishers, professional photographers, customers in the healthcare industry, customers in motion picture, television, commercial printing and publishing, office automation and government markets. Recent commercial imaging products developed by Kodak include commercial imaging applications for the recently introduced photo CD system.
Marketing and Competition. Kodak's commercial imaging products and services are distributed through a variety of channels. The Company also sells and leases business equipment directly to users. Most sales of the commercial imaging segment, however, are made through dealers.
Kodak's commercial imaging products and services compete with similar products and services of other small and large companies. Strong competition exists throughout the world. Kodak's products are continually improved to meet the changing needs and preferences of its customers.
Raw Materials. The raw materials used by the commercial imaging segment are many and varied and generally available. Silver is one of the essential materials in photographic film and paper manufacturing. Electronic components represent a significant portion of the cost of the materials used in the manufacture of business equipment. - - ------------------------------------------------------------------------------
DISCONTINUED OPERATIONS - HEALTH BUSINESSES
On May 3, 1994, the Company announced its intent to divest the following non-imaging health businesses: the pharmaceutical and consumer health businesses of Sterling Winthrop Inc., the household products and do-it-yourself products businesses of L&F Products and the Clinical Diagnostics Division. These businesses are reported as discontinued operations with results for prior periods restated. At December 31, 1994, the Company had completed the sales of all of these businesses for aggregate gross proceeds of $7,858 million. In addition, as part of the divestiture, the Company is actively negotiating with potential buyers for its pharmaceutical research and development facility and its NanoSystems unit, and anticipates completing these transactions in 1995.
Sales of products of these discontinued health businesses for the past three years were (1994 sales are through sales dates):
(in millions) 1994 1993 1992
$3,175 $3,694 $3,553
- - ------------------------------------------------------------------------------
DISCONTINUED OPERATIONS - CHEMICALS SEGMENT
On December 31, 1993, the Company distributed all of the outstanding shares of common stock of Eastman Chemical Company (Eastman), which represented substantially all of the Company's worldwide chemical business, as a dividend to the Company's shareowners (the spin-off) in a ratio of one share of Eastman common stock for every four shares of Kodak common stock. As a result of the spin-off, Eastman became an independent publicly held company listed on the New York Stock Exchange and its operation ceased to be owned by the Company. In connection with the spin-off, Eastman assumed $1.8 billion of new borrowings, the proceeds from which were used by the Company to retire other borrowings. The chemicals segment has been reported as discontinued operations and results for prior periods have been restated.
Sales of chemicals segment products, including intersegment sales, for the two years ended December 31, 1993 and 1992 were:
(in millions) 1993 1992
$3,976 $3,927
- - ------------------------------------------------------------------------------
RESEARCH AND DEVELOPMENT
Through the years, Kodak has engaged in extensive and productive efforts in research and development. In 1994, $859 million (1993 - $864 million; 1992 - $988 million) was expended for research and development in continuing operations. Research and development groups for continuing operations are located principally in the United States in Rochester, New York; outside the U.S., research and development groups are located in England, France, Japan and Germany. These groups, in close cooperation with manufacturing units and marketing organizations, are constantly developing new products and applications to serve both existing and new markets.
It has been Kodak's general practice to protect its investment in research and development and its freedom to use its inventions by obtaining patents where feasible. The ownership of these patents contributes to Kodak's ability to use its inventions but at the same time is accompanied by a liberal patent-licensing policy. While in the aggregate Kodak's patents are considered to be of material importance in the operation of its business, it does not consider that the patents relating to any single product or process are of material significance when judged from the standpoint of its total business.
- - ------------------------------------------------------------------------------
ENVIRONMENTAL PROTECTION
Kodak is subject to various laws and governmental regulations concerning environmental matters. Some of the U.S. federal environmental legislation having an impact on Kodak includes the Toxic Substances Control Act, the Resource Conservation and Recovery Act (RCRA), the Clean Air Act, and the Comprehensive Environmental Response, Compensation and Liability Act (the Superfund law).
Kodak continues to engage in a program for environmental protection and control. During 1994, expenditures for pollution prevention and waste treatment for continuing operations at various manufacturing facilities totaled $122 million. These costs included $83 million of recurring costs associated with managing hazardous substances and pollution in on-going operations, $36 million of capital expenditures to limit or monitor hazardous substances or pollutants, and $3 million of mandated expenditures to remediate previously contaminated sites. These expenditures have been accounted for in accordance with the Company's accounting policy for environmental costs. The Company expects these recurring and remediation costs to increase slightly and capital to increase significantly in the near future. While these costs will continue to be significant cash outflows for the Company, it is not expected that these costs will have an impact materially different from 1994's environmental expenditures on the Company's financial position, results of operations, cash flows or competitive position.
In October 1994, the Company, the Environmental Protection Agency (EPA), and the U.S. Department of Justice announced the settlement of a civil complaint alleging noncompliance by the Company with federal environmental regulations at the Company's Kodak Park manufacturing site in Rochester, New York. The Company paid a penalty of $5 million. A Consent Decree was signed under which the Company is subject to a Compliance Schedule by which the Company will improve its waste characterization procedures, upgrade one of its incinerators and evaluate and upgrade its industrial sewer system over a 12-year period. The expenditures that may be required to complete this program cannot currently be reasonably estimated since upgrade plans have not been finalized and must be developed on an ongoing basis. Further, most costs associated with the program will be for capital expenditures.
The Company has reviewed a RCRA Facility Assessment (RFA) pertaining to the Company's Kodak Park site in Rochester, New York and has completed a broad-based assessment of the site in response to the RFA. While future expenditures associated with any remediation activities could be significant, it is not possible to reasonably estimate those expenditures until remedial investigation and feasibility studies are performed.
The Company accrues for remediation costs that relate to an existing condition caused by past operations when it is probable that these costs will be incurred and can be reasonably estimated. The Company has accrued for remediation costs of $108 million in its financial statements at December 31, 1994, compared with $84 million at December 31, 1993.
The Clean Air Act Amendments were enacted in 1990. The Company may be required to incur significant costs, primarily capital in nature, over a period of several years to comply with the provisions of this Act. The expenditures that may be required cannot be currently reasonably estimated since either implementing regulations have not been issued or compliance plans have not been finalized.
- - ------------------------------------------------------------------------------
EMPLOYMENT
At the end of 1994, the Company employed 96,300 people, of whom 54,300 were employed in the U.S. The acquisition of Qualex during 1994 added approximately 7,600 people to the Company's U.S. employment. Acquisitions outside the U.S. during 1994 added approximately 1,200 people to the Company's employment levels. Approximately 5,100 personnel left the Company during 1994 under restructuring programs.
- - ------------------------------------------------------------------------------
Financial information by geographic areas for the past three years is shown in Segment Information on page 45.
- - ------------------------------------------------------------------------------
ITEM 2.



ITEM 2. PROPERTIES
The consumer imaging segment of Kodak's business in the United States is centered in and near Rochester, New York, where photographic goods are manufactured. Another manufacturing facility near Windsor, Colorado, also produces sensitized photographic goods. Regional distribution centers are located in various places within the United States.
Consumer imaging manufacturing facilities outside the United States are located in Australia, Brazil, Canada, France, Mexico and the United Kingdom. Kodak maintains marketing and distribution facilities in many parts of the world. The Company also owns processing laboratories in numerous locations worldwide.
Products in the commercial imaging segment are manufactured primarily in Rochester, New York and Windsor, Colorado. Manufacturing facilities outside the United States are located in Germany, Mexico and the United Kingdom.
The Company owns or leases administrative, manufacturing, marketing, and processing facilities in various parts of the world. The leases are for various periods and are generally renewable.
The manufacturing and marketing facilities are adequate and suitable, in relation to prevailing conditions, to serve the needs of their marketing areas.
- - ------------------------------------------------------------------------------
ITEM 3.

ITEM 3. LEGAL PROCEEDINGS
The Company is participating in the EPA's Toxic Substances Control Act (TSCA) Section 8(e) Compliance Audit Program. As a participant, the Company has agreed to audit its files for materials which under current EPA guidelines would be subject to notification under Section 8(e) of TSCA and to pay stipulated penalties for each report submitted under this program. The Company anticipates that its liability under the program will be $1,000,000.
In addition to the foregoing environmental actions, the Company has been designated as a potentially responsible party (PRP) under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended (the Superfund law), or under similar state laws, for environmental assessment and cleanup costs as the result of the Company's alleged arrangements for disposal of hazardous substances at approximately twenty-five Superfund sites. With respect to each of these sites, the Company's actual or potential allocated share of responsibility is small. Furthermore, numerous other PRPs have similarly been designated at these sites and, although the law imposes joint and several liability on PRPs, as a practical matter costs are shared with other PRPs. Settlements and costs paid by the Company in Superfund matters to date have not been material. Future costs are also not expected to be material to the Company's financial condition or results of operations.
The Company and its subsidiary companies are involved in lawsuits, claims, investigations, and proceedings, including product liability, commercial, environmental, and health and safety matters, which are being handled and defended in the ordinary course of business. There are no such matters pending that the Company and its General Counsel expect to be material in relation to the Company's business, financial condition, or results of operations.
- - ------------------------------------------------------------------------------
ITEM 4.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None - - ------------------------------------------------------------------------------
Executive Officers of the Registrant (as of December 31, 1994) Date First Elected an to Executive Present Name Age Positions Held Officer Office
George M. C. Fisher 54 Chairman of the Board, President and Chief Executive Officer 1993 1993 Michael P. Benard 47 Vice President 1994 1994 Richard T. Bourns 60 Senior Vice President 1988 1990 Harry L. Kavetas 57 Executive Vice President 1994 1994 James W. Meyer 51 Senior Vice President 1994 1994 Michael P. Morley 51 Senior Vice President 1994 1994 Wilbur J. Prezzano 54 Executive Vice President, Director 1980 1994 Leo J. Thomas 58 Executive Vice President, Director 1977 1994 Gary P. Van Graafeiland 48 Senior Vice President and Secretary 1992 1992
Executive officers are elected annually in February.
All of the executive officers have been employed by Kodak in various executive and managerial positions for more than five years, except for Mr. Fisher, who joined the Company on December 1, 1993, and Mr. Kavetas, who joined the Company on February 11, 1994. Prior to joining Kodak, Mr. Fisher held executive positions with Motorola, Inc., most recently as Chairman and Chief Executive Officer. Prior to joining Kodak, Mr. Kavetas held executive positions with International Business Machines (IBM) Corporation, most recently as President, Chief Executive Officer and a director of IBM Credit Corporation.
There have been no events under any bankruptcy act, no criminal proceedings, and no judgments or injunctions material to the evaluation of the ability and integrity of any executive officer during the past five years.
- - ------------------------------------------------------------------------------
PART II
ITEM 5.

ITEM 5. MARKET FOR THE REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
Eastman Kodak Company common stock is principally traded on the New York Stock Exchange. There were 151,349 shareholders of record of common stock as of December 31, 1994. See Cash Dividends and Market Price Data on pages 16 and 17, respectively. - - ------------------------------------------------------------------------------
The Company's net earnings of $557 million for 1994 were significantly impacted by the divestiture of its non-imaging health businesses, a program to pay down a substantial portion of its debt and financial instruments, and restructuring costs.
On May 3, 1994, the Company announced its intent to divest the following non-imaging health businesses: the pharmaceutical and consumer health businesses of Sterling Winthrop Inc., the household products and do-it-yourself products businesses of L&F Products and the Clinical Diagnostics Division. These businesses are reported as discontinued operations with results for prior periods restated. Earnings from discontinued operations include allocations of interest and taxes to the health businesses. At December 31, 1994, the Company had completed the sales of all of these businesses for aggregate gross proceeds of $7,858 million. In addition, as part of the divestiture, the Company is actively negotiating with potential buyers for its pharmaceutical research and development facility and its NanoSystems unit, and anticipates completing these transactions in 1995. The net gain on the sales of these businesses was $350 million or $1.03 per share.
The Company used $8,142 million from the divestiture, short-term borrowings and operations to extinguish $6,598 million (net carrying amount) of borrowings, $7,800 million (notional amount) of financial instruments, a $292 million master lease program and $200 million sale of receivables programs. As a result of these actions, the Company incurred an extraordinary loss of $266 million after-tax ($.79 per share). In addition, a $110 million pre-tax loss ($80 million or $.24 per share after-tax) was recorded in "other costs" for these actions.
On August 12, 1994, the Company acquired the remaining shares of Qualex, a photofinisher operating primarily in the U.S. Prior to that date, the Company had an investment in Qualex of approximately fifty percent of its outstanding common shares, which was accounted for under the equity method. The Company purchased the remaining shares for $150 million with a combination of $50 million cash paid at acquisition and a note. At December 31, 1994, $100 million remains to be paid in two equal installments in February and August 1995.
Sales from continuing operations in 1994 were $13,557 million, an increase of seven percent over sales for 1993. Excluding the sales of Qualex, sales from continuing operations increased five percent over a year ago.
Earnings from continuing operations of $554 million ($1.65 per share) for 1994 were adversely impacted by restructuring costs of $340 million pre-tax ($254 million or $.75 per share after-tax) in addition to the $110 million pre-tax loss ($80 million or $.24 per share after-tax) described above for the extinguishment of certain financial instruments. Earnings from continuing operations of $644 million ($1.95 per share) in 1993 were significantly reduced by restructuring costs of $495 million pre-tax ($353 million or $1.08 per share after-tax). Earnings from continuing operations, before deducting the restructuring costs in both years and the charge for extinguishment of certain financial instruments in 1994, were down approximately $109 million in 1994 when compared with 1993. Earnings for 1994 were adversely impacted by premium costs associated with currency hedges, while earnings for 1993 benefited from gains on currency hedges. The benefits to 1994 earnings from continuing operations from higher volumes and manufacturing productivity were more than offset by the adverse effects of cost escalation, lower effective selling prices, incremental charges associated with the review of the carrying value of all assets, increased levels of marketing and administrative activity, smaller gains from the sales of investments and a higher effective tax rate.
On December 31, 1993, the Company distributed to its shareowners its worldwide chemical business, which consisted of Eastman Chemical Company operations. Results for Eastman Chemical Company operations are being reported as discontinued operations and results for prior periods have been restated. Earnings from discontinued operations include allocations of interest and taxes to the Chemicals segment and transaction costs associated with the spin-off.
The Company posted sales from continuing operations of $12,670 million in 1993. Earnings from continuing operations for 1993 were $644 million ($1.95 per share) compared with earnings of $845 million ($2.60 per share) in 1992. Earnings from continuing operations were significantly reduced by restructuring costs in both years. The restructuring costs for continuing operations were $495 million ($353 million or $1.08 per share after-tax) in 1993 compared with $219 million ($140 million or $.43 per share after-tax) in 1992. Earnings from continuing operations, before deducting restructuring costs in both years, increased one percent in 1993 when compared with 1992. Earnings benefited from increased unit volumes, lower marketing and administrative activity, lower research and development activity, manufacturing productivity and lower interest expense; but were adversely affected by cost escalation, lower effective selling prices, higher retiree healthcare costs associated with the change in accounting for certain postretirement benefits, smaller gains from the sales of investments, and the unfavorable effects of foreign currency rate changes. Earnings for 1993 benefited from gains on currency hedges while earnings for 1992 were adversely impacted by premium costs associated with currency hedges. Net earnings for 1993 were reduced by an extraordinary charge of $14 million after-tax ($.04 per share) related to the early extinguishment of debt, while net earnings for 1992 benefited by approximately $75 million after-tax ($.23 per share) from gains on the sales of investments, including the sale of Eastman Kodak Credit Corporation (EKCC).
Net earnings for 1993 benefited by $23 million ($.07 per share) from discontinued operations compared with a benefit of $149 million ($.46 per share) in 1992. Earnings from discontinued operations for 1993 were lower when compared with 1992, as the benefits from higher unit volumes and higher effective selling prices were more than offset by cost escalation, higher retiree healthcare costs associated with the change in accounting for certain postretirement benefits, a provision for environmental costs, transaction costs associated with the spin-off of the Company's worldwide chemical business, the unfavorable effects of foreign currency rate changes, and restructuring costs of $55 million pre-tax ($34 million or $.10 per share after-tax).
The 1993 net loss was due to an after-tax charge of $2.17 billion ($6.60 per share) associated with the adoption of SFAS No. 106, Employers' Accounting for Postretirement Benefits Other Than Pensions, and SFAS No. 112, Employers' Accounting for Postemployment Benefits effective as of January 1, 1993. Net earnings for 1992 benefited by $152 million ($.47 per share) from the adoption of SFAS No. 109, Accounting for Income Taxes, effective as of January 1, 1992.
- - ------------------------------------------------------------------------------
SALES
Worldwide sales from continuing operations in 1994 were up seven percent when compared with a year ago primarily due to higher unit volumes. Sales for the Consumer Imaging segment increased significantly, while Commercial Imaging segment sales were up slightly.
Worldwide sales from continuing operations for 1993 were down two percent when compared with 1992, as slight increases in unit volumes were more than offset by the unfavorable effects of foreign currency rate changes and lower effective selling prices. The Consumer Imaging and Commercial Imaging segments both recorded a slight decline when compared with 1992.
In the Consumer Imaging segment, 1994 sales to customers inside the U.S. were up significantly over a year ago due to volume gains and the inclusion of revenues from Qualex, which was acquired in August of 1994. Excluding sales of Qualex, sales to customers in the U.S. posted a moderate increase. Sales to customers outside the U.S. in 1994 recorded good increases over 1993 as significant volume gains and the favorable effects of foreign currency rate changes were partially offset by lower effective selling prices. Worldwide volume increases were led by Ektacolor papers, Kodacolor 35mm films and single-use cameras.
In the Consumer Imaging segment, sales to customers inside the U.S. in 1993 were up one percent over sales for 1992, as slight increases in unit volumes were partially offset by lower effective selling prices. Outside the U.S., sales decreased in 1993, as moderate increases in unit volumes were more than offset by the unfavorable effects of foreign currency rate changes and lower effective selling prices. Worldwide volume gains were led by Kodacolor 35mm films, single-use cameras and Ektacolor papers.
In the Commercial Imaging segment, 1994 sales to customers in the U.S. were up one percent over a year ago as volume increases were partially offset by lower effective selling prices. Sales to customers outside the U.S. in 1994 increased moderately over a year ago as moderate volume gains and the favorable effects of foreign currency rate changes were partially offset by lower effective selling prices. Worldwide sales increases were led by printing and professional imaging, motion picture and television imaging, and health sciences products.
In the Commercial Imaging segment, 1993 sales comparisons with 1992 for customers in the U.S. and outside the U.S. were adversely affected by lower effective selling prices and the inclusion in 1992 of revenues from divested units. In addition, outside the U.S., volume increases for continuing businesses were more than offset by the unfavorable effects of foreign currency rate changes.
Earnings from operations for 1994 are shown after deducting restructuring costs of $190 million for Consumer Imaging and $150 million for Commercial Imaging. Earnings from operations for 1993 are shown after deducting restructuring costs of $141 million for Consumer Imaging and $354 million for Commercial Imaging. Earnings from operations for 1992 are shown after deducting restructuring costs of $58 million for Consumer Imaging and $161 million for Commercial Imaging.
Segment information is reported on pages 44 through 46, Notes to Financial Statements.
- - ------------------------------------------------------------------------------
EARNINGS
Operating earnings from continuing operations for the Consumer Imaging and Commercial Imaging segments were adversely affected by restructuring costs of $340 million in 1994, $495 million in 1993 and $219 million in 1992. The 1994 restructuring costs represent severance and other termination benefits for approximately 4,350 personnel and exit costs related to the realignment of Kodak's worldwide manufacturing, marketing, administrative and photofinishing operations. The 1993 restructuring costs represent the cost of separation benefits for a cost reduction program expected to reduce worldwide employment by approximately 9,000 personnel and the cost of closing a facility in Germany that manufactured a component for the Company's ink jet printing business. The restructuring costs in 1992 included costs of an early retirement plan, the restructuring of non-U.S. sensitized manufacturing and photofinishing operations, and the Company's exit from non-strategic businesses.
Operating earnings from continuing operations for the Consumer Imaging and Commercial Imaging segments for 1994 and 1993 were adversely impacted, when compared with 1992 earnings, by higher retiree healthcare costs associated with the change in accounting for certain postretirement benefits effective January 1, 1993.
Consumer Imaging segment operating earnings were adversely affected by restructuring costs in 1994, 1993 and 1992 of $190 million, $141 million and $58 million, respectively. Operating earnings for 1994 were essentially level with 1993, before deducting restructuring costs in both years. Earnings for 1994 benefited from higher volumes and manufacturing productivity, but were adversely affected by higher levels of marketing and administrative activity, cost escalation and lower effective selling prices. In addition, 1994 earnings were reduced by premium costs associated with strategic currency hedges, while 1993 earnings benefited from gains on strategic currency hedges. Operating earnings decreased in 1993 when compared with 1992, before deducting restructuring costs in both years, as the benefits from increased unit volumes, lower marketing and administrative activity and manufacturing productivity were more than offset by lower effective selling prices, cost escalation and the unfavorable effects of foreign currency rate changes. Earnings for 1993 benefited from gains on strategic currency hedges while earnings for 1992 were adversely impacted by premium costs associated with strategic currency hedges.
The Commercial Imaging segment operating earnings were adversely affected by restructuring costs in 1994, 1993 and 1992 of $150 million, $354 million and $161 million, respectively. Operating earnings for 1994 were lower when compared to 1993, before deducting restructuring costs in both years, as the benefits from manufacturing productivity, higher volumes and lower research and development activity were more than offset by cost escalation and lower effective selling prices. In addition, earnings for 1994 were reduced by premium costs associated with strategic currency hedges, while 1993 earnings included gains from strategic currency hedges. Operating earnings improved sharply in 1993 when compared with 1992, before deducting restructuring costs in both years, as the benefits from manufacturing productivity, lower marketing and administrative activity and lower research and development activity were only partially offset by cost escalation, the unfavorable effects of foreign currency rate changes and lower effective selling prices. Earnings for 1993 benefited from gains on strategic currency hedges, while earnings for 1992 were adversely affected by premium costs associated with strategic currency hedges.
Research and development expenditures for continuing operations amounted to $859 million in 1994, compared with $864 million in 1993 and $988 million in 1992. Research and development expenditures in 1994 were essentially level with 1993 as cost escalation offset the benefits of lower activity levels. Research and development expenditures in 1993 were significantly below 1992 as the benefits from lower activity levels were only partially offset by cost escalation. Amortization of goodwill for continuing operations amounted to $47 million in 1994, $29 million in 1993 and $23 million in 1992. The increase in amortization in 1994 was primarily due to the acquisition of Qualex. Advertising and sales promotion expenses for continuing operations were $744 million in 1994, $646 million in 1993 and $725 million in 1992. Other marketing and administrative expenses for continuing operations totaled $2,967 million in 1994, $2,774 million in 1993 and $3,000 million in 1992. Increases in advertising and sales promotion, and other marketing and administrative expenses in 1994 resulted from cost escalation, higher activity levels, the unfavorable effects of foreign currency rate changes and the acquisition of Qualex. Decreases in advertising and sales promotion, and other marketing and administrative expenses in 1993 when compared with 1992 resulted from the benefit of lower activity levels and the favorable effects of foreign currency rate changes, partially offset by cost escalation.
Earnings from equity interests and other revenues were $130 million in 1994, $203 million in 1993 and $342 million in 1992. The amounts for 1993 were higher than 1994 due to larger gains from the sales of investments and other items in 1993. The results for 1992 were higher than 1994 and 1993 due to larger gains from the sales of investments in 1992, including the sale of EKCC.
Interest expense of $142 million in 1994 was lower than the $175 million incurred in 1993 primarily due to lower levels of borrowings. Interest expense in 1993 was lower than the $247 million incurred in 1992 as a result of lower effective interest rates. Interest expense of approximately $390 million in 1994 and $586 million in 1993 and 1992, and capitalized interest of approximately $7 million in 1994 and $51 million in 1993 and 1992 were allocated to discontinued operations.
The increase in other costs in 1994 when compared with 1993 is primarily due to the inclusion in 1994 of $110 million of charges associated with the extinguishment of certain financial instruments. The increase in other costs in 1993 when compared with 1992 is primarily due to higher net losses in 1993 from foreign exchange transactions and the translation of net monetary items in highly inflationary economies.
The Company has a program in place to manage foreign currency risk. The Company currently uses foreign currency option contracts to hedge its exposure to changes in foreign currency exchange rates for anticipated sales and purchases for certain foreign affiliates and probable anticipated export sales. Currency changes against the U.S. dollar favorably affected 1994 sales from continuing operations by $135 million and unfavorably affected 1993 sales from continuing operations by $490 million. These effects were partially offset by premium costs of $86 million and gains of $73 million from strategic currency hedges in 1994 and 1993, respectively. The Company has also entered into foreign currency contracts to hedge a portion of its transactions in foreign currency denominated receivables and payables. The effect of these hedges and the gains and losses on transaction exposures was a loss of $46 million in 1994, a loss of $44 million in 1993 and a gain of $40 million in 1992.
The effective tax rates for continuing operations were 44.7% in 1994, 40.2% in 1993 and 38.7% in 1992. The higher rates in 1994 and 1993 are primarily due to higher operating losses and restructuring costs in jurisdictions outside the U.S. for which tax benefits cannot be taken.
- - ------------------------------------------------------------------------------
- - ------------------------------------------------------------------------------
CASH DIVIDENDS
Total cash dividends of approximately $537 million ($.40 per share each quarter), $657 million ($.50 per share each quarter) and $650 million ($.50 per share each quarter) were declared in 1994, 1993 and 1992, respectively.
The lower dividends in 1994 were due to the spin-off of the Eastman Chemical Company operations at year-end 1993. As a result of the spin-off, the Company's shareowners received one share of Eastman Chemical Company stock for every four shares of Kodak common stock.
- - ------------------------------------------------------------------------------
FINANCIAL POSITION
Cash and cash equivalents increased to $2,020 million at year-end 1994 from $1,635 million at year-end 1993. In connection with the spin-off of the worldwide chemical business at year-end 1993, the Company borrowed $1,800 million in December 1993, which subsequently was assumed by the worldwide chemical business on December 31, 1993. The proceeds from the borrowings, which were retained by Kodak, were used to retire other borrowings in 1994.
Cash and cash equivalents at year-end 1994 included a $1,550 million note received on December 31, 1994 when the Company completed the sale of its household products business of L&F Products. The note was paid in cash to the Company on January 3, 1995. The cash and cash equivalents at year-end 1994 is expected to be used in 1995 by the Company to pay taxes associated with the divestiture of the non-imaging health businesses and for normal operations.
The Company used $8,142 million from the divestiture, short-term borrowings and operations to extinguish $6,598 million (net carrying amount) of borrowings, $7,800 million (notional amount) of financial instruments, a $292 million master lease program and $200 million sale of receivables programs.
Approximately one-third of the restructuring costs recorded by the Company in 1994 is for separation benefits for approximately 4,350 personnel leaving the Company. Most of these benefits will be paid during 1995 from operating cash flows. Approximately $40 million represents future cash payments to be made over several years for noncancelable leases. The remainder of the 1994 restructuring costs represents the non-cash write-offs of assets for facility closures and business exits, most of which will be completed during 1995. After-tax savings from the 1994 restructuring program are expected to be approximately $100 million in 1995 and $125 million annually beginning in 1996 as a result of lower costs for salaries, benefits, depreciation and leasing. Approximately three-fourths of the restructuring costs recorded by the Company in 1993 represented the cost of separation benefits for personnel leaving under a workforce reduction program. Most of these benefits were paid during 1993 and 1994 from operating cash flows. The remainder of the 1993 restructuring costs were associated with the closure of a facility in Germany, which was completed in 1994. Approximately $40 million of these costs is for separation benefits to be paid to former employees over several years. The remainder of the costs represents the non-cash write-offs of assets associated with the facility closure. An analysis of restructuring costs for the last three years is provided in the Restructuring Costs note on pages 38 and 39.
The Company has access to a $2.5 billion revolving credit facility expiring in May, 1999. The Company also has a shelf registration statement on Form S-3 for debt securities with an available balance of $2.2 billion.
Projected operating cash flows are expected to be adequate to support normal business operations, planned capital expenditures and dividend payments in 1995.
- - ------------------------------------------------------------------------------
ENVIRONMENTAL PROTECTION
During 1994, expenditures for pollution prevention and waste treatment for continuing operations at various manufacturing facilities totaled $122 million. These costs included $83 million of recurring costs associated with managing hazardous substances and pollution in ongoing operations, $36 million of capital expenditures to limit or monitor hazardous substances or pollutants, and $3 million of mandated expenditures to remediate previously contaminated sites. The Company expects these recurring and remediation costs to increase slightly and capital to increase significantly in the near future. While these costs will continue to be significant cash outflows for the Company, it is not expected that these costs will have an impact materially different from 1994's environmental expenditures on the Company's financial position, results of operations or cash flows.
In October 1994, the Company, the Environmental Protection Agency (EPA), and the U.S. Department of Justice announced the settlement of a civil complaint alleging noncompliance by the Company with federal environmental regulations at the Company's Kodak Park manufacturing site in Rochester, New York. The Company paid a penalty of $5 million. A Consent Decree was signed under which the Company is subject to a Compliance Schedule by which the Company will improve its waste characterization procedures, upgrade one of its incinerators and evaluate and upgrade its industrial sewer system over a 12-year period. The expenditures that may be required to complete this program cannot currently be reasonably estimated since upgrade plans have not been finalized and must be developed on an ongoing basis. Further, most costs associated with the program will be for capital expenditures.
The Company has reviewed a Resource Conservation and Recovery Act (RCRA) Facility Assessment (RFA) pertaining to the Company's Kodak Park site in Rochester, New York and has completed a broad-based assessment of the site in response to the RFA. While future expenditures associated with any remediation activities could be significant, it is not possible to reasonably estimate those expenditures until remedial investigation and feasibility studies are performed.
The Clean Air Act Amendments were enacted in 1990. The Company may be required to incur significant costs, primarily capital in nature, over a period of several years to comply with the provisions of this Act. The expenditures that may be required cannot currently be reasonably estimated since either implementing regulations have not been issued or compliance plans have not been finalized.
- - ------------------------------------------------------------------------------
The Company was a party to a master lease agreement whereby it leased equipment with a right to buy the equipment at anytime at fair market value. This agreement was terminated by the Company in 1994 and cash was paid in the amount of approximately $292 million to purchase the equipment previously leased.
- - ------------------------------------------------------------------------------
Market Price Data for 1993 is shown prior to the spin-off of Eastman Chemical Company operations at year-end 1993. As a result of the spin-off, the Company's shareowners received one share of Eastman Chemical Company stock for every four shares of Kodak common stock.
- - ------------------------------------------------------------------------------
SUMMARY OF OPERATING DATA
A summary of operating data for 1994 and for the 4 years prior is shown on page 49.
- - ------------------------------------------------------------------------------
ITEM 8.




ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
MANAGEMENT'S RESPONSIBILITY FOR FINANCIAL STATEMENTS
Management is responsible for the preparation and integrity of the consolidated financial statements and related notes which appear on pages 19 through 48. These financial statements have been prepared in accordance with generally accepted accounting principles and of necessity include some amounts that are based on management's best estimates and judgments. The Company's accounting systems include extensive internal controls designed to provide reasonable assurance of the reliability of its financial records and the proper safeguarding and use of its assets. Such controls are based on established policies and procedures, are implemented by trained, skilled personnel with an appropriate segregation of duties, and are monitored through a comprehensive internal audit program. The Company's policies and procedures prescribe that the Company and all employees are to maintain the highest ethical standards and that its business practices throughout the world are to be conducted in a manner which is above reproach. The consolidated financial statements have been audited by Price Waterhouse LLP, independent accountants, who were responsible for conducting their audits in accordance with generally accepted auditing standards. Their resulting report is shown below. The Board of Directors exercises its responsibility for these financial statements through its Audit Committee, which consists entirely of non-management Board members. The independent accountants and internal auditors have full and free access to the Audit Committee. The Audit Committee meets periodically with the independent accountants and the Director of Corporate Auditing of the Company, both privately and with management present, to discuss accounting, auditing and financial reporting matters.
George M. C. Fisher Harry L. Kavetas Chairman of the Board, President and Executive Vice President and Chief Executive Officer Chief Financial Officer January 30, 1995 January 30, 1995
REPORT OF INDEPENDENT ACCOUNTANTS
To the Board of Directors and Shareowners of Eastman Kodak Company
In our opinion, the accompanying consolidated financial statements listed in the index appearing under Item 14(a)(1) and (2) on page 63 of this Annual Report on Form 10-K present fairly, in all material respects, the financial position of Eastman Kodak Company and subsidiary companies at December 31, 1994 and 1993, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 1994, in conformity with generally accepted accounting principles. These financial statements are the responsibility of the Company's management; our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with generally accepted auditing standards which require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for the opinion expressed above.
As discussed in the Nonpension Postretirement and Postemployment Benefits note, the Company changed its method of accounting for certain postretirement benefits and other postemployment benefits in 1993. As discussed in the Income Taxes note, the Company changed its method of accounting for income taxes in 1992.
PRICE WATERHOUSE LLP New York, New York January 30, 1995
The notes on pages 24 through 48 are an integral part of these financial statements.
The notes on pages 24 through 48 are an integral part of these financial statements.
* There are 100 million shares of $10 par value preferred stock authorized, none of which have been issued.
The notes on pages 24 through 48 are an integral part of these financial statements.
The notes on pages 24 through 48 are an integral part of these financial statements.
Eastman Kodak Company and Subsidiary Companies NOTES TO FINANCIAL STATEMENTS
SIGNIFICANT ACCOUNTING POLICIES
BASIS OF CONSOLIDATION
The consolidated financial statements include the accounts of Eastman Kodak Company and its majority owned subsidiary companies (the Company). Intercompany transactions are eliminated and net earnings are reduced by the portion of the earnings of subsidiaries applicable to minority interests.
FOREIGN CURRENCY
For most subsidiaries and branches outside the U.S., the local currency is the functional currency and translation adjustments are accumulated in a separate component of shareowners' equity.
For subsidiaries and branches that operate in U.S. dollars or whose economic environment is highly inflationary, the U.S. dollar is the functional currency and gains and losses that result from translation are included in earnings. The losses from translation were $7 million in 1994, $10 million in 1993 and $31 million in 1992.
The Company hedges certain foreign currency transactions, firm foreign currency commitments, anticipated sales and purchases for certain foreign affiliates and probable anticipated export sales by entering into forward exchange contracts and currency options. Gains and losses associated with currency rate changes on forward contracts hedging foreign currency transactions are recorded currently in earnings. The effect from foreign currency transactions, including related hedging activities, was a loss of $46 million in 1994, a loss of $44 million in 1993 and a gain of $40 million in 1992. Gains and losses related to hedges of firm commitments or probable anticipated transactions are deferred and recognized in earnings or as adjustments of carrying amounts when the transaction occurs.
CASH EQUIVALENTS
All highly liquid investments with an original maturity of three months or less at date of purchase are considered to be cash equivalents. At December 31, 1994, included in "cash and cash equivalents" is a $1,550 million note received in connection with the sale of the household products business which had a maturity of four days.
INVENTORIES
Inventories are valued at cost, which is not in excess of market. The cost of most inventories in the U.S. is determined by the "last-in, first-out" (LIFO) method. The cost of other inventories is determined by the "first-in, first-out" (FIFO), or average cost method.
PROPERTIES
Properties are recorded at cost reduced by accumulated depreciation. When assets are retired, or otherwise disposed of, the cost of such assets and the related accumulated depreciation are removed from the Company's accounts and any profit or loss is reflected in earnings. Depreciation expense is provided based on historical cost and estimated useful lives. The Company generally uses the straight-line method for calculating the provision for depreciation.
GOODWILL
Goodwill is charged to earnings on a straight-line basis over the period estimated to be benefited, not exceeding fifteen years for continuing operations. The Company regularly assesses the recoverability of unamortized amounts of goodwill utilizing relevant cash flow and profitability information.
INVESTMENTS IN DEBT AND EQUITY SECURITIES AND JOINT VENTURES
In accordance with Statement of Financial Accounting Standards (SFAS) No. 115, Accounting For Certain Investments in Debt and Equity Securities, which was adopted on January 1, 1994, the Company has classified applicable investments into the categories of "available-for-sale" and "held-to-maturity". The adoption of this standard did not have a material effect on the Company's results of operations or financial position. Investments classified as "available-for-sale" or as "held-to-maturity" are included in either "marketable securities" or "long-term receivables and other noncurrent assets" based on the maturity date of the investment.
Included in "long-term receivables and other noncurrent assets" are investments which are managed as integral parts of the Company's segment operations and are accounted for on an equity basis. The Company's share of the earnings of these joint ventures is included in consolidated revenues and in earnings from operations for the related segments.
REVENUE
Revenue is recognized from film and equipment sales (including sales-type leases for equipment) when the product is shipped; from maintenance and service contracts over the contractual period, or as the services are performed; from rentals under operating leases in the month in which they are realized; and from financing transactions at level rates of return over the term of the lease or receivable.
ADVERTISING
Advertising costs are expensed as incurred and included in "marketing and administrative expenses". Advertising expenses amounted to $744 million, $646 million and $725 million for 1994, 1993 and 1992, respectively.
ENVIRONMENTAL COSTS
Environmental expenditures that relate to current operations are expensed or capitalized, as appropriate. Remediation costs that relate to an existing condition caused by past operations are accrued when it is probable that these costs will be incurred and can be reasonably estimated.
NONPENSION POSTRETIREMENT AND POSTEMPLOYMENT BENEFITS
Postemployment benefits for former or inactive employees, excluding retirement benefits, are accounted for under the provisions of SFAS No. 112, Employers' Accounting for Postemployment Benefits, effective January 1, 1993. Thereafter, the cost of benefits (principally long-term disability coverage and certain severance benefits) are accrued over an employee's service life.
Postretirement benefits other than pensions (principally healthcare and life insurance) are accounted for under the provisions of SFAS No. 106, Employers' Accounting for Postretirement Benefits Other Than Pensions, effective January 1, 1993. Thereafter, the estimated cost of retiree benefit payments is accrued during an employee's active service life. Prior to January 1, 1993, the Company expensed the cost of these benefits on a "pay-as-you-go" basis. Prior service costs resulting from amendments to postretirement healthcare plans are amortized over the average remaining service period to full eligibility of the active employees.
INCOME TAXES
Income tax expense is based on reported earnings before income taxes. Deferred income taxes reflect the impact of temporary differences between the amounts of assets and liabilities recognized for financial reporting purposes and such amounts recognized for tax purposes. Deferred taxes are measured by applying currently enacted tax laws.
EARNINGS PER SHARE
Primary earnings per share are computed on the basis of the weighted average number of common shares outstanding. Fully diluted earnings per share assume the conversion of convertible debentures (with an increase in net income for the after-tax interest savings) and the issuance of common stock related to stock options.
RECLASSIFICATIONS
Certain reclassifications of 1993 and 1992 financial statement and related footnote amounts have been made to conform with the 1994 presentation.
- - ------------------------------------------------------------------------------
DISCONTINUED OPERATIONS
In May 1994, the Company announced its intent to divest the following non-imaging health businesses: the pharmaceutical and consumer health businesses of Sterling Winthrop Inc., the household products and do-it-yourself products businesses of L&F Products and the Clinical Diagnostics Division. These businesses are reported as discontinued operations. Accordingly, the financial statement information for 1993 and 1992 related to these businesses has been presented in the Consolidated Statement of Financial Position as "net assets of discontinued operations", and in the "discontinued operations" line of the Consolidated Statement of Earnings. The noncurrent asset classification is consistent with the Company's use of most of the proceeds to reduce long-term borrowings. Prior periods also include the allocation of interest expense to discontinued operations by reference to the interest expense on indebtedness repaid from the net sales proceeds.
On various dates during the fourth quarter of 1994, the Company consummated transactions divesting these businesses. The total cash or cash equivalent proceeds from the sales amounted to $7,858 million as follows: pharmaceutical business of Sterling Winthrop Inc. $1,675 million in cash; consumer health business of Sterling Winthrop Inc. $2,925 million in cash; household products business of L&F Products, a $1,550 million note received on December 31, 1994, and paid in cash on January 3, 1995; do-it-yourself products business of L&F Products $700 million in cash; Clinical Diagnostics Division $1,008 million in cash. In addition, the Company is actively negotiating with potential buyers for its pharmaceutical research and development facility and its NanoSystems unit and anticipates completing these transactions in 1995.
Amounts related to the remaining assets held for sale at December 31, 1994, are recorded at their net realizable value, and included in "other" current assets. Liabilities retained and related to the businesses sold amounted to approximately $2,137 million at December 31, 1994. These liabilities include "payables" of $296 million and "taxes-income and other" of $1,530 million in current liabilities and $311 million of "other long-term liabilities".
In the first half of 1994, the discontinued health businesses recorded sales of $1,800 million, loss before income taxes of $84 million (including approximately $230 million of allocated interest expense), benefit for income taxes of $3 million, and an after-tax loss of $81 million.
In the second half of 1994, the "phase-out period", the following financial data was recorded:
(in millions)
Sales $1,375 ====== Gross proceeds from sales of businesses $7,858 Loss before income taxes* (86) Net assets of businesses sold 5,531 Income and other taxes 1,509 Other costs and expenses 382 ------ Net gain on sales of businesses 350 Less: After-tax loss prior to measurement date (81) ------ Earnings from discontinued operations $ 269 ====== *Including approximately $163 million of allocated interest expense.
The 1994 effective tax rate for discontinued health businesses was 85%. The rate differs from the U.S. federal statutory tax rate of 35% due to the required form of the consumer health business divestiture. The stock sale of this business resulted in a significant tax loss for which no benefit was allowed in accordance with IRS regulations.
Summarized results of the discontinued health businesses for 1993 and 1992 are as follows:
(in millions) 1993 1992
Sales $3,694 $3,553 ====== ======
Loss before income taxes* $ (221) $ (161) Benefit for income taxes (52) (43) ------ ------ Loss before cumulative effect of changes in accounting principle $ (169) $ (118) ====== ======
*Including approximately $460 million of allocated interest expense for 1993 and 1992.
The effective tax rates for discontinued health businesses were 24% and 27% for 1993 and 1992, respectively. The rates differ from the applicable U.S. federal statutory income tax rates primarily due to the allocation of tax effects of non-deductible goodwill to discontinued operations.
Net assets of the discontinued health businesses at December 31, 1993 are comprised of the following:
Dec. 31, (in millions) 1993
Current assets $1,164 Land, buildings and equipment, net 1,339 Goodwill 3,900 Other assets 382 ------ Total assets 6,785 ------ Current liabilities 857 Long-term borrowings 126 Other liabilities 453 ------ Total liabilities 1,436 ------ Net assets $5,349 ======
In June 1993, the Company announced a plan to spin-off its Eastman Chemical Company operations, which was completed in December 1993. Summarized results of the chemicals segment for 1993 and 1992 including allocations of interest expense, taxes and transaction costs associated with the spin-off are as follows:
(in millions) 1993 1992
Sales $3,695 $3,638 ====== ====== Earnings before income taxes $ 267 $ 383 Provision for income taxes 75 116 ------ ------ Earnings before cumulative effect of changes in accounting principle $ 192 $ 267 ====== ======
The effective tax rates for discontinued chemicals operations were 28% and 30% in 1993 and 1992, respectively. The rates differ from the applicable U.S. federal statutory income tax rates primarily due to the allocation of foreign and state tax benefits to discontinued chemicals operations.
- - ------------------------------------------------------------------------------
CASH FLOW INFORMATION
Cash paid for interest and income taxes for continuing operations was:
(in millions) 1994 1993 1992
Interest, net of portion capitalized of $28, $35 and $43 $342 $217 $191
Income taxes 309 435 301
The following transactions are not reflected in the Consolidated Statement of Cash Flows: certain assets acquired and liabilities assumed as a result of the Qualex acquisition and the debentures and notes called by the Company resulting in the Company's common stock being issued. Except for $157 million of cash transferred with the Eastman Chemical Company spin-off in 1993, the spin-off was a non-cash transaction and is also not reflected in the Consolidated Statement of Cash Flows.
- - ------------------------------------------------------------------------------
MARKETABLE SECURITIES AND NONCURRENT INVESTMENTS
The following table summarizes the balances of investments at December 31, 1994 and activity during 1994 in accordance with SFAS No. 115. Comparable data is not presented for 1993 because SFAS No. 115 was adopted on a prospective basis, beginning January 1, 1994.
(in millions)
Held-to-Maturity
Description Maturity Amortized Cost
Certificates of deposit 1995-1999 $ 66 Collateralized mortgage obligations 1996 20 Commercial paper 1995 3 Government agency 1999-2006 1 Municipal bonds 2002-2003 22 Bank notes 1998-1999 12 ---- $124 Available-for-Sale ====
Description Cost
Equity Securities $ 27 ====
The fair value of held-to-maturity and available-for-sale securities approximates cost. Held-to-maturity securities consist of $21 million "marketable securities" and $103 million "long-term receivables and other noncurrent assets". Available-for-sale securities consist of $27 million of "marketable securities".
During 1994, proceeds from the sale of available-for-sale securities were $249 million. An $8 million loss was realized from the sale of these securities, using specific identification to determine the cost of securities sold.
Marketable securities (principally U.S. government securities and time deposits with commercial financial institutions) presented at December 31, 1993, are shown at cost which approximates market value. - - ------------------------------------------------------------------------------
RECEIVABLES (in millions) 1994 1993
Trade receivables $2,644 $2,374 Miscellaneous receivables 420 443 ------ ------ Total (net of allowances of $120 and $92) $3,064 $2,817 ====== ======
The Company sells to customers in a variety of industries, markets and geographies around the world. Receivables arising from these sales are generally not collateralized. Adequate provisions have been recorded for uncollectible receivables. There are no significant concentrations of credit risk for receivables.
The Company terminated two agreements to sell undivided interests in trade accounts receivable during 1994 for approximately $200 million. - - ------------------------------------------------------------------------------
INVENTORIES (in millions) 1994 1993
At FIFO or average cost (approximates current cost)
Finished goods $1,071 $1,123 Work in process 539 620 Raw materials and supplies 528 489 ------ ------ 2,138 2,232 Reduction to LIFO value (658) (700) ------ ------
$1,480 $1,532 ====== ======
Inventories valued on the LIFO method are about 60 percent of total inventories in each of the years. - - ------------------------------------------------------------------------------
At December 31, 1993 and 1992, the Company was a party to a master lease agreement whereby it leased equipment with a right to buy the equipment at any time at fair market value. This agreement was terminated by the Company in 1994 and cash was paid in the amount of approximately $292 million to purchase equipment previously leased, which is reflected in additions.
- - ------------------------------------------------------------------------------
- - ------------------------------------------------------------------------------
- - ------------------------------------------------------------------------------
The weighted average interest rate on short-term bank borrowings by subsidiaries outside the U.S. was 4.6% in 1994 and 4.8% in 1993.
- - ------------------------------------------------------------------------------
Annual maturities (in millions) of long-term borrowings outstanding at December 31, 1994, are as follows: 1995: $0; 1996: $0; 1997: $245; 1998: $0; 1999: $78; 2000 and beyond: $337.
Over the past several years, the Company had a program in place to manage interest rates related to its long-term borrowings portfolio. In connection with this program, the Company utilized various interest rate derivatives in order to achieve an acceptable overall interest rate on its portfolio of long-term borrowings. During 1994, and in connection with the Company's debt paydown program described below, all interest rate derivatives held in the Company's portfolio were extinguished.
In 1994, the Company tendered, defeased and called a total of $6,043 million (net carrying amount) of long-term borrowings and extinguished approximately $7,800 million (notional amount) of derivatives. The cash paid to the holders of long-term borrowings and derivatives over the respective net carrying amounts of such instruments was recorded as an extraordinary loss of $266 million after-tax ($367 million pre-tax) on the early extinguishment of debt. The effective tax rate for the extraordinary loss of 27% was unfavorably affected by the allocation of foreign tax credit impacts. In addition to the extraordinary loss, a $110 million pre-tax loss was recorded in "other costs" for certain financial instruments related to other programs.
The following table includes the long-term borrowings and related net carrying amounts extinguished through these actions:
(in millions) Maturity Net Carrying Tendered Dates Amount
7.25% - 8.9% 1997 - 1999 $ 293 9.2% - 9.95% 1995 - 2018 2,214 10.0% - 10.375% 1995 - 2001 207
Defeased
9.2% notes 1995 500 10 3/8% Eurobonds 1995 81 9 1/8% notes 1998 525 9 1/2% notes 2000 232 10.0% notes 2001 122 9 3/4% notes 2004 91 9 7/8% notes 2004 104
Called
9 5/8% notes 1999 274 6 3/8% convertible subordinated debentures 2001 275 Zero coupon convertible subordinated debentures 2011 1,125 ------
Total $6,043 ======
The total net carrying amount of all derivatives and long-term borrowings extinguished in 1994 amounted to approximately $6,725 million; certain amounts were previously recorded as "long-term borrowings" and "other long-term liabilities".
The cash paid to counterparties to extinguish the Company's derivative obligations and for related transaction costs amounted to $921 million. The tender offer resulted in $2,901 million of cash being paid to debt holders and for related transaction costs.
The in-substance defeasance was achieved by purchasing investment instruments under an arrangement consistent with the provisions of SFAS No. 76, Extinguishment of Debt. The Company believes that the investments placed in the defeasance trust will be sufficient to satisfy all future debt service requirements for the defeased debt instruments. The total cash paid for the investments placed in the defeasance trust, including transaction costs, amounted to $1,692 million.
The debentures and notes that were called by the Company resulted in a combination of approximately 8.3 million shares (6.3 million common shares and 2 million treasury shares) of the Company's common stock being issued (an increase of $353 million in common stock and additional capital paid in) and $1,349 million in cash being paid to debenture holders.
The extraordinary loss recorded in 1993 was the result of the early extinguishment of the 8 5/8% debentures due 2016 and zero coupon exchangeable senior debentures due 2006.
The Company has a $2,500 million unused revolving credit facility established in 1994 and expiring in May, 1999 which is available to support the Company's commercial paper borrowings. If unused, it has a commitment fee of $2.5 million per year. Interest on amounts borrowed under this facility is at rates based on spreads above certain reference rates. The Company also has a shelf registration statement on Form S-3 for debt securities with an available balance of $2.2 billion.
- - ------------------------------------------------------------------------------
OTHER LONG-TERM LIABILITIES (in millions) 1994 1993
Interest rate swap and option agreements $ - $ 654 Deferred compensation 93 77 Liabilities related to sale of non-imaging health businesses 311 - Other 386 452 ------ ------ Total $ 790 $1,183 ====== ======
- - ------------------------------------------------------------------------------
COMMITMENTS AND CONTINGENCIES
Expenditures for pollution prevention and waste treatment for continuing operations at various manufacturing facilities totaled $122 million, $134 million and $137 million in 1994, 1993 and 1992, respectively. These expenditures included the following elements:
1994 1993 1992 (in millions)
Recurring costs for managing hazardous substances and pollution $ 83 $100 $ 92
Capital expenditures to limit or monitor hazardous substances and pollutants 36 32 45
Site remediation costs 3 2 - ---- ---- ----
Total $122 $134 $137 ==== ==== ====
At December 31, 1994 and 1993, the Company's accrual for environmental remediation costs amounted to $108 million and $84 million, respectively.
In October 1994, the Company, the Environmental Protection Agency (EPA), and the U.S. Department of Justice announced the settlement of a civil complaint alleging noncompliance by the Company with federal environmental regulations at the Company's Kodak Park manufacturing site in Rochester, New York. The Company paid a penalty of $5 million. A Consent Decree was signed under which the Company is subject to a Compliance Schedule by which the Company will improve its waste characterization procedures, upgrade one of its incinerators and evaluate and upgrade its industrial sewer system over a 12-year period. The expenditures that may be required to complete this program cannot currently be reasonably estimated since upgrade plans have not been finalized and must be developed on an ongoing basis. Further, most costs associated with the program will be for capital expenditures.
The Company has been designated as a potentially responsible party (PRP) under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended (the Superfund law), or under similar state laws, for environmental assessment and cleanup costs as the result of the Company's alleged arrangements for disposal of hazardous substances at approximately twenty-five Superfund sites. With respect to each of these sites, the Company's actual or potential allocated share of responsibility is small. Furthermore, numerous other PRPs have similarly been designated at these sites and, although the law imposes joint and several liability on PRPs, as a practical matter, costs are shared with other PRPs. Settlements and costs paid by the Company in Superfund matters to date have not been material. Future costs are also not expected to be material to the Company's financial condition or results of operations.
In addition to the foregoing environmental actions, the Company has reviewed a Resource Conservation and Recovery Act (RCRA) Facility Assessment (RFA) pertaining to the Kodak Park site in Rochester, N.Y. and has completed a broad-based assessment of the site in response to the RFA. While future expenditures associated with any remediation activities could be significant, it is not possible to reasonably estimate those expenditures until remedial investigation and feasibility studies are performed.
The Clean Air Act Amendments were enacted in 1990. The Company may be required to incur significant costs, primarily capital in nature, over a period of several years to comply with the provisions of this Act. The expenditures that may be required cannot currently be reasonably estimated since either implementing regulations have not been issued or compliance plans have not been finalized.
The Company has retained certain obligations for environmental remediation matters related to non-imaging health businesses sold in 1994. Actions to fulfill these obligations are not expected to be completed in the near term and costs related to the obligations are included in remediation accruals recorded at December 31, 1994.
The Company has entered into agreements with several companies to provide the Company with products and services to be used in its normal operations. The minimum payments for these agreements are approximately $131 million in 1995, $120 million in 1996, $121 million in 1997, $113 million in 1998, $169 million in 1999 and $14 million in 2000 and thereafter.
The Company has also guaranteed debt and other obligations under agreements with certain affiliated companies and customers. At December 31, 1994, these guarantees totaled approximately $252 million. The Company does not expect that these guarantees will have a material impact on the Company's future financial position or results of operations.
The Company has issued letters of credit in lieu of making security deposits to insure the payment of possible Workers' Compensation claims.
The Company and its subsidiary companies are involved in lawsuits, claims, investigations and proceedings, including product liability, commercial, environmental, and health and safety matters, which are being handled and defended in the ordinary course of business. There are no such matters pending that the Company and its General Counsel expect to be material in relation to the Company's business, financial condition or results of operations. - - ------------------------------------------------------------------------------
FINANCIAL INSTRUMENTS
The following table presents the carrying amounts and the estimated fair values of financial instruments at December 31, 1994 and 1993; ( ) denotes liabilities:
1994 1993 (in millions) Carrying Fair Carrying Fair Amount Value Amount Value
Marketable securities: Current $ 48 $ 48 $ 223 $ 223 Long-term 103 99 108 104 Other investments 67 68 93 93 Long-term borrowings (660) (672) (6,727) (7,378) Interest rate swaps and options - - (864) (1,288) Foreign currency swaps held (74) (74) (31) (43) Foreign currency forwards held 6 6 19 19 Foreign currency options held 25 (25) 50 (19)
The fair values of long-term borrowings were determined by reference to quoted market prices or by obtaining quotes from dealers. Marketable securities and other investments are valued at quoted market prices, except for $66 million and $81 million of equity investments included in other investments at December 31, 1994 and 1993, respectively, which are reflected at their carrying value because it is not practical to estimate fair value as quoted market prices do not exist. The fair values for the remaining financial instuments in the above table are based on dealer quotes and reflect the estimated amounts the Company would pay or receive to terminate the contracts. The carrying value of cash and cash equivalents, receivables, short-term borrowings, and payables approximate their fair values.
The Company, as a result of its global operating and financial activities, is exposed to changes in interest rates and foreign currency exchange rates which may adversely affect its results of operations and financial condition. In seeking to minimize the risks and/or costs associated with such activities, the Company manages exposure to changes in interest rates and foreign currency exchange rates through its regular operating and financing activities and, when deemed appropriate, through the use of financial instruments. The instruments utilized include forward, option and swap agreements. The Company does not utilize financial instruments for trading or other speculative purposes, nor does it utilize leveraged financial instruments.
Furthermore, during 1994 and in connection with the Company's debt paydown program, all interest rate financial instruments were extinguished.
The Company's exposure to changes in foreign currency exchange rates arises from intercompany loans utilized to finance foreign subsidiaries, receivables, payables and firm commitments arising from international transactions. The Company attempts to hedge all such transaction exposures with internal natural offsets to the fullest extent possible and, once these opportunities have been exhausted, through forward and swap agreements with third parties. The Company currently also uses foreign currency option contracts to hedge its exposure to changes in foreign currency exchange rates for anticipated sales and purchases for certain foreign affiliates and probable anticipated export sales. All of the Company's foreign currency forward and option agreements outstanding at December 31, 1994, will mature throughout 1995. In connection with a long-term intercompany loan to a Japanese affiliate, the Company has entered into a currency swap contract to purchase Japanese yen with a contract value of $135 million to be settled in 1997.
Gains and losses related to effective hedges, including hedges of anticipated transactions, are recognized in income as part of, and concurrent with, the hedged transaction. The net unrealized loss deferred on such options as of December 31, 1994 totaled $50 million compared with a net unrealized loss of $69 million in 1993. These amounts represent the gain or loss that would have been recognized had these options been liquidated at market value in their respective years.
The table below summarizes by major currency the notional amounts of foreign currency forward and option contracts in U.S. dollars. Foreign currency amounts are translated at rates current at the reporting date. The "buy" amounts represent the U.S. dollar equivalent of commitments to purchase foreign currencies, and the "sell" amounts represent the U.S. dollar equivalent of commitments to sell foreign currencies.
1994 1993 (in millions) Buy Sell Buy Sell
German marks $117 $133 $ 816 $171 French francs 112 - 218 - British pounds - 99 - - Japanese yen 411 228 871 239 Others 39 240 104 173 ---- ---- ------ ---- $679 $700 $2,009 $583 ==== ==== ====== ====
The Company's financial instrument counterparties are substantial investment or commercial banks with significant experience with such instruments. The Company manages exposure to counterparty credit risk through specific minimum credit standards and diversification of counterparties. The Company has procedures to monitor the credit exposure amounts. While the maximum credit exposure at December 31, 1994 is approximately $100 million, the Company believes that its actual credit risk, in part because of the above practices and procedures, is significantly less.
- - ------------------------------------------------------------------------------
INCOME TAXES
Effective January 1, 1992, the Company adopted SFAS No. 109, Accounting for Income Taxes. The adoption of this standard changed the Company's method of accounting for income taxes from the deferred method to the liability method. The cumulative effect of adopting the standard as of January 1, 1992, was a $100 million credit to earnings from continuing operations and a $52 million credit to earnings from discontinued operations.
The components of earnings from continuing operations before income taxes and the related provision (benefit) for U.S. and other income taxes were as follows:
The components of earnings (loss) from consolidated operations before income taxes and the related provision (benefit) for U.S. and other income taxes were as follows:
The differences between the provision (benefit) for income taxes and income taxes computed using the U.S. federal income tax rate for continuing operations were as follows:
The significant components of deferred tax assets and liabilities were as follows:
The valuation allowance is primarily attributable to certain net operating loss carryforwards outside the U.S. A majority of the net operating loss carryforwards are available indefinitely.
Retained earnings of subsidiary companies outside the U.S. were approximately $1,810 million and $2,402 million at December 31, 1994 and 1993, respectively. Retained earnings at December 31, 1994 are considered to be reinvested indefinitely. If remitted, they would be substantially free of additional tax. It is not practicable to determine the deferred tax liability for temporary differences related to these retained earnings.
- - ------------------------------------------------------------------------------
- - ------------------------------------------------------------------------------
RESTRUCTURING COSTS
In December 1994, the Company committed to implement a restructuring program and recorded a fourth quarter provision of $340 million pre-tax ($254 million after-tax) for severance and other termination benefits and exit costs related to the realignment of the Company's worldwide manufacturing, marketing, administrative and photofinishing operations.
Severance actions included in the restructuring provision represent capacity reductions in manufacturing facilities and the consolidation of photofinishing operations and marketing and administrative functions in various locations of the Company's worldwide operations. This program will result in a worldwide headcount reduction of approximately 4,350 employees. The following table summarizes, by function, the number of terminations involved in the headcount reduction program:
Outside U.S. the U.S. Total
Manufacturing 500 350 850 Marketing 100 800 900 Administrative - 300 300 Photofinishing 1,400 900 2,300 ------ ------ ------
Total 2,000 2,350 4,350 ====== ====== ======
While most terminations will be completed by the end of 1995, the remaining terminations are expected to be completed by June 30, 1996. In 1994, 115 people were terminated in conjunction with this restructuring program at a cost of approximately $7 million.
The activities expected to be discontinued in conjunction with the realignment strategy include manufacturing and product assembly operations in certain locations, marketing presence in various parts of the world and photofinishing operations in certain locations. Exit costs of $23 million were incurred in 1994 related to this restructuring program.
The Company recorded restructuring costs in 1993 for continuing operations of $495 million. Approximately $350 million was provided for severance and termination benefit costs related to a cost reduction program to reduce worldwide employment by approximately 9,000 personnel. By the end of 1994, approximately 7,500 personnel had been terminated with $120 million and $100 million being paid in 1994 and 1993, respectively. The remaining 1,500 personnel are expected to be terminated by June 30, 1995. The remainder of the 1993 restructuring provision related to exit and severance costs associated with the closure of a German manufacturing facility. The costs charged to the reserve in 1994 amounted to approximately $47 million. The remaining accrual balance at December 31, 1994 will provide for severance and pension payments to be paid over several years to former employees of the facility.
The Company recorded restructuring costs in 1992 for continuing operations of $219 million. Approximately $150 million was provided for an early retirement program. Most of the costs associated with this program are being funded from the Company's pension plan assets. Accordingly, the remaining liability for these payments is reflected in the pension plan's benefit obligation. Consequently, the Company's cash flow has not been impacted by this liability, except to the extent of contributions made to the pension plan trust fund by the Company, of which there were no contributions in the past three years. The remainder of the costs provided in 1992 related primarily to a program to exit several non-strategic businesses and the restructuring of the Company's non-U.S. sensitized manufacturing and photofinishing businesses.
The following table summarizes the Company's restructuring activities for the last three years:
- - ------------------------------------------------------------------------------
RENTAL EXPENSE AND LEASE COMMITMENTS (in millions) 1994 1993 1992
Gross rentals $197 $185 $185 Sublease income 8 11 5 ---- ---- ---- Total $189 $174 $180 ==== ==== ====
The approximate amounts of noncancelable lease commitments with terms of more than one year, principally for the rental of real property, reduced by minor sublease income, are $75 million in 1995, $60 million in 1996, $54 million in 1997, $31 million in 1998, $29 million in 1999 and $62 million in 2000 and thereafter. - - ------------------------------------------------------------------------------
RETIREMENT PLANS
Substantially all U.S. employees are covered by a noncontributory plan, the Kodak Retirement Income Plan (KRIP), which is funded by Company contributions to an irrevocable trust fund. Assets in the fund are held for the sole benefit of retired employees. Periodically, the Company makes contributions to the KRIP trust fund as permitted by law. Retirement benefits earned by employees prior to January 1, 1996, are based on a point system (age plus years of service). Full, unreduced benefits are provided to individuals with 85 points. Participants with 75 or more points (or age 55 with 10 years of service) can retire with a reduced benefit. Retirement benefits earned by employees subsequent to December 31, 1995, will no longer be based on the 75/85 point system. Full, unreduced benefits will be provided to individuals who are age 60 and have 30 years of service. The minimum retirement age under the new plan is 55 years. The benefit formula used to calculate the actual benefit dollars paid to an individual once retired will not change as a result of these new plan provisions. This amendment to the pension plan was instituted by the Company July 1, 1994. Retirement benefits generally become vested upon the completion of five years of service. The assets of the trust fund are comprised of corporate equity and debt securities, U.S. government securities, partnership and joint venture investments, interests in pooled funds, and various types of interest rate and foreign currency financial instruments.
Continuing operations total pension expense for all plans included the following:
The funded status of KRIP for continuing operations was as follows:
The benefit obligations for KRIP include amounts for employees who retired from Eastman Chemical Company (ECC) on or before December 31, 1993, the date ECC was spun-off from the Company. Benefit obligations of all other ECC employees were transferred to ECC as part of the spin-off agreement. The benefit obligation of KRIP excludes amounts for all employees (both retired and active) of the non-imaging health businesses sold in 1994 because those obligations were transferred to the buyers of the non-imaging health businesses. The market value of assets of KRIP reflect the Company's estimates of the assets held for employees in continuing operations only. The transfer of assets from the KRIP trust fund to ECC and the buyers of the non-imaging health businesses was not completed as of December 31, 1994. The Company anticipates the transfer of assets will not be completed for several years to ensure compliance with agreements and applicable government regulations.
The assumptions used to compute pension amounts for KRIP were as follows: December 31, 1994 1993
Discount rate 8.5% 7.25% Salary increase rate 5% 4% Long-term rate of return on plan assets 9.5% 9.5%
The Company also sponsors another plan for certain U.S. employees (primarily executives). The benefits of this plan are obtained by applying KRIP provisions to all compensation, including compensation currently being deferred, and without regard to the legislated qualified plan maximums, reduced by benefits under KRIP. At December 31, 1994 and 1993, the projected benefit obligation of this plan amounted to $140 million and $131 million, respectively. The Company had recorded long-term liabilities at those dates of $124 million and $126 million, respectively. Pension expense for continuing operations recorded in 1994, 1993 and 1992 related to this plan was $17 million, $15 million and $13 million, respectively.
Most subsidiaries and branches operating outside the U.S. have retirement plans covering substantially all employees. Contributions by the Company for these plans are typically deposited under government or other fiduciary-type arrangements. Retirement benefits are generally based on contractual agreements that provide for benefit formulas using years of service and/or compensation prior to retirement. The actuarial assumptions used for these plans reflect the diverse economic environments within the various countries in which the Company operates. The financial impact of these plans is insignificant to the Company.
- - ------------------------------------------------------------------------------
NONPENSION POSTRETIREMENT AND POSTEMPLOYMENT BENEFITS
Nonpension postretirement expense for continuing operations for 1994 and 1993 was $183 million and $255 million, respectively. Prior to 1993, these costs were accounted for on a "pay-as-you-go" basis and were $100 million in 1992.
The Company provides healthcare, dental and life insurance benefits to eligible retirees and eligible survivors of retirees. In general, these benefits are provided to U.S. retirees that are covered by the provisions of the Company's principal pension plan. The Company has amended healthcare, dental, and life insurance benefits provided to eligible retirees and eligible survivors of retirees. The Company announced in 1992 a cap for people retiring after January 1, 1993 that would freeze the Company's contribution to healthcare and dental costs in the year when costs were twice the average amount paid in 1992.
In 1994, the Company announced that it will set a cap on the amount the Company pays for healthcare and dental costs in the future for many people who retired prior to January 1, 1993. This new cap will become effective in the year 2000 or the year in which the previously announced cap becomes effective, whichever is later. In addition, the basis of the Company's contribution to healthcare for eligible retirees and eligible survivors of retirees will be a managed care program. The reduction of SFAS No. 106 costs generated by the above changes as well as economic assumption changes in 1994 was $90 million ($57 million after-tax).
A few of the Company's subsidiaries and branches operating outside the U.S. offer healthcare benefits; however, the cost of such benefits is insignificant to the Company.
The Company adopted SFAS No. 106 on January 1, 1993. The obligation for continuing operations owed to current and retired employees, as of January 1, 1993, was recognized on that date as a cumulative effect of a change in accounting principle of $1,557 million after-tax. The Company plans to continue to fund these benefit costs on a "pay-as-you-go" basis and, consequently, the adoption of SFAS No. 106 will not significantly affect the Company's cash flows.
The net postretirement benefit cost for continuing operations includes the following components:
(in millions) 1994 1993
Service cost $ 26 $ 25 Interest cost 192 230 Net amortization (35) - ----- ----- Net postretirement benefit cost $ 183 $ 255 ===== =====
The total obligation and amount recognized for continuing operations in the Consolidated Statement of Financial Position at December 31, 1994 and 1993, were as follows:
(in millions) 1994 1993
Accumulated postretirement benefit obligation Retirees $1,765 $2,576 Fully eligible active plan participants 23 94 Other active plan participants 366 524 ------ ------
Total obligation 2,154 3,194
Unrecognized net loss (90) (344) Unrecognized negative plan amendment 839 - ------ ------ Accrued postretirement benefit cost $2,903 $2,850 ====== ======
To estimate this obligation, healthcare costs were assumed to increase 10% in 1995 with the rate of increase declining ratably to 5% by 2002 and thereafter. The discount rate utilized to measure the obligation at December 31, 1994 and 1993, was 8.5% and 7.25%, respectively. If the healthcare cost trend rates were increased by one percentage point, the accumulated postretirement benefit obligation for continuing operations, as of December 31, 1994, would increase by approximately $129 million while the net postretirement benefit cost for the year then ended would increase by approximately $17 million.
Effective January 1, 1993, the Company adopted SFAS No. 112. The obligation for continuing operations as of January 1, 1993 was recognized as a cumulative effect of a change in accounting principle of $150 million ($92 million after-tax). Adoption of SFAS No. 112 did not have a material effect on the Company's earnings before cumulative effect of changes in accounting principle.
- - ------------------------------------------------------------------------------
STOCK OPTION AND COMPENSATION PLANS
The 1990 Omnibus Long-Term Compensation Plan provides for a variety of awards to key employees. Some of these awards are based upon performance criteria relating to the Company established by the Executive Compensation and Development Committee of the Board of Directors.
The 1990 Omnibus Long-Term Compensation Plan provides that options can be granted through January 31, 1995, to key employees for the purchase of up to 16,000,000 shares of the Company's common stock at an option price not less than 50 percent of the per share fair market value on the date of the stock option's grant. No options below fair market value have been granted to date. Options with dividend equivalents were awarded during 1994, 1993 and 1992 under the 1990 Omnibus Long-Term Compensation Plan. Provisions under this plan amounted to $6 million in 1994, $5 million in 1993 and $5 million in 1992. The 1990 Plan also provides for the granting of Stock Appreciation Rights (SARs) either in tandem with options or freestanding. SARs allow optionees to receive a payment equal to the appreciation in market value of a stated number of shares of the Company's common stock from the SARs exercise price to the market value on the date of its exercise. Exercise of a tandem SAR requires the optionee to surrender the related option. At December 31, 1994, there were 198,912 tandem SARs and 558,712 freestanding SARs outstanding at option prices ranging from $30.25 to $44.50.
The 1985 Stock Option Plan provided that options could be granted through 1989 to key employees for the purchase of up to 6,000,000 (prior to giving effect to the 3-for-2 partial stock split in 1987) shares of the Company's common stock at an option price not less than the per share fair market value at the time the option was granted. Options granted have maximum durations of 7 or 10 years from the date of grant but may expire sooner if the optionee's employment terminates. The 1985 Plan also provided for the granting of SARs either in tandem with options or freestanding. At December 31, 1994, there were 661,457 tandem SARs and 68,205 freestanding SARs outstanding at option prices ranging from $33.79 to $39.53.
Summarized option data as of December 31, 1994 are as follows:
Shares Range of Price Under Option Per Share ------------ --------------- Options Outstanding December 31, 1993 20,231,934 $25.92 - $50.47
Options Granted 3,397,049 $42.94 - $49.44
Options Exercised 927,113 $25.92 - $44.50
Options Cancelled 145,627 $25.92 - $44.50
Options Surrendered 757,869 $25.92 - $43.18 ---------- --------------- Options Outstanding December 31, 1994 21,798,374 $30.25 - $50.47 ========== ===============
At December 31, 1994, 16,689,314 of the options outstanding were exercisable.
Approximately 725,000 options were surrendered in 1994 as a result of the spin-off of the Company's worldwide chemical business on December 31, 1993.
- - ------------------------------------------------------------------------------
ACQUISITION OF REMAINING SHARES OF QUALEX
In August 1994, the Company acquired the remaining shares of Qualex, a photofinisher operating primarily in the U.S. Prior to August 12, 1994, the Company had an investment in Qualex of approximately fifty percent of its outstanding common shares, which was accounted for under the equity method.
The Company purchased the remaining shares of Qualex for $150 million with a combination of cash and a note. At December 31, 1994, $100 million remains to be paid in two equal installments in February and August 1995 and is included in "payables". The tangible and identifiable intangible assets acquired, principally receivables and properties, amounted to approximately $375 million. The liabilities assumed, principally debt, amounted to approximately $410 million. After recognizing the amount of the Company's investment which had been recorded by the Company prior to the acquisition date, approximately $160 million, the amount of goodwill resulting from this acquisition approximated $345 million. The Company's investment in Qualex was previously included in "long-term receivables and other noncurrent assets". The results of operations of Qualex are included in the Company's Consolidated Statement of Earnings for the period following the transaction date as a component of the Consumer Imaging segment. Net sales and costs of sales amounts consolidated for this period were $279 million and $200 million, respectively. Current and prior year pro forma information for the acquisition is not presented due to its relative insignificance.
- - ------------------------------------------------------------------------------
SEGMENT INFORMATION
In conjunction with the Company's intention to focus its attention on its consumer and commercial imaging businesses, the Company has changed its segments for financial reporting purposes. The Consumer Imaging business unit, which was previously included in the former Imaging segment, is now reported as a separate segment. The Commercial Imaging segment includes the other business units from the former Imaging segment, the business units from the former Information segment, Digital and Applied Imaging operations and the Health Sciences business unit, which was previously included in the Health segment. Financial data for prior periods have been restated to conform with the 1994 segment presentation.
The products of each segment are manufactured and marketed both in the U.S. and in other parts of the world. The Consumer Imaging segment includes amateur films, photographic papers, chemicals and equipment for photographic imaging and photofinishing operations. The Commercial Imaging segment includes motion picture, professional and graphic arts films, microfilms, copiers, printers and other equipment for information management. Sales between segments are made on a basis intended to reflect the market value of the products.
Sales are reported in the geographic area where they originate. Transfers among geographic areas are made on a basis intended to reflect the market value of the products, recognizing prevailing market prices and distributor discounts.
The parent company's equity in the net assets of subsidiaries outside the U.S. was as follows:
(in millions) 1994 1993 1992
Net assets $3,057 $2,912 $2,729 ====== ====== ======
- - ------------------------------------------------------------------------------
- - ------------------------------------------------------------------------------
- - ------------------------------------------------------------------------------
ITEM 9.

ITEM 9. DISAGREEMENTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None
- - ------------------------------------------------------------------------------
PART III
ITEM 10.



ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT.
Nominees to Serve as Directors for a Three-Year Term Expiring at the 1998 Annual Meeting (Class II Directors)
ALICE F. EMERSON
Dr. Emerson, 63, is Senior Fellow of The Andrew W. Mellon Foundation, a position she assumed in 1991 after having served as President of Wheaton College in Massachusetts since 1975. Prior to 1975, Dr. Emerson served the University of Pennsylvania, first as Dean of Women from 1966 to 1969 and subsequently as Dean of Students. Elected to the Kodak Board of Directors in May 1992, Dr. Emerson received her bachelor's degree from Vassar College and her Ph.D. degree from Bryn Mawr College. She is a member of the boards of directors of AES Corporation, Bank of Boston Corporation and Champion International Corp.
ROBERTO C. GOIZUETA
Mr. Goizueta, 63, is Chairman and Chief Executive Officer of The Coca-Cola Company. He was elected to this position in March 1981, having served as President from May 1980 to March 1981. Prior to becoming President, he was a Vice Chairman and Executive Vice President. Mr. Goizueta, who was elected to the Kodak Board of Directors in May 1989, received a B.S. degree in chemical engineering from Yale University. He is a member of the boards of directors of Ford Motor Company, SONAT Inc. and SunTrust Banks, Inc.
WILBUR J. PREZZANO
Mr. Prezzano, 54, who joined the Kodak Board of Directors in May 1992, is an Executive Vice President of Eastman Kodak Company. Mr. Prezzano joined the Company in 1965 in the statistical department and has held positions in Treasurer's, Business Systems Markets, Customer Equipment Services Division, Copy Products, Marketing Division, International Photographic Operations and Photographic Products. He served as Group Vice President and General Manager, International, from January 1990 to September 1991, when he became President of Kodak's Health Group. In August, 1994, he was elected an Executive Vice President and was named chairman and president of the Greater China Region. Mr. Prezzano received B.S. and M.B.A. degrees from the University of Pennsylvania's Wharton School.
LEO J. THOMAS
Dr. Thomas, 58, who joined the Kodak Board of Directors in May 1992, is an Executive Vice President of Eastman Kodak Company. Dr. Thomas began his Kodak career in 1961, and held various positions in the Research Laboratories before being named Director of Research and elected a Vice President in 1977. In December 1978, he was elected a Senior Vice President and in 1984, he was appointed General Manager, Life Sciences. Following the acquisition of Sterling Drug Inc. in 1988, Dr. Thomas was named Sterling Vice Chairman, and was elected the subsidiary's Chairman in September 1988. He became General Manager of the Health Group in 1989 and was elected a Group Vice President in November 1989. In September 1991, Dr. Thomas became President of the Imaging Group, which was formed to consolidate Kodak's photographic and commercial imaging businesses. In August, 1994, he was elected an Executive Vice President. Dr. Thomas holds a B.S. degree from the University of Minnesota and M.S. and Ph.D. degrees from the University of Illinois. He is a member of the boards of directors of Frontier Corporation and John Wiley & Sons, Inc.
Directors Serving a Term Expiring at the 1996 Annual Meeting (Class III Directors)
RICHARD S. BRADDOCK
Mr. Braddock, 53, who was elected to the Kodak Board of Directors in May 1987, is a principal of Clayton, Dubilier & Rice, a position he has held since June 1994. From January 1993 until October 1993, he was Chief Executive Officer of Medco Containment Services, Inc. From January 1990 through October 1992, he served as President and Chief Operating Officer of Citicorp and its principal subsidiary, Citibank, N.A. Prior to that, he served for approximately five years as Sector Executive in charge of Citicorp's Individual Bank, one of the financial services company's three core businesses. Mr. Braddock was graduated from Dartmouth College in 1963 with a degree in history, and received his M.B.A. from the Harvard School of Business Administration in 1965. He is a director of Lotus Development, True North Communications Inc., DFS Group Limited, and Van Kampen American Capital, Inc.
KARLHEINZ KASKE
Dr. Kaske, 66, served as President and Chief Executive Officer of Siemens AG from 1981 until his retirement in September 1992. Dr. Kaske joined Siemens in 1960 and held a variety of positions with Siemens AG, including head of Process Engineering and head of the Power Engineering Group. Dr. Kaske is a professor at the Technical University of Munich. He holds a diploma in physics from the Technical University of Aachen and a Doctorate of Engineering from the Technical University of Brunswick. Dr. Kaske is Chairman of the supervisory board of MAN Aktiengesellschaft and a member of the supervisory boards of Philipp Holzmann AG and Linde AG.
RICHARD A. ZIMMERMAN
Mr. Zimmerman, 63, who joined the Kodak Board of Directors in July 1989, is the retired Chairman and Chief Executive Officer of Hershey Foods Corporation. Mr. Zimmerman joined Hershey in 1958 and was named Vice President in 1971. Appointed a Group Vice President later in 1971, he became President and Chief Operating Officer in 1976. He was named Chief Executive Officer in January 1984 and Chairman of the Board in March 1985. Mr. Zimmerman was graduated from Pennsylvania State University. He is a member of the boards of directors of Lance, Inc. and Westvaco Corporation.
Directors Serving a Term Expiring at the 1997 Annual Meeting (Class I Directors)
MARTHA LAYNE COLLINS
Governor Collins, 58, was elected to the Board of Directors in May 1988. She is President of Martha Layne Collins and Associates, a consulting firm, and is also President of St. Catharine College in Springfield, Kentucky, a position she assumed in July 1990. Following her receipt of a B.S. from the University of Kentucky, Governor Collins taught from 1959 to 1970. After acting as Coordinator of Women's Activities in a number of political campaigns, she served as Clerk of the Supreme Court of the Commonwealth of Kentucky from 1975 to 1979. She was elected to a four-year term as Governor of the Commonwealth of Kentucky in 1983 after having served as Lieutenant Governor from 1979 to 1983. Governor Collins, who has served as a Fellow at the Institute of Politics, Harvard University, is a director of R. R. Donnelley & Sons Company and Bank of Louisville.
GEORGE M. C. FISHER
Mr. Fisher, 54, who joined the Kodak Board of Directors on December 1, 1993, is Chairman, President and Chief Executive Officer of Eastman Kodak Company. Mr. Fisher most recently served as Chairman and Chief Executive Officer of Motorola, Inc., after having served as President and Chief Executive Officer between 1988 and 1990 and Senior Executive Vice President and Deputy to the Chief Executive Officer between 1986 and 1988. Mr. Fisher holds a bachelor's degree in engineering from the University of Illinois and a masters in engineering and doctorate in applied mathematics from Brown University.
PAUL E. GRAY
Dr. Gray, 63, was elected to the Board of Directors in September 1990. Chairman of the Corporation of the Massachusetts Institute of Technology (M.I.T.) since October 1990, Dr. Gray served for the ten preceding years as President of M.I.T. He has also served on the M.I.T. faculty and in the academic administration, including responsibilities as Associate Provost, Dean of Engineering, and Chancellor. Dr. Gray earned his bachelor's, master's, and doctorate degrees in electrical engineering from M.I.T. He is a director of Arthur D. Little, Inc., The Boeing Co., and The New England.
JOHN J. PHELAN, JR.
Mr. Phelan, 63, who joined the Kodak Board of Directors in December 1987, is the retired Chairman and Chief Executive Officer of the New York Stock Exchange, a position which he held from 1984 until 1990. He was President of the International Federation of Stock Exchanges from 1991 through 1993. He is a member of the Council on Foreign Relations and is a senior advisor to the Boston Consulting Group. Mr. Phelan, a graduate of Adelphi University, is active in educational and philanthropic organizations and is also a director of Avon Products, Inc., Merrill Lynch & Co., Inc., Metropolitan Life Insurance Company and SONAT Inc.
ITEM 11.

ITEM 11. EXECUTIVE COMPENSATION
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS
COMPENSATION OF DIRECTORS Directors who are compensated as employees of the Company receive no additional compensation as directors. Each director who is not an employee of the Company receives an annual retainer of $38,000, payable $20,000 in common stock of the Company and $18,000 in cash. In addition, each such director receives a fee of $1,000 for each Board meeting attended and $900 for each Board committee and special meeting attended, and $1,000 for each Board committee and special meeting which he or she chairs. There is a deferred compensation plan available to all such directors for the cash portion of their compensation, in which two directors participated in 1994. Directors participating in this plan may choose between an interest-bearing account and a phantom Kodak stock fund. Each director who is not an employee of the Company is eligible to participate in a retirement plan for directors which provides an annual retirement benefit equal to the then-current annual retainer, if the director has served at least five years. Directors who have served fewer than five years are entitled to a pro rata retirement benefit. Each director who is not an employee of the Company is covered by group term life insurance in the amount of $100,000, which decreases to $50,000 at the later of retirement from the Board under the retirement plan described above or age 65. In the event of a change in control (as defined in the applicable plans) each account under the deferred compensation plan will be paid in a single lump sum cash payment and all retirement benefit payments will be paid in a single lump sum cash payment equal to the present value of the remaining retirement benefits.
Each non-employee director is eligible to participate in the Company's Directors' Charitable Award Program, which provides for a contribution by the Company of $1,000,000 following the director's death to up to four charitable institutions recommended by the director. The individual directors derive no financial benefits from this Program, which is funded by joint life insurance policies purchased by the Company and self insurance. The purposes of the Program are to further the Company's philanthropic endeavors, with particular emphasis on education, acknowledge the service of the Company's directors, recognize the interest of the Company and the directors in supporting worthy charitable and educational institutions and enable the Company to attract and retain directors of the highest caliber. Directors who are participating in the Program are Messrs. Braddock, Duncan, Phelan, and Zimmerman, Drs. Emerson, Gray, and Kaske, and Gov. Collins.
COMPENSATION OF EXECUTIVE OFFICERS The individuals named in the following table were the Company's Chief Executive Officer and the four highest paid executive officers during 1994.
Long-Term Incentive Plan
In March 1993, the 1993-1995 Restricted Stock Program, a performance share unit arrangement under the 1990 Omnibus Long-Term Compensation Plan, was approved by the Executive Compensation and Development Committee. Payouts of Awards, if any, are tied to achieving specified levels of stock price, return on assets, and total shareholder return relative to the Standard & Poor's 500 Index, over the period 1993-1995. The target amount will be earned if the target level for each of these three criteria is achieved. The target stock price must be achieved to trigger a payment of 100% of target. The threshold stock price must be achieved to trigger a payment of 50% of target. If the threshold stock price is not achieved, no payment is made. The Committee will determine the payout based upon its review of Company performance at the end of the performance period. Awards, if any, will be paid in the form of restricted stock, which restrictions will lapse upon the participant's attainment of age 60. Participants who terminate employment for reasons of death, disability, retirement or an approved reason, prior to the completion of the performance cycle, will receive their award, if any, at the conclusion of the performance period in the form of shares of Kodak common stock with no restrictions. Participation in this Program commenced in 1993 for the CEO and the other named executive officers, except H. L. Kavetas, whose participation commenced in 1994. Shown in the table below is the threshold and target number of shares for H. L. Kavetas under this Program offset by the 12,810 shares of restricted stock awarded to H. L. Kavetas under his employment contract.
EMPLOYMENT CONTRACTS
On October 27, 1993, the Company entered into an agreement covering a period of five years, for the employment of George M. C. Fisher as Chairman, President and Chief Executive Officer of the Company. Upon execution of the agreement, Mr. Fisher received $5,000,000 as an inducement for entering into the agreement and as reimbursement for compensation and benefits that he would forfeit upon termination of his employment with his previous employer. Mr. Fisher's base salary is $2,000,000, subject to review on an annual basis. Mr. Fisher participates in MAPP and has an annual target award opportunity of at least $1,000,000, with that amount guaranteed for services rendered in each of 1994 and 1995. Mr. Fisher was granted 20,000 shares of restricted stock with the restrictions lapsing at the end of five years. Pursuant to the agreement, Mr. Fisher was granted 1,323,539 stock options in 1993. The agreement provided for the Company to make two loans to Mr. Fisher in the total amount of $8,284,400 for five years with interest at the rate of 4.86% (which is the most recently announced rate under Section 1274(d) of the Internal Revenue Code, prior to the date of the loan). $4,284,400 of this amount was loaned to Mr. Fisher due to his forfeiture of 80,000 stock options from his prior employer resulting from his accepting employment with the Company. Mr. Fisher was required to use all of the loan proceeds except $1,500,000 to purchase Kodak stock. The shares he purchased are reflected in the security ownership table. Twenty percent of the principal and all of the accrued interest on each of these loans are to be forgiven on each of the first five anniversaries of such loans. Forgiveness of the $4,000,000 loan is conditioned upon Mr. Fisher's not having voluntarily terminated his employment with the Company and forgiveness of the $4,284,400 loan is conditioned upon Mr. Fisher's not entering into competition with the Company. The amount of the forgiveness for 1994 is shown in the column of the Summary Compensation Table entitled "All Other Compensation", on page 54.
In addition, where necessary, Mr. Fisher has been given credit for a period of service sufficient to allow him to obtain the maximum benefit available under the Company's benefit plans. In particular, Mr. Fisher was credited with five years of service for purposes of the Wage Dividend and seventeen years of service for purposes of calculating a retirement benefit. Any pension benefit payable to Mr. Fisher by the Company will be offset by any pension benefit paid to Mr. Fisher by his prior employer. The Company provided Mr. Fisher with an apartment until he purchased a permanent residence in the Rochester area. The Company purchased Mr. Fisher's residence in Barrington Hills, Illinois. In addition, the Company reimbursed Mr. Fisher for all closing costs associated with a previous residence, which was sold after he accepted employment with the Company. The Company is providing Mr. Fisher with term life insurance equal to 3.5 times his base salary and a disability benefit equal to 60% of base salary. In the event of Mr. Fisher's death prior to the termination of this agreement, the agreement provides for salary continuation for ninety days, the payment of the annual incentive for the year of his death and annual and long-term incentives earned but not yet paid, and vesting of all stock options and awards and the forgiveness of the loans. In the event of Mr. Fisher's disability prior to termination of the agreement, the agreement provides for a disability benefit payable to age 65, the payment of the annual incentive for the year in which his disability occurs and annual and long-term incentives earned but not yet paid, and vesting of all stock options and awards. If Mr. Fisher's employment is terminated by the Company without cause, including following a change in control, Mr. Fisher is entitled to the greater of the remaining term of his employment contract or 36 months of salary continuation, immediate vesting of stock options, the lapsing of any restrictions on any restricted stock award and the payment of any incentive awards earned but not yet paid. Mr. Fisher is entitled to reimbursement for taxes paid on certain of the foregoing payments, including any amounts constituting "parachute payments" under the Internal Revenue Code. If Mr. Fisher dies prior to retirement, his spouse is entitled to a 50% survivor annuity.
On February 11, 1994, the Company entered into an agreement covering a period of five years, for the employment of Harry L. Kavetas as Chief Financial Officer of the Company. Mr. Kavetas's base salary is $550,000, subject to review on an annual basis. Mr. Kavetas participates in MAPP and has an annual target award opportunity of at least $330,000, with that amount guaranteed for services rendered in 1994. Mr. Kavetas was granted 12,810 shares of restricted stock with the restrictions lapsing at the end of five years. Pursuant to the agreement, Mr. Kavetas was granted 200,000 stock options that become exercisable at the end of five years.
In addition, where necessary, Mr. Kavetas has been given credit for a period of service sufficient to allow him to obtain the maximum benefits available under Kodak's benefit plans. In particular, Mr. Kavetas was credited with five years of service for purposes of the Wage Dividend and will be credited with six years of service for each of the first five years of employment for purposes of calculating a retirement benefit. Any pension benefit payable to Mr. Kavetas by the Company will be offset by any pension benefit paid to Mr. Kavetas by his prior employer. The Company provided Mr. Kavetas with temporary housing until he purchased a permanent residence in the Rochester area. In the event of Mr. Kavetas's death prior to the termination of the agreement, the agreement provides for salary continuation for 90 days, the pro rata payment of all annual and long terms incentives and pro rata vesting of stock options and restricted stock awards. In the event of Mr. Kavetas's disability prior to termination of the agreement, the agreement provides for the pro rata payment of all annual and long term incentives, and pro rata vesting of stock options and restricted stock awards. If Mr. Kavetas's employment is terminated by the Company without cause, Mr. Kavetas is entitled to 18 months of salary continuation, immediate pro rata vesting of stock options and restricted stock awards and the payment of any incentive awards earned but not yet paid.
TERMINATION OF EMPLOYMENT
The Company has a general severance arrangement available to substantially all employees. This Termination Allowance Plan provides two weeks of compensation for every year of service with a maximum of fifty-two weeks of salary.
The Company has entered into a retention arrangement with Mr. Prezzano. The agreement provides that if Mr. Prezzano's employment is terminated prior to September 30, 1995 by the Company other than for cause, or by Mr. Prezzano as a result of a diminution in duties or base salary, he shall be entitled to an unreduced retirement annuity and a termination allowance equal to two weeks of pay for each year of service up to a maximum of 52 weeks of pay. The agreement also prohibits Mr. Prezzano from working for a competitor for a period of three years following termination of employment.
CHANGE IN CONTROL ARRANGEMENTS
In the event of a change in control, the following would occur: (i) each participant in the Executive Deferred Compensation Plan would receive the balance in his or her account in a single lump sum cash payment; (ii) each participant in the Management Annual Performance Plan would be paid his or her target award for such year and any other year for which payment of awards had not been made as of such date; and (iii) all outstanding stock options and stock appreciation rights would become fully vested and each holder would be paid in a lump sum cash payment the difference between the exercise price and market price of Kodak common stock on the date of such event; each of the foregoing payments would be made in a single lump sum cash payment as soon as possible but no later than the 90th day following such event.
RETIREMENT PLAN
The Company funds a tax-qualified, defined benefit pension plan for virtually all U.S. employees. Retirement income benefits are based upon the individual's "average participating compensation," which is the average of three years of those earnings described in the Plan as "participating compensation." "Participating compensation", in the case of the executive officers included in the Summary Compensation Table, is annual compensation (salary and Management Annual Performance Plan payments), including allowances in lieu of salary for authorized periods of absence, such as illness, vacation or holidays.
For an employee with up to 35 years of accrued service, the annual normal retirement income benefit is computed by multiplying the number of years of accrued service by the sum of (a) 1.3% of "average participating compensation" ("APC") for the employee's final three years, plus (b) .3% of APC in excess of the average Social Security wage base for the employee's final three years. For an employee with more than 35 years of accrued service, the amount computed above is increased by 1% for each year in excess of 35 years.
The retirement income benefit is not subject to any deductions for Social Security benefits or other offsets. Officers are entitled to benefits on the same basis as other employees. The normal form of benefit is an annuity, but a lump sum payment is available as an option.
The following table shows the years of accrued service credited to each of the five individuals named in the Summary Compensation Table. This table also shows for each named individual the amount of his "average participating compensation" at the end of 1994.
"Average Years of Participating Service Compensation" -------- ------------- G. M. C. Fisher 18* $1,999,998 R. T. Bourns 36 516,087 H. L. Kavetas 6** 550,004 W. J. Prezzano 29 714,017 L. J. Thomas 33 819,589
*Under the terms of his employment contract, Mr. Fisher has been credited with seventeen years of service for purposes of calculating his retirement benefit. Any pension benefit payable to Mr. Fisher by the Company will be offset by any pension benefit paid to Mr. Fisher by his prior employer.
**Under the terms of his employment contract, Mr. Kavetas is credited with six years of service for purposes of calculating his retirement benefit for each year of his first five years of employment with the Company. Any pension benefit payable to Mr. Kavetas by the Company will be offset by any pension benefit paid to Mr. Kavetas by his prior employer.
In the event of a change in control (as defined in the Retirement Plan), a participant whose employment is terminated, for a reason other than death, disability, cause or voluntary resignation, within 5 years of the date of such event would be credited with up to 5 additional years of service and, where the participant is age 50 or over on the date of such event, up to 5 additional years of age, for the following plan purposes: (i) to determine eligibility for early and normal retirement; (ii) to determine eligibility for a vested right; and (iii) to calculate the amount of retirement benefit. The actual number of years of service and years of age that would be granted to such a participant would decrease proportionately depending upon the number of years that elapse between the date of a change in control and the date of the participant's termination of employment. Further, if the Plan is terminated within 5 years after a change in control, the benefit for each plan participant will be calculated as indicated above.
ITEM 12.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
BENEFICIAL SECURITY OWNERSHIP OF DIRECTORS, NOMINEES AND EXECUTIVE OFFICERS
Directors, Nominees and Executive Number of Common Shares Officers Owned on Jan. 3, 1995 - - ------------------- ----------------------- Richard T. Bourns 82,041*+ Richard S. Braddock 2,535 Martha Layne Collins 2,340 Charles T. Duncan 2,592 Alice F. Emerson 1,392 George M. C. Fisher 392,108*= Roberto C. Goizueta 4,499 Paul E. Gray 1,859 Karlheinz Kaske 1,353 Harry L. Kavetas 12,810- John J. Phelan, Jr. 2,698 Wilbur J. Prezzano 176,445* Leo J. Thomas 161,801* Richard A. Zimmerman 2,919 All Directors, Nominees and 965,015*#+ Executive Officers as a Group (18), including the above
NOTES:
* Includes shares which may be acquired in the following amounts by exercise of stock options: R. T. Bourns - 77,250; G. M. C. Fisher - 264,708; W. J. Prezzano - 165,200; L. J. Thomas - 150,568; and all directors, nominees and executive officers as a group - 770,606.
= Includes 20,000 shares of restricted stock.
- - - The transfer of these shares is restricted.
+ The shares shown do not include the following Eastman Kodak Company common stock equivalents which are held in the Eastman Kodak Company 1982 Executive Deferred Compensation Plan: R. T. Bourns - 5,008 and all executive officers as a group - 9,541.
# The total number of shares beneficially owned by all directors, nominees and executive officers as a group is less than one percent of the Company's outstanding shares.
Beneficial security ownership as reported in the above table has been determined in accordance with Rule 13d-3 under the Securities Exchange Act of 1934. Accordingly, except as noted below, all Company securities over which the directors, nominees and executive officers directly or indirectly have or share voting or investment power have been deemed beneficially owned. The figures above include shares held for the account of the above persons in the Automatic Dividend Reinvestment Plan for Shareholders of Eastman Kodak Company, in the Kodak Employee Stock Ownership Plan, and the interests, if any, of those of the above persons in the Kodak Stock Fund of the Eastman Kodak Employees' Savings and Investment Plan, stated in terms of Kodak shares.
The table does not include approximately 8,124,116 shares of the Company's stock (less than 3 percent of the outstanding shares) held in the Kodak Stock Fund of the Eastman Kodak Employees' Savings and Investment Plan for the benefit of some 25,250 employees and former employees, over which a committee consisting of five individuals, including four Company officers, has discretionary voting power.
ITEM 13.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
None
PART IV
ITEM 14.

ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K
Page No.
(a) 1. Consolidated financial statements: Report of independent accountants 18 Consolidated statement of earnings 19-20 Consolidated statement of financial position 21 Consolidated statement of shareowners' equity 22 Consolidated statement of cash flows 23 Notes to financial statements 24-48
2. Financial statement schedules:
II - Valuation and qualifying accounts 66
All other schedules have been omitted because they are not applicable or the information required is shown in the financial statements or notes thereto.
3. Additional data required to be furnished:
Exhibits required as part of this report are listed in the index appearing on pages 67 through 69. The management contracts and compensatory plans and arrangements required to be filed as exhibits to this form pursuant to Item 14(c) of this report are listed on pages 67 through 68, Exhibit Numbers (10)A - (10)R.
(b) Report on Form 8-K.
Eastman Kodak Company filed the following Current Reports on Form 8-K during the fourth quarter of 1994:
1. Current Report on Form 8-K dated June 30, 1994 (filed October 17, 1994), as amended by Amendment No. 1 (filed October 21, 1994). The 8-K reported Items 2, 5, and 7.
2. Current Report on Form 8-K dated November 30, 1994 (filed December 5, 1994). The 8-K reported Items 2, 5, and 7 and included under Item 5 financial data, consolidated financial statements, financial statement schedules, and additional data to provide historical financial information excluding the results of the non-imaging health businesses which the Company divested in 1994.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
EASTMAN KODAK COMPANY (Registrant)
By: By: George M. C. Fisher, Chairman of Harry L. Kavetas, Executive Vice the Board, President and Chief President, Chief Financial Executive Officer Officer and Acting General Comptroller
Date: March 10, 1995
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.
Richard S. Braddock, Director Paul E. Gray, Director
Martha Layne Collins, Director Karlheinz Kaske, Director
Charles T. Duncan, Director John J. Phelan, Jr., Director
Alice F. Emerson, Director Wilber J. Prezzano, Director
George M. C. Fisher, Director Leo J. Thomas, Director
Roberto C. Goizueta, Director Richard A. Zimmerman, Director
Date: March 10, 1995
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Prospectuses constituting part of the Registration Statements on Form S-3 (No. 33-48258 and No. 33-49285), Form S-4 (No. 33-48891) and Form S-8 (No. 2-77145, No. 33-5803, No. 33-36731, No. 33-35214 and No. 33-56499), of Eastman Kodak Company of our report dated January 30, 1995, appearing on page 18 of this Annual Report on Form 10-K.
PRICE WATERHOUSE LLP New York, New York March 10, 1995
Eastman Kodak Company and Subsidiary Companies Index to Exhibits Exhibit Number
(3) A. Certificate of Incorporation. (Incorporated by reference to the Eastman Kodak Company Annual Report on Form 10-K for the fiscal year ended December 25, 1988, Exhibit 3.)
B. By-laws, as amended through September 11, 1992. (Incorporated by reference to the Eastman Kodak Company Annual Report on Form 10-K for the fiscal year ended December 31, 1992, Exhibit 3.)
(4) A. Indenture dated as of June 15, 1986 between Eastman Kodak Company as issuer of 8.55% Notes due 1997 and The Bank of New York as Trustee. (Incorporated by reference to the Eastman Kodak Company Annual Report on Form 10-K for the fiscal year ended December 28, 1986, Exhibit 4.)
B. Indenture dated as of January 1, 1988 between Eastman Kodak Company as issuer of (i) 9 3/8% Notes Due 2003, (ii) 9.95% Debentures Due 2018, (iii) 9 1/2% Notes Due 2008, (iv) 9.20% Debentures Due 2021, and (v) 7 1/4% Notes Due 1999, and The Bank of New York as Trustee. (Incorporated by reference to the Eastman Kodak Company Annual Report on Form 10-K for the fiscal year ended December 25, 1988, Exhibit 4.)
C. First Supplemental Indenture dated as of September 6, 1991 and Second Supplemental Indenture dated as of September 20, 1991, each between Eastman Kodak Company and The Bank of New York as Trustee, supplementing the Indenture described in B. (Incorporated by reference to the Eastman Kodak Company Annual Report on Form 10-K for the fiscal year ended December 31, 1991, Exhibit 4.)
D. Third Supplemental Indenture dated as of January 26, 1993, between Eastman Kodak Company and The Bank of New York as Trustee, supplementing the Indenture described in B. (Incorporated by reference to the Eastman Kodak Company Annual Report on Form 10-K for the fiscal year ended December 31, 1992, Exhibit 4.)
E. Fourth Supplemental Indenture dated as of March 1, 1993, between Eastman Kodak Company and The Bank of New York as Trustee,supplementing the Indenture described in B. (Incorporated by reference to the Eastman Kodak Company Annual Report on Form 10-K for the fiscal year ended December 31, 1993.)
Eastman Kodak Company and certain subsidiaries are parties to instruments defining the rights of holders of long-term debt that was not registered under the Securities Act of 1933. Eastman Kodak Company has undertaken to furnish a copy of these instruments to the Securities and Exchange Commission upon request.
(10) A. Eastman Kodak Company Retirement Plan for Directors, as amended effective March 1, 1990.
B. Eastman Kodak Company 1985 Long Term Performance Award Plan, as amended effective December 31, 1993.
C. 1982 Eastman Kodak Company Executive Deferred Compensation Plan, as amended effective December 31, 1993.
D. Kodak Unfunded Retirement Income Plan, amended effective January 1, 1992.
Eastman Kodak Company and Subsidiary Companies Index to Exhibits (continued) Exhibit Number Page
E. Eastman Kodak Company Management Annual Performance Plan, as amended effective February 1994. 70
F. Eastman Kodak Company 1956 Deferred Compensation Plan, as amended effective January 1, 1990.
G. Eastman Kodak Company 1981 Incentive Stock Option Plan, as amended effective December 31, 1993.
H. Eastman Kodak Company Insurance Plan for Directors. (Incorporated by reference to the Eastman Kodak Company Annual Report on Form 10-K for the fiscal year ended December 29, 1988, Exhibit 10.)
I. Eastman Kodak Company Deferred Compensation Plan for Directors, as amended effective January 1, 1995. 76
J. Eastman Kodak Company 1985 Stock Option Plan, as amended effective December 31, 1993.
K. Kodak Supplementary Group Life Insurance Plan, as amended effective March 1, 1994. 87
L. Eastman Kodak Company 1990 Omnibus Long-Term Compensation Plan, as amended effective March 10, 1994. 101
M. Kodak Excess Retirement Income Plan, as amended effective December 1, 1991.
N. Kodak Executive Financial Counseling Program.
O. Umbrella Insurance Coverage. (Incorporated by reference to the Eastman Kodak Company Annual Report on Form 10-K for the fiscal year ended December 31, 1991, Exhibit 10.)
P. Kodak Executive Health Management Plan, as amended effective December 7, 1990.
Q. Wilbur J. Prezzano Retention Agreement dated September 3, 1993.
R. Wilbur J. Prezzano Amendment to Retention Agreement dated January 3, 1995. 116
S. George M. C. Fisher Employment Agreement dated October 27, 1993.
$4,000,000 Promissory Note dated November 2, 1993
$4,284,400 Promissory Note dated November 2, 1993
Notice of Award of Restricted Stock dated November 11, 1993
Notice of Award of Incentive Stock Options dated November 11, 1993
Notice of Award of Non-Qualified Stock Options dated November 11, 1993
First Amendment to Notice of Award of Non-Qualified Stock Options dated November 11, 1993.
Amendment No. 1 to Employment Agreement dated as of April 4, 1994.
Eastman Kodak Company and Subsidiary Companies Index to Exhibits (continued) Exhibit Number Page
T. Harry L. Kavetas Employment Agreement dated as of February 11, 1994, Notice of Award of Non-Qualified Stock Options dated February 15, 1994, Notice of Award of Incentive Stock Options dated February 15, 1994, and Notice of Award of Restricted Stock dated February 15, 1994. 117
Exhibits (10) A and F are incorporated by reference to the Eastman Kodak Company Annual Report on Form 10-K for the fiscal year ended December 31, 1990, Exhibit 10.
Exhibits (10) D, M, N, and P are incorporated by reference to the Eastman Kodak Company Annual Report on Form 10-K for the fiscal year ended December 31, 1992, Exhibit 10.
Exhibits (10) B, C, G, J, Q and S are incorporated by reference to the Eastman Kodak Company Annual Report on Form 10-K for the fiscal year ended December 31, 1993, Exhibit 10.
(11) Statement Re Computation of Earnings Per Common Share. 147
(12) Statement Re Computation of Ratio of Earnings to Fixed Charges. 150
(22) Subsidiaries of Eastman Kodak Company. 151
(24) Consent of Independent Accountants. 65
(27) Financial Data Schedule, Exhibit (27) - Submitted with the EDGAR filing as a second document to this Form 10-K.
(28) A. Eastman Kodak Employees' Savings and Investment Plan Annual Report on Form 11-K for the fiscal year ended December 30, 1994 (to be filed by amendment).
B. L & F Products Employees' Savings Plan I Annual Report on Form 11-K for the fiscal year ended December 30, 1994 (to be filed by amendment).
C. L & F Products Employees' Savings Plan II Annual Report on Form 11-K for the fiscal year ended December 30, 1994 (to be filed by amendment).
Exhibit (10) E
1994 Management Annual Performance Plan
SUMMARY
The Management Annual Performance Plan (MAPP) is a Kodak management- level compensation plan. The compensation of each participant consists of a base salary and an annual award based on business performance. Expected financial performance is considered the target level of performance and yields the participant's target award. MAPP awards vary from zero, if goals are not met, to a maximum of two times the target award. Target awards range from 18% of base salary for the lowest level of participants to 75% of base salary for the CEO. Payments are made to plan participants in April of the year following the year for which performance was measured.
PLAN ADMINISTRATION
The Executive Compensation and Development Committee of the Board of Directors is responsible for: policy setting and interpretation, approving performance goals at the Company and Group levels, evaluating Company and Group performance against the goals, and determining Company and Group level performance awards. The Chief Executive Officer provides advice and counsel to the Committee. Management is responsible for administering the Plan.
PARTICIPATION
The Plan is intended for management-level individuals in key roles which impact the financial performance of the organization. Participation is determined by Group Presidents and Senior Vice Presidents. The Chief Executive Officer is the final approval level for participation.
Individuals who become participants as a result of a job change begin participation on the first day of the month of their appointment to the new job, or on the following January 1 if the job change occurs late in the year.
Participants who retire, become disabled under the Kodak Long-Term Disability Plan, or leave the Company as part of an approved early separation program, receive a pro rata award at the normal time of payout based on base salary at the time of separation and financial performance at the end of the performance cycle (year-end).
The estates of participants who die receive a pro rata award based on base salary at the time of death and financial performance at the end of the performance cycle (year-end).
Participants who resign or are terminated for cause receive an award only if they worked until the end of a performance cycle (complete calendar year).
Participants who change jobs during a performance cycle receive a pro rata award for the interval of time spent in each job. Pro rata awards are calculated using the base salary at year-end and are based on the financial performance of the full performance cycle (complete calendar year).
GOAL SETTING
The Executive Compensation and Development Committee, in consultation with the Chief Executive Officer, establishes in December of each year the next year's financial goals for each performance level for: total Company, Imaging Group, and the Health Group. Each goal is weighed for importance in determining final awards. Three performance levels are established: Threshold, Target and Maximum. On occasion, two of the levels may be set at the same performance level in order to reinforce business goals.
Within each Group, goals may be established at organizational levels below the Group. If established, they are to be the same financial goals, aligned with Group goals, and approved by the Group President. There are no individual or personal goals.
GOAL WEIGHTING
Goals are weighted not only by specific financial performance measure but also by organizational position as follows:
Position Corporate Group
Chief Executive Officer 100% 0% Corporate Staffs 100% 0% Group Presidents 50% 50% Corporate Officers in The Groups 35% *65% Other 25% *75%
*Group President determines the weighting of these goals within the Group.
AWARDS
Award Pools
MAPP award pools are determined at the Group and Corporate Staffs levels. An award pool is the amount of money required to pay all participants in a Group in relation to meeting specific performance levels (Threshold through Maximum) of financial performance in that Group. For example, Imaging, Health and Corporate Staffs have a target level of financial performance set by the Executive Compensation and Development Committee of the Board for each MAPP performance level. A corresponding award pool is determined for each performance level. The award pools are calculated based on: 1) the number of MAPP participants in the Group; 2) their grade and salary levels at year-end; and 3) their target MAPP award (18% to 75%). Following the conclusion of the performance cycle, the Committee conducts its evaluation of performance against goals in its February meeting. At that time, award levels are determined and award pools established.
Award Determination
The Executive Compensation and Development Committee, in consultation with the CEO, evaluates financial performance against agreed upon goals for the Corporation and for each Group. In making its evaluation, the Committee takes into consideration unanticipated influences (e.g., economic downturn) impacting the difficulty of achieving the results, as well as performance relative to peer companies. Peer company comparisons may be made at the Group level and for the Corporation. The Committee decides, based on the recommendation of the CEO, the appropriate peer company comparisons for each Group and the Corporation. In addition, the Committee judges results in relation to its expectations for improving overall shareowner return. Extraordinary gains and losses are included in financial performance evaluation both at Corporate and, where appropriate, at Group levels. Major adjustments may be considered separately at the request of the CEO. Taking into account these various considerations, the Committee determines the performance award level for the Corporation and each Group.
The Threshold performance level established for each goal is the minimum hurdle for payment of award monies for performance against that goal. The Threshold level must be attained before any award is earned for that goal. This applies at all organizational levels at which goals may be established. If goals are established below the Group level, the Group must earn some award monies for its performance before any sub-Group awards are paid.
After the award pools have been established, the CEO and the Group Presidents have the discretion to determine how a portion of the monies will be distributed. Within each Group, the Group President has the latitude to redistribute up to 30 percent of the award funds resulting from non-corporate performance. The CEO has the same latitude to redistribute up to 30 percent of the award funds within the Corporate Staffs units. No additional award monies are created, solely a redistribution. The potential redistribution will be based upon performance achievements -- tangible, quantifiable results - - -- of individuals or units. It is intended to provide the ability to recognize special contributions and provide a greater level of accountability.
The Executive Compensation and Development Committee approves actual MAPP award amounts for the following: Chief Executive Officer, Group Presidents, Chief Financial Officer, Senior Vice President - Legal, Senior Vice President - - - Human Resources and the five highest paid officers listed in the proxy, if they are different from individuals in the positions identified above.
Unacceptable individual performance, as determined by management, may result in no performance award, regardless of Company, Group or unit performance. Management has discretion to override the established guidelines to avoid inappropriate or inequitable results. Final approval for such an override resides at the Group President or equivalent level. The Chief Executive Officer may recommend to the Executive Compensation and Development Committee that no awards be paid through this plan should the Company's overall financial performance warrant such action.
Award Calculation
Achievement Level Award Factor
Maximum 2X Target (Expected Performance) 1X Threshold .25X
X = Target Award %
Awards are paid in April, for performance in the previous year, based on goal achievement. In the example below, the participant has three goals, one with a weighting of 20% and each of the other two weighted 40%. The weighted performance is calculated on a scale of zero (0) to 200, with Target equal to 100. In this way, regardless of their target award percentage (18% to 75%), the performance for all participants can be calculated using the same scale. In the example, the performance for goal 1 was 125, resulting in a weighted performance (20% times 125) of 25. Goal 2 performance was 75 on the 200 scale (weighted performance was 30 [75 times 40%]). Goal 3 performance was 150 (weighted performance was 60 [150 times 40%]). This resulted in a total weighted performance of 115%.
Performance Levels
Maximum Target Threshold 200 100 25
Goals Weight % Weighted Performance
1 20 125 25% 2 40 75 30% 3 40 150 60% Total = 115%
In this example, consider that the participant had a year-end base salary of $90,000 and a target award of 18% of base salary. To calculate this participant's award, determine the Target Award and multiply it by the Total Weighted Performance.
Target Award = Base Salary times Target Award Percent Target Award = $90,000 X 18% = $16,200
Performance Award = Target Award times Total Weighted Performance Performance Award = $16,200 X 115.0% = $18,630
This Performance Award might then be increased or decreased based upon the potential redistribution of a portion of the available award monies by the CEO or Group President.
RELATIONSHIP BETWEEN MAPP AND PERFORMANCE APPRAISALS
MAPP is intended to reward participants for the achievement of a few focused financial goals. Performance appraisals and rate reviews determine an individual's base salary with consideration for overall performance relative to the expectations for the job. MAPP is financially and organizationally oriented while performance appraisals are more individually oriented.
SALARY ADJUSTMENT UPON ENTRY INTO MAPP
MAPP is a variable compensation, or pay at risk, program. Participants have their base salary administered on reduced rate ranges. New participants to MAPP are immediately administered on the reduced rate range for their assigned grade. This may reduce or eliminate promotional increases, depending upon the person's pay position in the rate range for their new grade. Subsequent salary treatment will depend upon pay/performance relationships in the reduced rate range for their assigned grade.
RELATIONSHIP TO BENEFITS
Benefits are calculated as follows:
Base Salary and Actual Base Salary & Base Benefit Plan MAPP Received Targeted MAPP Salary Rate
Wage Dividend X Retirement X Life Insurance X Long-Term Disability X Termination Allowance X Short-Term Disability X Vacation X Holidays X Personal Absence X
PLAN AUDIT
The Director of Executive Compensation and Corporate Compensation Planning has responsibility for monitoring and reporting on the administration and effectiveness of MAPP. The role of that position is to provide independent objective appraisal and guidance to both the Executive Compensation and Development Committee of the Board and the CEO in the administration of MAPP. Each year, the Director will provide a formal review to the Committee and the CEO on the overall effectiveness of MAPP.
February, 1994
Exhibit (10) I
EASTMAN KODAK COMPANY
DEFERRED COMPENSATION PLAN FOR DIRECTORS
Amended and Restated Effective as of January 1, 1995
Eastman Kodak Company Deferred Compensation Plan For Directors
Section Page
Preamble 79
Section 1. Definitions 79
Section 2. Term 80
Section 3. Participation 80
Section 4. Deferral of Compensation 80
Section 5. Time of Election of Deferral 81
Section 6. Hypothetical Investments 81 Section 6.1 Deferred Compensation Account 81 Section 6.2 Stock Account 81
Section 7. Manner of Electing Deferral 81
Section 8. Investment in Stock Account 81 Section 8.1 Elections 81 Section 8.2 Election into the Stock Account 82 Section 8.3 Election out of the Stock Account 82 Section 8.4 Dividend Equivalents 82 Section 8.5 Stock Dividends 82 Section 8.6 Recapitalization 83 Section 8.7 Distributions 83
Section 9. Payment of Deferred Compensation 83 Section 9.1 Background 83 Section 9.2 Manner of Payment 83 Section 9.3 Timing of Payments 83 Section 9.4 Valuation 83
Section 10. Payment of Deferred Compensation After Death 83 Section 10.1 Stock Account 84 Section 10.2 Distribution 84 Section 10.3 Beneficiary Designation 84
Eastman Kodak Company Deferred Compensation Plan For Directors
Table of Contents Continued
Section Page
Section 11. Participant's Rights Unsecured 84
Section 12. Non-Assignability 85
Section 13. Statement of Account 85
Section 14. Administration 85 Section 14.1 Responsibility 85 Section 14.2 Authority of Administrator 85 Section 14.3 Discretionary Authority 85 Section 14.4 Delegation of Authority 85
Section 15. Amendment 85
Section 16. Governing Law 85
Section 17. Change in Control 86 Section 17.1 Background 86 Section 17.2 Payment of Deferred Compensation 86 Section 17.3 Amendment On or After Change In Control 86
Section 18. No Guarantee of Tax Consequences 86 Section 19. Compliance with Securities Laws 86
EASTMAN KODAK COMPANY
DEFERRED COMPENSATION PLAN FOR DIRECTORS
Preamble. The name of this Plan is the Eastman Kodak Company Deferred Compensation Plan for Directors. Its purpose is to provide certain members of the Board of Directors of Eastman Kodak Company with an opportunity to defer compensation earned as a Director.
Section 1. Definitions.
Section 1.1. "Account" means the Deferred Compensation Account or the Stock Account.
Section 1.2. "Beneficiary" means the person or persons (including, but not limited to, a trust) designated as such in accordance with Section 10.3.
Section 1.3. "Board" means Board of Directors of Kodak.
Section 1.4. "Change in Control" means a change in control of Kodak of a nature that would be required to be reported (assuming such event has not been "previously reported") in response to Item 1(a) of the Current Report of Form 8-K, as in effect on August 1, 1989, pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"); provided that, without limitation, a Change in Control shall be deemed to have occurred at such time as (i) any "person" within the meaning of Section 14(d) of the Exchange Act is or has become the "beneficial owner" as defined in Rule 13d-3 under the Exchange Act, directly or indirectly, of 25% or more of the combined voting power of the outstanding securities of Kodak ordinarily having the right to vote at the election of directors ("Voting Securities"), or (ii) individuals who constitute the Board of Directors of Kodak on March 1, 1990 (the "Incumbent Board") have ceased for any reason to constitute at least a majority thereof, provided that any person becoming a director subsequent to March 1, 1990 whose election, or nomination for election by Kodak's stockholders, was approved by a vote of at least three-quarters (3/4) of the directors comprising the Incumbent Board (either by a specific vote or by approval of the proxy statement of Kodak in which such person is named as a nominee for director without objection to such nomination) shall be, for purposes of this clause (ii), considered as though such person were a member of the Incumbent Board.
Section 1.5. "Common Stock" means the common stock of Kodak.
Section 1.6. "Deferrable Amount" means the amount of cash compensation otherwise payable to a Participant (exclusive of expense reimbursements) for serving on the Board and attending meetings or committee meetings thereof.
Section 1.7. "Deferred Compensation Account" means the account established by Kodak for each Participant for compensation deferred pursuant to this Plan. The maintenance of individual Deferred Compensation Accounts is for bookkeeping purposes only.
Section 1.8. "Enrollment Period" means the period designated by the Administrator each year; provided however, that the Enrollment Period for a given calendar year shall always commence and end in the year immediately prior to such calendar year.
Section 1.9. "Interest Rate" means the base rate, as reported in the "Money Rates" section of The Wall Street Journal, on corporate loans posted by at least 75% of the nation's 30 largest banks (known as the "Prime Rate").
Section 1.10. "Kodak" means Eastman Kodak Company.
Section 1.11. "Market Value" means the mean between the high and low at which the Common Stock trades on the New York Stock Exchange as quoted in the New York Stock Exchange Composite Transactions as published in The Wall Street Journal on the day for which the determination is to be made or, if such day is not a trading day, the immediately preceding trading day.
Section 1.12. "Plan" means the Eastman Kodak Company Deferred Compensation Plan For Directors as adopted by the Board and amended.
Section 1.13. "Participant" means (i) any member of the Board who is not an employee of Kodak; or (ii) any former member of the Board who has a balance in an Account under the Plan.
Section 1.14. "Stock Account" means the account established by Kodak for each Participant, the performance of which shall be measured by reference to the Market Value of Common Stock. The maintenance of individual Stock Accounts is for bookkeeping purposes only.
Section 1.15. "Valuation Date" means, with regards to a Participant's Deferred Compensation Account, the last day of each calendar month and, with regards to the Participant's Stock Account, the last business day of each calendar month.
Section 2. Term. The Plan shall become effective January 1, 1979.
Section 3. Participation. Only Participants shall be eligible to participate in the Plan.
Section 4. Deferral of Compensation. For any given calendar year, a Participant may elect to defer receipt of all or any portion of his or her Deferrable Amount to be earned during such year. Any Deferrable Amount which is so deferred shall be credited to the Participant's Deferred Compensation Account. A Participant may not defer the receipt of any Deferrable Amounts directly to his or her Stock Account, but can only transfer amounts to such Account pursuant to Section 8.
Section 5. Time of Election of Deferral. A Participant who wishes to defer compensation must irrevocably elect to do so during an Enrollment Period.
An election made in accordance with Section 7 below shall be effective for the calendar year immediately following the Enrollment Period during which such election was made and for all succeeding calendar years, unless the Participant revokes his or her election or files a new election during the Enrollment Period for such a succeeding calendar year. In which case, such revocation or election, as the case may be, shall be effective on the first day of such succeeding calendar year.
Section 6. Hypothetical Investments.
Section 6.1. Deferred Compensation Account. Amounts in a Participant's Deferred Compensation Account are hypothetically invested in an interest bearing account which bears interest computed at the Interest Rate, compounded monthly.
Section 6.2. Stock Account. Amounts in a Participant's Stock Account are hypothetically invested in units of Common Stock. Amounts transferred to a Stock Account are recorded as units of Common Stock, and fractions thereof, with one unit equating to a single share of Common Stock. Thus, the value of one unit shall be the Market Value of a single share of Common Stock. The use of units is merely a bookkeeping convenience; the units are not actual shares of Common Stock. Kodak will not reserve or otherwise set aside any Common Stock for or to any Stock Account.
Section 7. Manner of Electing Deferral. A Participant may elect to defer compensation by executing and returning to the Administrator during the Enrollment Period a deferred compensation form provided by Kodak upon which the Participant shall indicate the amount of the Deferrable Amount to be deferred.
Amounts to be deferred shall be credited to the Participant's Deferred Compensation Account on the date such amounts would otherwise be payable.
Section 8. Investment in the Stock Account.
Section 8.1. Elections. A Participant may direct that all or any portion, designated as a whole dollar amount, of the existing balance of one of his or her Accounts be transferred to his or her other Account, effective as of the close of business on the last day of any calendar month (hereinafter the election's "Effective Date"), by filing a written election with the Administrator on or prior to such date.
Section 8.2. Election into the Stock Account. If a Participant elects pursuant to Section 8.1 to transfer an amount from his or her Deferred Compensation Account to his or her Stock Account, effective as of the election's Effective Date, (i) his or her Stock Account shall be credited with that number of units of Common Stock, and fractions thereof, obtained by dividing the dollar amount elected to be transferred by the Market Value of the Common Stock on the Valuation Date immediately preceding or coincident with the election's Effective Date; and (ii) his or her Deferred Compensation Account shall be reduced by the amount elected to be transferred.
Section 8.3. Election out of the Stock Account. If a Participant elects pursuant to Section 8.1 to transfer an amount from his or her Stock Account to his or her Deferred Compensation Account, effective as of the election's Effective Date, (i) his or her Deferred Compensation Account shall be credited with a dollar amount equal to the amount obtained by multiplying the number of units to be transferred by the Market Value of the Common Stock on the Valuation Date immediately preceding or coincident with the election's Effective Date; and (ii) his or her Stock Account shall be reduced by the number of units elected to be transferred.
Section 8.4. Dividend Equivalents. Effective as of the payment date for each cash dividend on the Common Stock, additional units of Common Stock shall be credited to the Stock Account of each Participant who has a balance in his or her Stock Account on the record date for such dividend. The number of units that shall be credited to the Stock Account of such a Participant shall be computed by multiplying the dollar value of the dividend paid upon a single share of Common Stock by the number of units of Common Stock held in the Participant's Stock Account on the record date for such dividend and dividing the product thereof by the Market Value of the Common Stock on the payment date for such dividend.
Section 8.5. Stock Dividends. Effective as of the payment date for each stock dividend (as defined in Section 305 of the Internal Revenue Code of 1986) on the Common Stock, additional units of Common Stock shall be credited to the Stock Account of each Participant who has a balance in his or her Stock Account on the record date for such dividend. The number of units that shall be credited to the Stock Account of such a Participant shall equal the number of shares of Common Stock which the Participant would have received as stock dividends had he or she been the owner on the record date for such stock dividend of the number of shares of Common Stock equal to the number of units credited to his or her Stock Account on such record date. To the extent the Participant would have also received cash, in lieu of fractional shares of Common Stock, had he or she been the record owner of such shares for such stock dividend, then his or her Stock Account shall also be credited with that number of units, or fractions thereof, equal to such cash amount divided by the Market Value of the Common Stock on the payment date for such dividend.
Section 8.6. Recapitalization. If Kodak undergoes a reorganization as defined in Section 368 (a) of the Internal Revenue Code of 1986, the Administrator may, in his or her sole and absolute discretion, take whatever action he or she deems necessary, advisable or appropriate with respect to the Stock Accounts in order to reflect such transaction, including, but not limited to, adjusting the number of units credited to a Participant's Stock Account.
Section 8.7. Distributions. Amounts in respect of units of Common Stock shall be distributed in cash in accordance with Sections 9, 10 and 17. For purposes of a distribution pursuant to Section 9, 10 or 17, the number of units to be distributed from a Participant's Stock Account shall be valued by multiplying the number of such units by the Market Value of the Common Stock as of the Valuation Date immediately preceding the date such distribution is to occur. Pending the complete distribution under Section 9.2 of the Stock Account of a Participant who is no longer a member of the Board, the Participant shall continue to be able to make elections pursuant to Sections 8.2 and 8.3 and his or her Stock Account shall continue to be credited with additional units of Common Stock pursuant to Sections 8.4, 8.5, and 8.6.
Section 9. Payment of Deferred Compensation.
Section 9.1. Background. No withdrawal may be made from a Participant's Accounts except as provided in this Section 9 and Sections 10 and 17.
Section 9.2. Manner of Payment. Payment of a Participant's Accounts shall be made at the sole discretion of the Administrator in a single sum or in annual installments. The maximum number of annual installments is ten. All payments from the Plan shall be made in cash.
Section 9.3. Timing of Payments. Payments shall be made on the fifth business day in March and shall commence in any year designated by the Administrator up through the tenth year following the year in which the Participant for any reason ceases to be a member of the Board.
Section 9.4. Valuation. The amount of each payment shall be equal to the value, as of the immediately preceding Valuation Date, of the Participant's Accounts, divided by the number of installments remaining to be paid. If payment of a Participant's Accounts is determined by the Administrator to be paid in installments and the Participant has a balance in his or her Stock Account at the time of the payment of an installment, the amount that shall be distributed from his or her Stock Account shall be the amount obtained by multiplying the total amount of the installment determined in accordance with the immediately preceding sentence by the percentage obtained by dividing the balance in the Stock Account as of the immediately preceding Valuation Date by the total value of the Participant's Accounts as of such Valuation Date. Similarly, in such case, the amount that shall be distributed from the Participant's Deferred Compensation Account shall be the amount obtained by multiplying the total amount of the installment determined in accordance with the first sentence of this Section 9.4 by the percentage obtained by dividing the balance in the Deferred Compensation Account as of the immediately preceding Valuation Date by the total value of the Participant's Accounts as of such Valuation Date.
Section 10. Payment of Deferred Compensation After Death. If a Participant dies prior to complete payment of his or her Accounts, the provisions of this Section 10 shall become operative.
Section 10.1. Stock Account. Effective as of the date of a Participant's death, the entire balance of his or her Stock Account shall be transferred to his or her Deferred Compensation Account. For purposes of valuing the units of Common Stock subject to such a transfer, the deceased Participant's Deferred Compensation Account shall be credited with a dollar amount equal to the amount obtained by multiplying the number of units in the deceased Participant's Stock Account at the time of his or her death by the Market Value of the Common Stock on the date of his or her death. Thereafter, no amounts in the deceased Participant's Deferred Compensation Account shall be eligible for transfer to the deceased Participant's Stock Account by any person, including, but not by way of limitation, the deceased Participant's beneficiary or legal representative.
Section 10.2. Distribution. The balance of the Participant's Accounts, valued as of the Valuation Date immediately preceding the date payment is made, shall be paid in a single, lump-sum payment to: (1) the beneficiary or contingent beneficiary designated by the Participant in accordance with Section 10.3; or, in the absence of a valid designation of a beneficiary or contingent beneficiary, (2) the Participant's estate within 30 days after appointment of a legal representative of the deceased Participant.
Section 10.3. Beneficiary Designation. Each Participant shall have the right, at any time, to designate any person or persons as his or her Beneficiary or Beneficiaries (both primary and contingent) to whom payment under this Plan shall be paid in the event of his or her death prior to complete distribution to the Participant of the benefits due him or her under the Plan. Each Beneficiary designation shall become effective only when filed in writing with the Administrator during the Participant's lifetime on a form provided by the Administrator. The filing of a new Beneficiary designation form with the Administrator will cancel all Beneficiary designation(s) previously filed.
Section 11. Participant's Rights Unsecured. The amounts payable under the Plan shall be unfunded, and the right of any Participant or his or her estate to receive any payment under the Plan shall be an unsecured claim against the general assets of Kodak. No Participant shall have the right to exercise any of the rights or privileges of a shareholder with respect to the units credited to his or her Stock Account.
Section 12. Non-Assignability. The right of a Participant to the payment of deferred compensation as provided in this Plan shall not be subject in any manner to alienation, anticipation, sale, transfer (except by will or the laws of descent and distribution), assignment, pledge, or encumbrance.
Section 13. Statement of Account. Statements will be sent no less frequently than annually to each Participant or his or her beneficiary or estate showing the value of the Participant's Accounts.
Section 14. Administration.
Section 14.1. Responsibility. The Administrator of the Plan shall be the Comptroller of Kodak. The Administrator shall have total and exclusive responsibility to control, operate, manage and administer the Plan in accordance with its terms.
Section 14.2. Authority of the Administrator. The Administrator shall have all the authority that may be necessary or helpful to enable him or her to discharge his or her responsibilities with respect to the Plan. Without limiting the generality of the preceding sentence, the Administrator shall have the exclusive right: to interpret the Plan, to determine eligibility for participation in the Plan, to decide all questions concerning eligibility for and the amount of benefits payable under the Plan, to construe any ambiguous provision of the Plan, to correct any default, to supply any omission, to reconcile any inconsistency, and to decide any and all questions arising in the administration, interpretation, and application of the Plan.
Section 14.3. Discretionary Authority. The Administrator shall have full discretionary authority in all matters related to the discharge of his or her responsibilities and the exercise of his or her authority under the Plan including, without limitation, the construction of the terms of the Plan and the determination of eligibility for participation and benefits under the Plan. It is the intent of the Plan that the decisions of the Administrator and his or her actions with respect to the Plan shall be final and binding upon all persons having or claiming to have any right or interest in or under the Plan and that no such decision or action shall be modified upon judicial review unless such decision or action is proven to be arbitary or capricious.
Section 14.4. Delegation of Authority. The Administrator may delegate some or all of his or her authority under the Plan to any person or persons provided that any such delegation be in writing.
Section 15. Amendment. The Plan may at any time or from time to time be amended, modified, suspended or terminated by resolution of the Board. However, no amendment, modification, or termination shall, without the consent of a Participant, adversely affect such Participant's accruals in his or her Accounts.
Section 16. Governing Law. The Plan shall be construed, governed and enforced in accordance with the law of New York State, except as such laws are preempted by applicable federal law.
Section 17. Change in Control.
Section 17.1. Background. Upon a Change In Control: (i) the terms of this Section 17 shall immediately become operative, without further action or consent by any person or entity, (ii) all terms, conditions, restrictions, and limitations in effect on any deferred compensation shall immediately lapse as of the date of such event; and (iii) no other terms, conditions, restrictions, and/or limitations shall be imposed upon any deferred compensation on or after such date, and in no circumstance shall any Account be forfeited on or after such date.
Section 17.2. Payment of Deferred Compensation. Upon a Change in Control, each Participant, whether or not he or she is still a member of the Board, shall be paid in a single, lump-sum cash payment the balance of his or her Accounts as of the Valuation Date immediately preceding the date payment is made. Such payment shall be made as soon as practicable, but in no event later than 90 days after the date of the Change in Control.
Section 17.3. Amendment On or After Change In Control. Upon a Change in Control, no action, including, but not by way of limitation, the amendment, modification, suspension or termination of the Plan, shall be taken which would affect the rights of any Participant or the operation of this Plan with respect to the balance in the Participant's Accounts.
Section 18. No Guarantee of Tax Consequences. No person connected with the Plan in any capacity, including, but not limited to, Kodak and its directors, officers, agents and employees makes any representation, commitment, or guarantee that any tax treatment, including, but not limited to, federal, state and local income, estate and gift tax treatment, will be applicable with respect to amounts deferred under the Plan, or paid to or for the benefit of a Participant or Beneficiary under the Plan, or that such tax treatment will apply to or be available to a Participant or Beneficiary on account of participation in the Plan.
Section 19. Compliance with Securities Laws. The Board may, from time to time, impose additional, or modify or eliminate existing, Plan terms, provisions, restrictions or requirements, including, but not by way of limitation, the provisions regarding a Participant's ability to elect into and out of his or her Stock Account under Sections 8.2 and 8.3 or the requirement of an automatic transfer pursuant to Section 10.1, as it deems necessary, advisable or appropriate in order to comply with applicable federal or state securities laws.
Exhibit (10) K
BENEFIT PLAN 1I.03 Effective Date: March 1, 1994 No. of Pages: 16
Supplementary Group Life Insurance Plan
Article Page
1. Introduction ................................................... 87
2. Definitions .................................................... 87
3. Eligibility .................................................... 93
4. Amount of Coverage and Cost .................................... 93
5. Beneficiaries .................................................. 95
6. Irrevocable Assignment ......................................... 95
7. Contributions .................................................. 96
8. Payment of Benefits ............................................ 96
9. Maximum Benefits ............................................... 96
10. Coverage--Continuation, Termination, Conversion, On Return to Work 96
11. Administration and General Provisions ........................... 100
ARTICLE 1. INTRODUCTION
The SGLI Plan is designed to help Kodak men and women meet burial and other last expenses (including bills unpaid at time of death) and to help provide for the financial security of their surviving dependents.
ARTICLE 2. DEFINITIONS
2.01 Average Weekly Hours
"Average Weekly Hours" means a weekly average obtained by dividing all hours worked plus all paid absence hours in the previous 52 weeks by weeks out of the last 52 weeks where work was performed or a paid absence occurred.
2.02 College Cooperative Intern
"College Cooperative Intern" is a college student pursuing studies of interest to Kodak and who generally works a full-time schedule on an alternate work/school block basis.
2.03 Company
"Company" is Eastman Kodak Company and the following subsidiaries: Eastman Chemical International Ltd.; Eastman Chemical Products, Inc.; Eastman Gelatine Corporation; Eastman Kodak International Capital Company, Inc.; Eastman Kodak International Sales Corporation; Holston Defense Corporation; Kodak Caribbean, Limited; and Kodak Processing Laboratory, Inc.
2.04 Disabled Person
"Disabled Person" is any person who is approved for benefits under the Kodak Long Term Disability Plan or the predecessor Total and Permanent Disability Plan.
2.05 Employee
"Employee" is any person (other than a Limited Service Employee) who is employed by the Company in the U.S. and is compensated for services in the form of a salary or an hourly wage. "Employee" also means certain persons employed abroad by the Company as determined by the Plan Administrator.
2.06 Family Protection Program (FPP)
"Family Protection Program" (FPP) is the program consisting of: Basic Life Insurance, Contributory Optional Life Insurance, Non-Contributory Optional Life Insurance, Dependents Life Insurance, Basic Survivor Income Benefit, Optional Survivor Income Benefit, Occupational Accidental Death Insurance, and Supplementary Group Life Insurance.
2.07 Insurance Annual Salary Rate
"IASR" or "Insurance Annual Salary Rate" means:
(a) An Employee's individual (hourly) rate in effect on a particular day, plus the average shift allowance in effect on the same day, multiplied by:
(1) 2,080 hours for:
(A) Regular Full-Time Employees (B) Full-Time Provisional Employees (C) Full-Time Supplementary Employees (D) Full-Time Special Program Employees (E) Full-Time Buffer Workers at Eastman Chemical Company
(2) Moving average weekly hours in effect on that day (or normal scheduled weekly hours up to 40 if the Employee had not been employed for the full year immediately preceding that day) multiplied by 52 for:
(A) Nonexempt Regular Part-Time Employees (B) Nonexempt Part-Time Provisional Employees (C) Nonexempt Part-Time Supplementary Employees (D) Nonexempt Part-Time Special Program Employees (E) Nonexempt Part-Time Employees at Eastman Chemical Company (for the purpose of calculating Benefits)
(3) Normal scheduled weekly hours in effect on that day multiplied by 52 for:
(A) Exempt Regular Part-Time Employees (B) Exempt Part-Time Provisional Employees (C) Exempt Part-Time Supplementary Employees (D) Exempt Part-Time Special Program Employees (E) Nonexempt Part-Time Employees at Eastman Chemical Company (for the purpose of calculating Price Tags)
(4) 1,040 hours for:
(A) College Cooperative Interns (B) All Employees, other than regular part-time physicians, whose moving average weekly hours or normal scheduled hours is less than 20.
(b) An Employee's IASR is rounded to the nearest $100.
(c) When an Employee's employment classification changes from a part-time class to a full-time class described above, or from a full-time class to a part-time class described above, the hours component of IASR is adjusted as of the date of such reclassification for determining Benefits and Price Tags.
(d) Because the individual rate for certain commission-eligible employees is reduced below the normal rate for their applicable salary grade, IASR is adjusted by multiplying the individual rate times the commission calculating factor for the appropriate commission plan specified in Compensation Plan 2C1.
(e) Because the base salary rate for each Employee eligible for certain management performance incentives is reduced below the normal rate for his applicable salary grade, IASR is adjusted to reflect what the normal rate would be in the absence of the reduction under the management performance incentive arrangement.
(f) Because the base salary rate for each Employee of the Eastman Chemical Company participating in the Success Sharing Program is reduced below the normal rate for his applicable salary rate, IASR is adjusted to reflect what the normal rate would be in the absence of the reduction under the Success Sharing Program.
2.08 Insurance Company
"Insurance Company" is Metropolitan Life Insurance Company, One Madison Avenue, New York, New York 10010, and any other Insurance Company which may issue one or more group policies to Eastman Kodak Company for coverage under the SGLI Plan.
2.09 Key Employee
"Key Employee" is any Employee who meets the criteria of Key Employee as defined in Section 416(i)(1)(A) of the Internal Revenue Code.
2.10 Limited Service Employee
"Limited Service Employee" is a person who is hired by the Company for the specified purpose of meeting short-term needs of 900 hours or less in any consecutive 12-month period and who is designated as a Limited Service Employee when hired.
2.11 Long Term Disability (LTD)
The terms "Long Term Disability" and "LTD" are, for purposes of the SGLI Plan, restricted to their meanings under the Long Term Disability Plan or any predecessor thereto.
2.12 Normal Retirement Age
"Normal Retirement Age" is 65 (60, in the case of Employees employed as aircraft pilots on their 60th birthdays).
2.13 Normal Retirement Date
"Normal Retirement Date" is the first day of the calendar month immediately following an Employee's or Disabled Person's 65th birthday (60th birthday, in the case of an Employee employed as an aircraft pilot).
2.14 Plan Administrator
"Plan Administrator" is the person authorized to control and manage the operation and administration of the SGLI Plan. The current Plan Administrator, who is also the "named fiduciary" as defined in the Employee Retirement Income Security Act (ERISA), is the Director, Employee Benefits, Eastman Kodak Company.
2.15 Regular Full-Time Employee
"Regular Full-Time Employee" is an Employee who does not fall into another employment classification and who works a schedule of:
40 or more hours per week (shorter time periods where required by law, by Company needs, or by the Employee's health); or
Alternative work schedules such as alternating 36 and 48 hour workweeks comprised of 12-hour days.
2.16 Regular Part-Time Employee
"Regular Part-Time Employee" is an Employee who does not fall into another employment classification and who works a regular schedule of less than 40 hours per week.
2.17 Retiree
"Retiree," as used in this Plan, is either:
a) any former Employee or Disabled Person who is eligible to commence a benefit under the early or normal retirement provisions of the Kodak Retirement Income Plan or under the provisions of any of the Company's special early retirement supplement plans (other than persons retired from Ridge Construction Corporation, Bays Mountain Construction Company, or Caddo Construction Company); or
b) any former Employee who separated from employment under a special separation program of the Company with a total of age and service equal to at least 75 years.
2.18 Special Program Employee
"Special Program Employee" includes the following:
1) Temporary Employee. A "Temporary Employee" is an Employee in the Eastman Chemical Company who is expected to work a full-time or a part-time schedule for a specified length of time, which is normally less than 6 months. Other forms of Temporary Employee are as follows:
i) Drafting Trainee/Assistant. "Drafting Trainee/Assistant" is a technical school drafting student working a full-time schedule for 10 to 12 weeks during the final year of school.
ii) Summer Technical Employee. "Summer Technical Employee" is a business/technical degree student on a summer work schedule (including, but not limited to, Kodak Scholars and other Company-sponsored educational aid program students). A Summer Technical Employee is similar to an "EK Scholar" or a "Summer Intern" at other divisions of Eastman Kodak Company.
iii) Study-Work Student. "Study-Work Student" is a high school vocational student working a part-time schedule in areas related to his/her curriculum. A Study-Work Student is similar to a "High School Co-op" or a "High School Intern" at other divisions of Eastman Kodak Company.
iv) Clerical Assistant Trainee. "Clerical Assistant Trainee" is a technical school office administrative student who is employed to work a full-time schedule for one quarter or semester during the final year of school.
2) High School Co-op. A "High School Co-op" is a high school senior working a part-time schedule (normally 20 hours per week, but more hours may be worked during vacation or school breaks, following graduation, or where school conditions permit). A High School Co-op is limited to 9 months of employment (a school year) except where 12 months is needed in special situations.
3) High School Intern. A "High School Intern" is a high school student working a full-time schedule during summer vacations (including the summer immediately following graduation), and is generally limited to 8 weeks of employment.
4) General Summer Employee. A "General Summer Employee" is a person hired on a full-time or part-time basis for the summer following the completion of at least one year of college. Employment of any individual as a General Summer Employee is limited to two summers.
5) EK Scholar. An "EK Scholar" is a two-year or four-year college student employed on a full-time basis during the summer or a school break whose tuition, housing, and miscellaneous expenses may be paid for by Kodak.
6) PRIS2M. A "PRIS2M" is a third- or fourth-year high school student with a mathematics and science major, who generally works a part-time schedule (usually for 8 weeks).
7) Summer (College) Intern. A "Summer (College) Intern" is a college student pursuing studies of interest to Kodak, who generally works a full-time schedule during the summer.
8) Teacher Intern. A "Teacher Intern" is a high school or college teacher hired on a full-time basis, generally for a minimum of 10 weeks up to the length of the summer break.
9) DP2 Intern. A "DP 2 Intern" is a disabled person working full time in a 10-week training program.
2.19 Spouse
"Spouse" is a Subscriber's husband or wife, including a husband or wife through common-law marriage.
2.20 Subscriber
"Subscriber" is an Employee or former Employee who is covered under the SGLI Plan.
2.21 Supplementary Employee
"Supplementary Employee" is an Employee who is classified as a Supplementary Employee by an agreement and works a full-time or part-time schedule. The duration of employment with the Company is expected to last no more than 2 years, at which time the individual may be reclassified as a regular employee or terminated. The termination date originally specified in the agreement may be extended by the Company for a short duration for business reasons.
2.22 Supplementary Group Life Insurance (SGLI)
Supplementary Group Life Insurance (SGLI) is group term life insurance designed to provide death benefits for active Employees, Retirees, and Disabled Persons, based on length of service and annual earnings.
ARTICLE 3. ELIGIBILITY
The groups indicated below are eligible to participate in the SGLI Plan:
a) Employees. Employees who:
- were employed by the Company on December 31, 1983;
- were age 55 or older on January 1, 1984;
- enrolled in SGLI before January 1, 1987; and
- had an annual salary at the time of enrollment which equaled or exceeded the minimum amount identified on the SGLI Eligibility Schedule issued by the Plan Administrator.
b) Disabled Persons. Disabled persons who were covered under the SGLI Plan on the effective date of their disability and have been covered on a continuous basis since that date.
c) Retirees. Retirees who were covered under the SGLI Plan on a continuous basis since the date which they first became eligible for coverage through their effective date of retirement. However, anyone who was a Key Employee on or after January 1, 1984, and who was not age 55 or older on that date may not participate in the SGLI Plan after December 31, 1986.
ARTICLE 4. AMOUNT OF COVERAGE AND COST
4.01 Coverage for Employees and Disabled Persons
The amount of SGLI for a covered Employee is 2.0 times his IASR. The amount of coverage for any covered Employee will never be reduced except in the case of a decrease in IASR because of a general wage decrease.
If a covered Employee becomes disabled under the LTD Plan, the amount of coverage in force immediately before the effective date of disability will be continued for the duration of the disability.
4.02 Coverage for Retirees
If retirement occurs prior to age 65 following the completion of 10 or more years of service, the coverage will be continued in full through age 65. The coverage in effect at age 65 will be reduced in five equal decrements on the first of the month following each of the Retiree's 66th through 70th birthdays.
The amount of the reduction varies according to the Retiree's years of service. The level of coverage at age 70 and later is expressed as a percentage of the coverage in effect at age 65 as shown in the following table:
Coverage at Age 70 as a Percentage of Years of Service Coverage at Age 65*
10 25 11 27 1/2 12 30 13 32 1/2 14 35 15 37 1/2 16 40 17 42 1/2 18 45 19 47 1/2 20 or more 50
*Coverage in retirement will be based on one of two factors, whichever is more beneficial to the Subscriber:
(1) the amount of coverage at age 65, or (2) the amount of coverage at retirement.
The higher of these two amounts will be multiplied by the appropriate percentage from this column (the percentage used is that corresponding to the Subscriber's years of service, prorated for partial years).
If retirement occurs at age 65 following the completion of 10 or more years of service, the SGLI coverage will be reduced in five equal decrements so that coverage at age 70 will be as described in the above table.
If retirement occurs after age 65 following the completion of at least 10 but less than 20 years of service, the SGLI coverage will be reduced to the level which would have been in effect had retirement occurred at age 65.
For a retirement occurring after age 65 with the completion of 20 or more years of service, the coverage in effect at retirement will be reduced on the first of the month following each of the retiree's birthdays through age 70 in accordance with the following table:
Ages Level Available
66 1.80 Times IASR 67 1.60 " " 68 1.40 " " 69 1.20 " " 70 & Over 1.00 " "
If a covered Employee completed at least 5 but fewer than 10 years of service as of the date of retirement, the coverage will be reduced to $1,000 upon retirement; for those with fewer than 5 years of service, the coverage will be reduced to $500 upon retirement.
Coverage will be canceled upon retirement if it has not been maintained continuously since the date on which the Subscriber first became eligible for coverage.
4.03 Cost
SGLI is non-contributory for Retirees, Disabled Persons while they remain disabled, and, in some cases, for eligible Employees as specified in Section 10.01.
4.04 Contribution Rate for Employees
For covered Employees who are age 60 or older and for covered Key Employees, regardless of age, the monthly cost of SGLI is 60 cents per $1,000 of coverage. For covered Employees younger than age 60, the monthly cost of SGLI is 38 cents per $1,000 of coverage.
Contributions for a year are based on the Employee's IASR as of January 1 of that year.
ARTICLE 5. BENEFICIARIES
5.01 Beneficiaries
The Subscriber can name one or more primary beneficiaries plus one or more contingent beneficiaries. If a beneficiary dies before the Subscriber dies, the rights and interest of that beneficiary automatically terminate.
All beneficiary designations must be made on forms approved by the Plan Administrator.
5.02 Changing a Beneficiary
A Subscriber can change his SGLI beneficiaries at any time without the consent of those beneficiaries. All notices of beneficiary change must be made on forms approved by the Plan Administrator. When the notice of change is received by the Company, it will take effect on the date the notice was signed, whether or not the Subscriber is living at the time such notice is received. However, both the Company and the Insurance Company are discharged from any further liability if a previously named beneficiary is paid before the Company receives a change-of-beneficiary form.
5.03 If No Beneficiary is Named
The proceeds of any SGLI in force when the Subscriber dies will be paid to the beneficiaries. If there is no named beneficiary, if no named beneficiary is living, or if the beneficiary designation is invalid, payment will be made to the Subscriber's surviving Spouse; if none, to the Subscriber's surviving children in equal shares; if none, to the Subscriber's surviving parents in equal shares; if none, to the Subscriber's estate.
ARTICLE 6. IRREVOCABLE ASSIGNMENT
The Subscriber's rights of ownership in the SGLI coverage may be assigned to another person or a trust for any purpose except as security for a loan. Assignments are irrevocable and, to be effective, must be approved by the Company and the Insurance Company. The rights of ownership include the right to any future additional amounts of insurance provided by the coverage, the right to designate beneficiaries and elect settlement options, and the right to reduce coverage.
The Company and the Insurance Company assume no responsibility for the validity, effect, or sufficiency of any assignment for any purpose whatsoever.
ARTICLE 7. CONTRIBUTIONS
7.01 First and Last Contribution
Subscriber contributions required for SGLI are taken from the first full week of coverage through the end of the month in which coverage terminates or, where coverage changes from contributory to non-contributory, through the end of the final month of contributory coverage.
ARTICLE 8. PAYMENT OF BENEFITS
Payment of SGLI proceeds may be made under a number of options, including a lump-sum settlement, periodic installments, a life-income arrangement, an interest option, or a combination of these. The Subscriber may leave the election to his beneficiary or he may make his election (revocably or irrevocably) in advance.
The number and form of the payment options, as well as the applicable interest rates, can change from time to time as determined by the Insurance Company. Up-to-date information and election forms are available from a Personnel Relations representative.
ARTICLE 9. MAXIMUM BENEFITS
For subscribers to the Group Life Insurance/Survivor Benefit Insurance Plans, the combined maximum allowed under the Group Life Insurance Plan, the Survivor Benefit Insurance Plan, and SGLI Plan is $1,000,000 with SGLI being limited to $500,000. If this combined maximum is reached, coverage is reduced in the following sequence:
a) Survivor Benefit Insurance b) SGLI c) Group Life Insurance
For subscribers to the Family Protection Program, the combined maximum amount payable for Basic Life Insurance, Optional Life Insurance and SGLI is $3,000,000. If this combined maximum is reached, coverage is reduced in the following sequence:
a) Optional Life Insurance b) SGLI c) Basic Life Insurance
ARTICLE 10. COVERAGE -- CONTINUATION, TERMINATION, CONVERSION, ON RETURN TO WORK
10.01 Coverage Continuation
a) Leave of Absence. If an Employee was a Subscriber immediately before the leave, SGLI coverage may be continued during the leave if, before the leave, the Subscriber makes arrangements to pay his contributions during the leave. Contributions will change if SGLI contribution rates change during the leave.
If a Subscriber who carried SGLI coverage during a leave fails to return to work when the leave expires, coverage ends on the last day of the month in which the leave expires. If, before the leave expires, the Company receives notification that the Subscriber does not intend to return to work, coverage ends on the last day of the month in which such notification is received.
b) Layoff. SGLI coverage continues on a non-contributory basis for four months after the end of the month in which the layoff commenced.
c) Short-Term Disability. Where the employment of a Subscriber terminates upon the exhaustion of benefits payable under the Short-Term Disability Plan and the Subscriber does not qualify for benefits under the Long-Term Disability Plan, SGLI coverage continues on a noncontributory basis for two months following the month in which employment terminates.
d) Retirement or Long Term Disability. If a person was a Subscriber immediately before his effective date of retirement under the Kodak Retirement Income Plan or immediately before the date on which he became a Disabled person, coverage continues as provided in Sections 4.01 and 4.02.
e) Termination Under Special Separation Plans. The Company may, at its option, extend coverage on a non-contributory basis for eligible Employees whose employment terminates under any special separation plan, special early retirement plan, or special early retirement supplement plan.
f) Divestiture. Where the employment of a Subscriber is terminated by his or her Company due to a "divestiture," as defined in Section 10.05, by such Company and the Subscriber is not offered an "equivalent job," as hereafter defined, in the same geographic area by the acquirer, purchaser or other transferee of the division, business, function, facility, unit or group of assets sold or otherwise disposed of by way of the "divestiture," the SGLI coverage continues on a noncontributory basis for the two (2) months following the month in which employment terminates. For purposes of this Article 10, an "equivalent job" means any job whose base rate is within ten percent (10%) of current base rate; except that in the Eastman Chemicals Division, "equivalent job" means any job whose base rate is within ten percent (10%) of the highest base rate held during the preceding twelve (12) months.
g) Completion of Supplementary, Provisional or Special Program Employment. Supplementary Group Life Insurance coverage continues, on a non-contributory basis, until the end of the month in which supplementary or special program employment terminates. However, if a Subscriber accepts a transfer to a position as a Supplementary, Provisional or Special Program Employee in lieu of layoff or termination under a special separation plan, he will have SGLI coverage on a non-contributory basis at the end of the supplementary, provisional or special program employment for the period of time that such coverage would have been available had he been laid off or terminated under a special separation plan.
10.02 When Coverage Ends
SGLI coverage ends at midnight on the last day of the month in which the earliest of the following dates occurs:
a) The coverage termination date communicated by the Subscriber to the Company in a written notice.
b) The date on which employment is terminated except as specified in Section 10.01.
c) The date on which the group policy is discontinued.
SGLI coverage also ends at midnight on the last day of the month in which the earlier of the following events occurs:
a) The Subscriber fails to make a required monthly contribution for contributory coverages.
b) The Employee-Subscriber who has not maintained continuous coverage under SGLI retires.
10.03 Conversion Privilege
A conversion privilege is available for Supplementary Group Life Insurance when coverage ceases or is reduced under the circumstances described below:
a) Employment is Terminated. If employment terminates for any reason, coverage may be continued under an individual life insurance policy, without disability or accidental death benefits. The policy may be in any form customarily issued by the Insurance Company, except term insurance. A Subscriber may, however, elect a term insurance policy for a period of up to one year. The amount of such individual policy will be equal to (or at the Subscriber's option, less than) the amount of his coverage in effect on his employment termination date.
b) The Group Policy is Terminated. If the group policy is terminated, then a Subscriber may obtain an individual policy of life insurance, subject to the same terms and conditions as upon cessation of such coverage due to termination of employment. However, the amount of such individual policy will not exceed the amount of the coverage under the group policy on the date of cessation of such coverage, reduced by any amount of coverage for which he may be or may become eligible under any group policy issued or reinstated by the Insurance Company or any other insurer within 45 days after such cessation.
c) Attainment of Certain Ages. If the amount of a Subscriber's coverage is reduced, for any reason upon attainment of age 65 or later, by at least twenty percent (20%), the life insurance conversion privilege described above will be available to him on the date of the reduction. The twenty percent (20%) may be the result of one reduction or a series of smaller reductions. For any subsequent reduction in the amount of his coverage which is at least twenty percent (20%), the conversion privilege will again be available. The amount of any individual policy issued, as a result of any reduction, will not be more than the amount of the reduction. However, in the event that the Subscriber does not apply for that amount during the conversion period described below, he will not be able to apply for that amount during a later conversion period which may be available to him.
Conversion periods begin on the first day following the day on which coverage terminates or is reduced by at least twenty percent (20%) and end 31 days thereafter. If the Subscriber should die during a conversion period, the amount of his coverage will be payable to his beneficiary whether or not he applied for an individual policy.
If a Subscriber is not given written notice at least 15 days before or after the first day of the conversion period of the right to obtain an individual life insurance policy, he will have additional time in which to apply for such a policy. If such notice is given more than 15 days but less than 90 days after the first day of the conversion period, he will then have 45 days from the date notice is given in which to apply for an individual policy. In no event may a Subscriber apply later than the 90th day after the first day of the conversion period.
In any of the cases described above, to obtain an individual policy, a Subscriber must apply to the Insurance Company in writing and must pay the applicable premium no later than the last day of the conversion period. The individual policy will become effective when the group coverage terminates.
10.04 Coverage on Return to Work After Termination or Leave of Absence
Continued participation in SGLI on reemployment, reinstatement (including return from retirement or Long-Term Disability), or return from leave of absence is based on the following provisions:
a) If a person was covered under the SGLI Plan continuously from the date of leaving to the date of return and meets the requirements of Article 3 at the time of returning, such coverage is continued upon return.
b) In all other cases, this coverage is not available upon return to work.
10.05 Divestiture
Except to the extent expressly provided in Section 10.01(f), a Subscriber whose employment by his or her Company is terminated due to a "divestiture," as defined below, by such Company is no longer eligible for SGLI coverage and, therefore, his or her coverage(s) shall end as specified in Section 10.02. For purposes of this Article 10, the term "divestiture" shall mean the sale or other disposition, other than a sale or disposition of a subsidiary company or venture, by a Company of a division, business, function, facility or unit or other group of assets.
ARTICLE 11. ADMINISTRATION AND GENERAL PROVISIONS
Whenever a covered Employee or covered Disabled Person retires, insurance certificates are provided describing the provisions that apply specifically to him.
11.01 Plan Amendment, Suspension, or Termination
Eastman Kodak Company may amend, suspend, or terminate the Plan in whole or in part at any time, for any reason. For purposes of ERISA Section 402(b)(3), the procedure for amending, suspending and terminating the Plan is the adoption of a resolution by the Board or Benefit Plans Committee to such effect. A resolution is considered adopted when a majority of the members of the Board or Benefit Plans Committee approve of the resolution by voice or written vote at a Board or Committee meeting, whichever is applicable, or if no meeting is held, the resolution is in writing and signed by all of the members of the Board or Benefit Plans Committee.
11.02 Claims and Appeal Procedures
The claims and appeal procedures are described in the General Administration section of You and Kodak.
11.03 Governing Law
This document shall be construed in accordance with the laws of New York State, except where the law of some other jurisdiction must be applied in respect of individual Subscribers or those claiming under or through them, and except as such laws are preempted by ERISA.
11.04 Gender and Number
Throughout this document, the masculine includes the feminine and the singular includes the plural unless the context indicates otherwise.
EMPLOYEE BENEFITS EASTMAN KODAK COMPANY
Exhibit (10) L
1990 OMNIBUS LONG-TERM COMPENSATION PLAN
EASTMAN KODAK COMPANY Effective March 10, 1994
1990 OMNIBUS LONG-TERM COMPENSATION PLAN March 10, 1994
Paragraph Title Page
1 Purpose 103 2 Definitions 103 3 Administration 105 4 Eligibility 105 5 Shares Available 106 6 Term 106 7 Participation 106 8 Stock Options 106 9 Stock Appreciation Rights 107 10 Stock Awards 108 11 Performance Units 108 12 Performance Shares 109 13 Payment of Awards 109 14 Dividends and Dividend Equivalents 110 15 Deferral of Awards 110 16 Termination of Employment 110 17 Nonassignability 110 18 Adjustment of Shares Available 111 19 Withholding Taxes 111 20 Noncompetition Provision 111 21 Amendments to Awards 111 22 Regulatory Approvals and Listings 112 23 No Right to Continued Employment or Grants 112 24 Amendment 112 25 Governing Law 112 26 Change in Ownership 112 27 Change in Control 114 28 No Right, Title, or Interest in Company Assets 115 29 Gender 115
EASTMAN KODAK COMPANY 1990 OMNIBUS LONG-TERM COMPENSATION PLAN
1. Purpose
The purpose of the Plan is to provide motivation to Key Employees of the Company and its subsidiaries to put forth maximum efforts toward the continued growth, profitability, and success of the Company and its Subsidiaries by providing incentives to such Key Employees through the ownership and performance of the Common Stock of the Company. Toward this objective, the Committee may grant stock options, stock appreciation rights, Stock Awards, performance units, performance shares, and/or other incentive awards to Key Employees of the Company and its Subsidiaries on the terms and subject to the conditions set forth in the Plan.
2. Definitions
2.1 "Award" means any form of stock option, stock appreciation right, Stock Award, performance unit, performance shares, or other incentive award granted under the Plan, whether singly, in combination, or in tandem, to a Participant by the Committee pursuant to such terms, conditions, restrictions and/or limitations, if any, as the Committee may establish by the Award Notice or otherwise.
2.2 "Award Notice" means a written notice from the Company to a Participant that establishes the terms, conditions, restrictions, and/or limitations applicable to an Award in addition to those established by this Plan and by the Committee's exercise of its administrative powers.
2.3 "Board" means the Board of Directors of the Company.
2.4 "Cause" means (a) the willful and continued failure by a Key Employee to substantially perform his duties with his employer after written warnings identifying the lack of substantial performance are delivered to the Key Employee by his employer to specifically identify the manner in which the employer believes that the Key Employee has not substantially performed his duties, or (b) the willful engaging by a Key Employee in illegal conduct which is materially and demonstrably injurious to the Company or a Subsidiary.
2.5 "Change In Control" means a change in control of the Company of a nature that would be required to be reported (assuming such event has not been "previously reported") in response to Item 1(a) of the Current Report on Form 8-K, as in effect on August 1, 1989, pursuant to Section 13 or 15(d) of the Exchange Act; provided that, without limitation, a Change In Control shall be deemed to have occurred at such time as (i) any "person" within the meaning of Section 14(d) of the Exchange Act, other than the Company, a subsidiary of the Company, or any employee benefit plan(s) sponsored by the Company or any subsidiary of the Company, is or has become the "beneficial owner", as defined in Rule 13d-3 under the Exchange Act, directly or indirectly, of 25% or more of the combined voting power of the outstanding securities of the Company ordinarily having the right to vote at the election of directors, or (ii) individuals who constitute the Board on February 1, 1990 (the "Incumbent Board") have ceased for any reason to constitute at least a majority thereof, provided that any person becoming a director subsequent to February 1, 1990 whose election, or nomination for election by the Company's shareholders, was approved by a vote of at least three-quarters (3/4) of the directors comprising the Incumbent Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director without objection to such nomination) shall be, for purposes of this Plan, considered as though such person were a member of the Incumbent Board.
2.6 "Change In Control Price" means the highest closing price per share paid for the purchase of Common Stock on the New York Stock Exchange during the ninety (90) day period ending on the date the Change In Control occurs.
2.7 "Change In Ownership" means a Change In Control which results directly or indirectly in the Company's Common Stock ceasing to be actively traded on the New York Stock Exchange.
2.8 "Code" means the Internal Revenue Code of 1986, as amended from time to time.
2.9 "Committee" means the Compensation Committee of the Board or such other committee designated by the Board, authorized to administer the Plan under paragraph 3 hereof. The Committee shall consist of not less than three members. A member of the Committee shall not be, and shall not within one year prior to appointment to the Committee have been, eligible to be selected to participate in the Plan or any other plan of the Company or any of its affiliates entitling participants to acquire stock, stock options, or stock appreciation rights of the Company or its affiliates.
2.10 "Common Stock" means common stock of the Company.
2.11 "Company" means Eastman Kodak Company.
2.12 "Exchange Act" means the Securities and Exchange Act of 1934, as amended.
2.13 "Key Employee" means an employee of the Company or a Subsidiary who holds a position of responsibility in a managerial, administrative, or professional capacity, and whose performance, as determined by the Committee in the exercise of its sole and absolute discretion, can have a significant effect on the growth, profitability, and success of the Company.
2.14 "Participant" means any individual to whom an Award has been granted by the Committee under this Plan.
2.15 "Plan" means the Eastman Kodak Company 1990 Omnibus Long-Term Compensation Plan.
2.16 "Stock Award" means an award granted pursuant to paragraph 10 hereof in the form of shares of Common Stock, restricted shares of Common Stock, and/or Units of Common Stock.
2.17 "Subsidiary" means a corporation or other business entity in which the Company directly or indirectly has an ownership interest of 80 percent or more.
2.18 "Unit" means a bookkeeping entry used by the Company to record and account for the grant of the following Awards until such time as the Award is paid, cancelled, forfeited or terminated, as the case may be; Units of Common Stock, performance units, and performance shares which are expressed in terms of Units of Common Stock.
3. Administration
The Plan shall be administered by the Committee. The Committee shall have the authority to: (a) interpret the Plan; (b) establish such rules and regulations as it deems necessary for the proper operation and administration of the Plan; (c) select Key Employees to receive Awards under the Plan; (d) determine the form of an Award, whether a stock option, stock appreciation right, Stock Award, performance unit, performance share, or other incentive award established by the Committee in accordance with (h) below, the number of shares or Units subject to the Award, all the terms, conditions, restrictions and/or limitations, if any, of an Award, including the time and conditions of exercise or vesting, and the terms of any Award Notice; (e) determine whether Awards should be granted singly, in combination or in tandem; (f) grant waivers of Plan terms, conditions, restrictions, and limitations; (g) accelerate the vesting, exercise, or payment of an Award or the performance period of an Award when such action or actions would be in the best interest of the Company; (h) establish such other types of Awards, besides those specifically enumerated in paragraph 2.1 hereof, which the Committee determines are consistent with the Plan's purpose; and (i) take any and all other action it deems necessary or advisable for the proper operation or administration of the Plan. In addition, in order to enable Key Employees who are foreign nationals or are employed outside the United States or both to receive Awards under the Plan, the Committee may adopt such amendments, procedures, regulations, subplans and the like as are necessary or advisable, in the opinion of the Committee, to effectuate the purposes of the Plan. The Committee shall also have the authority to grant Awards in replacement of Awards previously granted under this Plan or any other executive compensation plan of the Company or a Subsidiary. All determinations of the Committee shall be made by a majority of its members, and its determinations shall be final, binding and conclusive.
The Committee, in its discretion, may delegate its authority and duties under the Plan to the Chief Executive Officer and/or to other senior officers of the Company under such conditions and/or limitations as the Committee may establish; provided, however, that only the Committee may select and grant Awards to Participants who are subject to Section 16 of the Exchange Act.
4. Eligibility
Any Key Employee is eligible to become a Participant of the Plan.
In addition, any individual who on the effective date of the Plan is both (i) a former Key Employee of the Company or a Subsidiary, and (ii) a participant under the Eastman Kodak Company 1985 Long-Term Performance Award Plan (the "1985 Plan"), shall be eligible to become a Participant of the Plan. However, the participation of any such individual under the Plan shall be limited solely to receiving Awards granted by the Committee under this Plan in replacement of any unpaid or unearned award under the 1985 Plan on the effective date of the Plan.
5. Shares Available
The maximum number of shares of Common Stock, $2.50 par value per share, of the Company which shall be available for grant of Awards under the Plan (including incentive stock options) during its term shall not exceed Twenty-Two Million Thirty-Three Thousand and Six Hundred (22,033,600). (Such amount shall be subject to adjustment as provided in paragraph 18.) Any shares of Common Stock related to Awards which terminate by expiration, forfeiture, cancellation or otherwise without the issuance of such shares, are settled in cash in lieu of Common Stock, or are exchanged with the Committee's permission for Awards not involving Common Stock, shall be available again for grant under the Plan. Further, any shares of Common Stock which are used by a Participant for the full or partial payment to the Company of the purchase price of shares of Common Stock upon exercise of a stock option, or for any withholding taxes due as a result of such exercise, shall again be available for Awards under the Plan. Similarly, shares of Common Stock with respect to which an SAR has been exercised and paid in cash shall again be eligible for grant under the Plan. The shares of Common Stock available for issuance under the Plan may be authorized and unissued shares or treasury shares.
6. Term
The Plan shall become effective as of February 1, 1990, subject to its approval by the Company's shareholders at the 1990 annual meeting. No awards shall be exercisable or payable before approval of the Plan has been obtained from the Company's shareholders. Awards shall not be granted pursuant to the Plan after January 31, 1995.
7. Participation
The Committee shall select, from time to time, Participants from those Key Employees who, in the opinion of the Committee, can further the Plan's purposes. Once a Participant is so selected, the Committee shall determine the type or types of Awards to be made to the Participant and shall establish in the related Award Notices the terms, conditions, restrictions and/or limitations, if any, applicable to the Awards in addition to those set forth in this Plan and the administrative rules and regulations issued by the Committee.
8. Stock Options
(a) Grants. Awards may be granted in the form of stock options. These stock options may be incentive stock options within the meaning of Section 422A of the Code or non-qualified stock options (i.e., stock options which are not incentive stock options), or a combination of both.
(b) Terms and Conditions of Options. An option shall be exercisable in whole or in such installments and at such times as may be determined by the Committee. The price at which Common Stock may be purchased upon exercise of a stock option shall be established by the Committee, but such price shall not be less than 50 percent of the fair market value of the Common Stock, as determined by the Committee, on the date of the stock option's grant.
(c) Restrictions Relating to Incentive Stock Options. Stock options issued in the form of incentive stock options shall, in addition to being subject to all applicable terms, conditions, restrictions and/or limitations established by the Committee, comply with Section 422A of the Code. Accordingly, the aggregate fair market value (determined at the time the option was granted) of the Common Stock with respect to which incentive stock options are exercisable for the first time by a Participant during any calendar year (under this Plan or any other plan of the Company or any of its Subsidiaries) shall not exceed $100,000 (or such other limit as may be required by the Code). Further, the per-share option price of an incentive stock option shall not be less than 100 percent of the fair market value of the Common Stock, as determined by the Committee, on the date of grant. Also, each option shall expire not later than ten years from its date of grant. The number of shares of Common Stock that shall be available for incentive stock options granted under the Plan is 16,000,000.
(d) Additional Terms and Conditions. The Committee may, by way of the Award Notice or otherwise, establish such other terms, conditions, restrictions and/or limitations, if any, of any stock option Award, provided they are not inconsistent with the Plan.
(e) Exercise. Upon exercise, the option price of a stock option may be paid in cash, shares of Common Stock, shares of restricted Common Stock, a combination of the foregoing, or such other consideration as the Committee may deem appropriate. The Committee shall establish appropriate methods for accepting Common Stock, whether restricted or unrestricted, and may impose such conditions as it deems appropriate on the use of such Common Stock to exercise a stock option.
9. Stock Appreciation Rights
(a) Grants. Awards may be granted in the form of stock appreciation rights ("SARs"). An SAR may be granted in tandem with all or a portion of a related stock option under the Plan ("Tandem SARs"), or may be granted separately ("Freestanding SARs"). A Tandem SAR may be granted either at the time of the grant of the related stock option or at any time thereafter during the term of the stock option. SARs shall entitle the recipient to receive a payment equal to the appreciation in market value of a stated number of shares of Common Stock from the exercise price to the market value on the date of exercise. In the case of SARs granted in tandem with stock options granted prior to the grant of such SARs, the appreciation in value is from the option price of such related stock option to the market value on the date of exercise.
(b) Terms and Conditions of Tandem SARs. A Tandem SAR shall be exercisable to the extent, and only to the extent, that the related stock option is exercisable, and the "exercise price" of such an SAR (the base from which the value of the SAR is measured at its exercise) shall be the option price under the related stock option. However, at no time shall a Tandem SAR be issued if the option price of its related stock option is less than 50 percent of the fair market value of the Common Stock, as determined by the Committee, on the date of the Tandem SAR's grant. If a related stock option is exercised as to some or all of the shares covered by the Award, the related Tandem SAR, if any, shall be cancelled automatically to the extent of the number of shares covered by the stock option exercise. Upon exercise of a Tandem SAR as to some or all of the shares covered by the Award, the related stock option shall be cancelled automatically to the extent of the number of shares covered by such exercise, and such shares shall again be eligible for grant in accordance with paragraph 5 hereof, except to the extent any shares of Common Stock are issued to settle the SAR.
(c) Terms and Conditions of Freestanding SARs. Freestanding SARs shall be exercisable in whole or in such installments and at such times as may be determined by the Committee. The exercise price of a Freestanding SAR shall also be determined by the Committee; provided, however, that such price shall not be less than 50 percent of the fair market value of the Common Stock, as determined by the Committee, on the date of the Freestanding SAR's grant.
(d) Deemed Exercise. The Committee may provide that an SAR shall be deemed to be exercised at the close of business on the scheduled expiration date of such SAR if at such time the SAR by its terms remains exercisable and, if so exercised, would result in a payment to the holder of such SAR.
(e) Additional Terms and Conditions. The Committee may, by way of the Award Notice or otherwise, determine such other terms, conditions, restrictions and/or limitations, if any, of any SAR Award, provided they are not inconsistent with the Plan.
10. Stock Awards
(a) Grants. Awards may be granted in the form of Stock Awards. Stock Awards shall be awarded in such numbers and at such times during the term of the Plan as the Committee shall determine.
(b) Award Restrictions. Stock Awards shall be subject to such terms, conditions, restrictions, and/or limitations, if any, as the Committee deems appropriate including, but not by way of limitation, restrictions on transferability and continued employment. The Committee may modify or accelerate the delivery of a Stock Award under such circumstances as it deems appropriate.
(c) Rights as Shareholders. During the period in which any restricted shares of Common Stock are subject to the restrictions imposed under paragraph 10(b), the Committee may, in its discretion, grant to the Participant to whom such restricted shares have been awarded all or any of the rights of a shareholder with respect to such shares, including, but not by way of limitation, the right to vote such shares and to receive dividends.
(d) Evidence of Award. Any stock award granted under the Plan may be evidenced in such manner as the Committee deems appropriate, including, without limitation, book-entry registration or issuance of a stock certificate or certificates.
11. Performance Units
(a) Grants. Awards may be granted in the form of performance units. Performance units, as that term is used in this Plan, shall refer to Units valued by reference to designated criteria established by the Committee, other than Common Stock.
(b) Performance Criteria. Performance units shall be contingent on the attainment during a performance period of certain performance objectives. The length of the performance period, the performance objectives to be achieved during the performance period, and the measure of whether and to what degree such objectives have been attained shall be conclusively determined by the Committee in the exercise of its absolute discretion. Performance objectives may be revised by the Committee, at such times as it deems appropriate during the performance period, in order to take into consideration any unforeseen events or changes in circumstances.
(c) Additional Terms and Conditions. The Committee may, by way of the Award Notice or otherwise, determine such other terms, conditions, restrictions, and/or limitations, if any, of any Award of performance units, provided they are not inconsistent with the Plan.
12. Performance Shares
(a) Grants. Awards may be granted in the form of performance shares. Performance shares, as that term is used in this Plan, shall refer to shares of Common Stock or Units which are expressed in terms of Common Stock.
(b) Performance Criteria. Performance shares shall be contingent upon the attainment during a performance period of certain performance objectives. The length of the performance period, the performance objectives to be achieved during the performance period, and the measure of whether and to what degree such objectives have been attained shall be conclusively determined by the Committee in the exercise of its absolute discretion. Performance objectives may be revised by the Committee, at such times as it deems appropriate during the performance period, in order to take into consideration any unforeseen events or changes in circumstances.
(c) Additional Terms and Conditions. The Committee may, by way of the Award Notice or otherwise, determine such other terms, conditions, restrictions and/or limitations, if any, of any Award of performance shares, provided they are not inconsistent with the Plan.
13. Payment of Awards
At the discretion of the Committee, payment of Awards may be made in cash, Common Stock, a combination of cash and Common Stock, or any other form of property as the Committee shall determine. In addition, payment of Awards may include such terms, conditions, restrictions and/or limitations, if any, as the Committee deems appropriate, including, in the case of Awards paid in the form of Common Stock, restrictions on transfer and forfeiture provisions. Further, payment of Awards may be made in the form of a lump sum or installments, as determined by the Committee.
14. Dividends and Dividend Equivalents
If an Award is granted in the form of a Stock Award, stock option, or performance share, or in the form of any other stock-based grant, the Committee may choose, at the time of the grant of the Award or any time thereafter up to the time of the Award's payment, to include as part of such Award an entitlement to receive dividends or dividend equivalents, subject to such terms, conditions, restrictions and/or limitations, if any, as the Committee may establish. Dividends and dividend equivalents shall be paid in such form and manner (i.e., lump sum or installments), and at such time as the Committee shall determine. All dividends or dividend equivalents which are not paid currently may, at the Committee's discretion, accrue interest, be reinvested into additional shares of Common Stock or, in the case of dividends or dividend equivalents credited in connection with performance shares, be credited as additional performance shares and paid to the Participant if and when, and to the extent that, payment is made pursuant to such Award.
15. Deferral of Awards
At the discretion of the Committee, payment of a Stock Award, performance share, performance unit, dividend, dividend equivalent, or any portion thereof may be deferred by a Participant until such time as the Committee may establish. All such deferrals shall be accomplished by the delivery of a written, irrevocable election by the Participant prior to the time such payment would otherwise be made, on a form provided by the Company. Further, all deferrals shall be made in accordance with administrative guidelines established by the Committee to ensure that such deferrals comply with all applicable requirements of the Code and its regulations. Deferred payments shall be paid in a lump sum or installments, as determined by the Committee. The Committee may also credit interest, at such rates to be determined by the Committee, on cash payments that are deferred and credit dividends or dividend equivalents on deferred payments denominated in the form of Common Stock.
16. Termination of Employment
If a Participant's employment with the Company or a Subsidiary terminates for a reason other than death, disability, retirement, or any approved reason, all unexercised, unearned, and/or unpaid Awards, including, but not by way of limitation, Awards earned but not yet paid, all unpaid dividends and dividend equivalents, and all interest accrued on the foregoing shall be cancelled or forfeited, as the case may be, unless the Participant's Award Notice provides otherwise. The Committee shall have the authority to promulgate rules and regulations to (i) determine what events constitute disability, retirement, or termination for an approved reason for purposes of the Plan, and (ii) determine the treatment of a Participant under the Plan in the event of his death, disability, retirement or termination for an approved reason. Anything herein to the contrary notwithstanding, Participants who cease to be employed by the Company or a Subsidiary and are employed by Eastman Chemical Company or one of its subsidiaries in connection with the distribution of the common stock of Eastman Chemical Company to the shareholders of the Company, shall not be deemed to have terminated employment for purposes of this Plan and all Awards outstanding on the date of such distribution.
17. Nonassignability
No Awards or any other payment under the Plan shall be subject in any manner to alienation, anticipation, sale, transfer (except by will or the laws of descent and distribution), assignment, pledge, or encumbrance, nor shall any Award be payable to or exercisable by anyone other than the Participant to whom it was granted.
18. Adjustment of Shares Available
If there is any change in the number of outstanding shares of Common Stock through the declaration of stock dividends, stock splits or the like, the number of shares available for Awards, the shares subject to any Award and the option prices or exercise prices of Awards shall be automatically adjusted. If there is any change in the number of outstanding shares of Common Stock through any change in the capital account of the Company, or through any other transaction referred to in Section 425(a) of the Code, the Committee shall make appropriate adjustments in the maximum number of shares of Common Stock which may be issued under the Plan and any adjustments and/or modifications to outstanding Awards as it deems appropriate. In the event of any other change in the capital structure or in the Common Stock of the Company, the Committee shall also be authorized to make such appropriate adjustments in the maximum number of shares of Common Stock available for issuance under the Plan and any adjustments and/or modifications to outstanding Awards as it deems appropriate.
19. Withholding Taxes
The Company shall be entitled to deduct from any payment under the Plan, regardless of the form of such payment, the amount of all applicable income and employment taxes required by law to be withheld with respect to such payment or may require the Participant to pay to it such tax prior to and as a condition of the making of such payment. In accordance with any applicable administrative guidelines it establishes, the Committee may allow a Participant to pay the amount of taxes required by law to be withheld from an Award by withholding from any payment of Common Stock due as a result of such Award, or by permitting the Participant to deliver to the Company, shares of Common Stock having a fair market value, as determined by the Committee, equal to the amount of such required withholding taxes.
20. Noncompetition Provision
Unless the Award Notice specifies otherwise, a Participant shall forfeit all unexercised, unearned, and/or unpaid Awards, including, but not by way of limitation, Awards earned but not yet paid, all unpaid dividends and dividend equivalents, and all interest, if any, accrued on the foregoing if, (i) in the opinion of the Committee, the Participant, without the written consent of the Company, engages directly or indirectly in any manner or capacity as principal, agent, partner, officer, director, employee, or otherwise, in any business or activity competitive with the business conducted by the Company or any Subsidiary; or (ii) the Participant performs any act or engages in any activity which in the opinion of the Chief Executive Officer of the Company is inimical to the best interests of the Company. In addition, the Committee may, in its discretion, condition the deferral of any Award, dividend, or dividend equivalent under paragraph 15 hereof on a Participant's compliance with the terms of this paragraph 20, and cause such a Participant to forfeit any payment which is so deferred if the Participant fails to comply with the terms hereof.
21. Amendments to Awards
The Committee may at any time unilaterally amend any unexercised, unearned, or unpaid Award, including, but not by way of limitation, Awards earned but not yet paid, to the extent it deems appropriate; provided, however, that any such amendment which, in the opinion of the Committee, is adverse to the Participant shall require the Participant's consent.
22. Regulatory Approvals and Listings
Notwithstanding anything contained in this Plan to the contrary, the Company shall have no obligation to issue or deliver certificates of Common Stock evidencing Stock Awards or any other Award resulting in the payment of Common Stock prior to (a) the obtaining of any approval from any governmental agency which the Company shall, in its sole discretion, determine to be necessary or advisable, (b) the admission of such shares to listing on the stock exchange on which the Common Stock may be listed, and (c) the completion of any registration or other qualification of said shares under any state or federal law or ruling of any governmental body which the Company shall, in its sole discretion, determine to be necessary or advisable.
23. No Right to Continued Employment or Grants
Participation in the Plan shall not give any Key Employee any right to remain in the employ of the Company or any Subsidiary. The Company or, in the case of employment with a Subsidiary, the Subsidiary, reserves the right to terminate any Key Employee at any time. Further, the adoption of this Plan shall not be deemed to give any Key Employee or any other individual any right to be selected as a Participant or to be granted an Award.
24. Amendment
The Benefit Plans Committee of the Company may suspend or terminate the Plan at any time. In addition, the Benefit Plans Committee of the Company may, from time to time, amend the Plan in any manner, but may not without shareholder approval adopt any amendment which would (a) materially increase the benefits accruing to Participants under the Plan, (b) materially increase the number of shares of Common Stock which may be issued under the Plan (except as specified in paragraph 18), or (c) materially modify the requirements as to eligibility for participation in the Plan.
25. Governing Law
The Plan shall be governed by and construed in accordance with the laws of the State of New York, except as superseded by applicable Federal Law.
26. Change In Ownership
(a) Background. Upon a Change In Ownership: (i) the terms of this paragraph 26 shall immediately become operative, without further action or consent by any person or entity; (ii) all terms, conditions, restrictions, and limitations in effect on any unexercised, unearned, unpaid, and/or deferred Award, or any other outstanding Award, shall immediately lapse as of the date of such event; (iii) no other terms, conditions, restrictions and/or limitations shall be imposed upon any Awards on or after such date, and in no circumstance shall an Award be forfeited on or after such date; (iv) all unexercised, unvested, unearned, and/or unpaid Awards or any other outstanding Awards shall automatically become one hundred percent (100%) vested immediately.
(b) Dividends and Dividend Equivalents. Upon a Change In Ownership, all unpaid dividends and dividend equivalents and all interest accrued thereon, if any, shall be treated and paid under this paragraph 26 in the identical manner and time as the Award under which such dividends or dividend equivalents have been credited. For example, if upon a Change In Ownership, an Award under this paragraph 26 is to be paid in a prorated fashion, all unpaid dividends and dividend equivalents with respect to such Award shall be paid according to the same formula used to determine the amount of such prorated Award.
(c) Treatment of Performance Units and Performance Shares. If a Change In Ownership occurs during the term of one or more performance periods for which the Committee has granted performance units and/or performance shares (hereinafter a "current performance period"), the term of each such performance period shall immediately terminate upon the occurrence of such event. Upon a Change In Ownership, for each "current performance period" and each completed performance period for which the Committee has not on or before such date made a determination as to whether and to what degree the performance objectives for such period have been attained (hereinafter a "completed performance period"), it shall be assumed that the performance objectives have been attained at a level of one hundred percent (100%) or the equivalent thereof.
A Participant in one or more "current performance periods" shall be considered to have earned and, therefore, be entitled to receive, a prorated portion of the Awards previously granted to him for each such performance period. Such prorated portion shall be determined by multiplying the number of performance shares or performance units, as the case may be, granted to the Participant by a fraction, the numerator of which is the total number of whole and partial years (with each partial year being treated as a whole year) that have elapsed since the beginning of the performance period, and the denominator of which is the total number of years in such performance period.
A Participant in one or more "completed performance periods" shall be considered to have earned and, therefore, be entitled to receive all the performance shares or performance units, as the case may be, previously granted to him during each such performance period.
(d) Valuation of Awards. Upon a Change In Ownership, all outstanding Units of Common Stock, Freestanding SARs, stock options (including incentive stock options), and performance shares (including those earned as a result of the application of paragraph 26(c) above) and all other outstanding stock-based Awards, including those granted by the Committee pursuant to its authority under paragraph 3(h) hereof, shall be valued and cashed out on the basis of the Change In Control Price.
(e) Payment of Awards. Upon a Change In Ownership, any Participant, whether or not he is still employed by the Company or a Subsidiary, shall be paid, in a single lump-sum cash payment, as soon as practicable but in no event later than 90 days after the Change In Ownership, all of his outstanding Units of Common Stock, Freestanding SARs, stock options (including incentive stock options), performance units (including those earned as a result of the application of paragraph 26(c) above), and performance shares (including those earned as a result of paragraph 26(c) above), and all other outstanding Awards, including those granted by the Committee pursuant to its authority under paragraph 3(h) hereof.
(f) Deferred Awards. Upon a Change In Ownership, all Awards deferred by a Participant under paragraph 15 hereof, but for which he has not received payment as of such date, shall be paid to him in a single lump-sum cash payment as soon as practicable, but in no event later than 90 days after the Change In Ownership. For purposes of making such payment, the value of all Awards which are stock based shall be determined by the Change In Control Price.
(g) Section 16 of Exchange Act. Notwithstanding anything contained in this paragraph 26 to the contrary, any Participant who, on the date of the Change In Ownership, holds any stock options or Freestanding SARs that have not been outstanding for a period of at least six months from their date of grant and who on such date is required to report under Section 16 of the Exchange Act shall not be paid such Award until the first day next following the end of such six-month period.
(h) Miscellaneous. Upon a Change In Ownership, (i) the provisions of paragraphs 16, 20 and 21 hereof shall become null and void and of no further force and effect; and (ii) no action, including, but not by way of limitation, the amendment, suspension, or termination of the Plan, shall be taken which would affect the rights of any Participant or the operation of the Plan with respect to any Award to which the Participant may have become entitled hereunder on or prior to the date of such action or as a result of such Change In Ownership.
27. Change In Control.
(a) Background. All Participants shall be eligible for the treatment afforded by this Paragraph 27 if their employment terminates within two years following a Change In Control, unless the termination is due to (i) death, (ii) disability entitling the Participant to benefits under his employer's long-term disability plan, (iii) Cause, (iv) resignation other than (A) resignation from a declined reassignment to a job that is not reasonably equivalent in responsibility or compensation (as defined in the Company's Termination Allowance Plan), or that is not in the same geographic area (as defined in the Company's Termination Allowance Plan), or (B) resignation within thirty days following a reduction in base pay, or (v) retirement entitling the Participant to benefits under his employer's retirement plan.
(b) Vesting and Lapse of Restrictions. If a Participant is eligible for treatment under this paragraph 27, (i) all of the terms, conditions, restrictions, and limitations in effect on any of his unexercised, unearned, unpaid and/or deferred Awards shall immediately lapse as of the date of his termination of employment; (ii) no other terms, conditions, restrictions and/or limitations shall be imposed upon any of his Awards on or after such date, and in no event shall any of his Awards be forfeited on or after such date; and (iii) all of his unexercised, unvested, unearned and/or unpaid Awards shall automatically become one hundred percent (100%) vested immediately upon his termination of employment.
(c) Dividends and Dividend Equivalents. If a Participant is eligible for treatment under this paragraph 27, all of his unpaid dividends and dividend equivalents and all interest accrued thereon, if any, shall be treated and paid under this Paragraph 27 in the identical manner and time as the Award under which such dividends or dividend equivalents have been credited.
(d) Treatment of Performance Units and Performance Shares. If a Participant holding either performance units or performance shares is terminated under the conditions described in (a) above, the provisions of this paragraph (d) shall determine the manner in which such performance units and/or performance shares shall be paid to him. For purposes of making such payment, each "current performance period," as that term is defined in paragraph 26(c) hereof, shall be treated as terminating upon the date of the Participant's termination of employment, and for each such "current performance period" and each "completed performance period," as that term is defined in paragraph 26(c) hereof, it shall be assumed that the performance objectives have been attained at a level of one hundred percent (100%) or the equivalent thereof. If the Participant is participating in one or more "current performance periods," he shall be considered to have earned and, therefore, be entitled to receive that prorated portion of the Awards previously granted to him for each such performance period, as determined in accordance with the formula established in paragraph 26(c) hereof. A Participant in one or more "completed performance periods" shall be considered to have earned and, therefore, be entitled to receive all the performance shares and performance units previously granted to him during each performance period.
(e) Valuation of Awards. If a Participant is eligible for treatment under this paragraph 27, his Awards shall be valued and cashed out in accordance with the provisions of paragraph 26(d) hereof.
(f) Payment of Awards. If a Participant is eligible for treatment under this paragraph 27, he shall be paid, in a single lump-sum cash payment, as soon as practicable but in no event later than 90 days after the date of his termination of employment, all of his outstanding Units of Common Stock, Freestanding SARs, stock options (including incentive stock options), performance units (including those earned as a result of the application of paragraph 27(d) above), and performance shares (including those earned as a result of paragraph 27(d) above), and all of his other outstanding Awards, including those granted by the Committee pursuant to its authority under paragraph 3(h) hereof.
(g) Deferred Awards. If a Participant is eligible for treatment under this paragraph 27, all of his deferred Awards for which he has not received payment as of the date of his termination of employment shall be paid to him in a single lump-sum cash payment as soon as practicable, but in no event later than 90 days after the date of his termination. For purposes of making such payment, the value of all Awards which are stock based shall be determined by the Change In Control Price.
(h) Section 16 of Exchange Act. Notwithstanding anything contained in this paragraph 27 to the contrary, any Participant who, on the date of his termination of employment under the conditions described in subparagraph (a) above, holds any stock options or Freestanding SARs that have not been outstanding for a period of at least six months from their date of grant and who on the date of such termination is required to report under Section 16 of the Exchange Act shall not be paid such Award until the first day next following the end of such six-month period.
(i) Miscellaneous. Upon a Change In Control, (i) the provisions of paragraphs 16, 20 and 21 hereof shall become null and void and of no force and effect insofar as they apply to a Participant who has been terminated under the conditions described in (a) above; and (ii) no action, including, but not by way of limitation, the amendment, suspension or termination of the Plan, shall be taken which would affect the rights of any Participant or the operation of the Plan with respect to any Award to which the Participant may have become entitled hereunder on or prior to the date of the Change In Control or to which he may become entitled as a result of such Change In Control.
(j) Legal Fees. The Company shall pay all legal fees and related expenses incurred by a Participant in seeking to obtain or enforce any payment, benefit or right he may be entitled to under the Plan after a Change In Control; provided, however, the Participant shall be required to repay any such amounts to the Company to the extent a court of competent jurisdiction issues a final and non-appealable order setting forth the determination that the position taken by the Participant was frivolous or advanced in bad faith.
28. No Right, Title, or Interest in Company Assets
No Participant shall have any rights as a shareholder as a result of participation in the Plan until the date of issuance of a stock certificate in his name, and, in the case of restricted shares of Common Stock, such rights are granted to the Participant under paragraph 10(c) hereof. To the extent any person acquires a right to receive payments from the Company under this Plan, such rights shall be no greater than the rights of an unsecured creditor of the Company.
29. Gender
Throughout this Plan, the masculine gender shall include the feminine.
Exhibit (10) R
January 3, 1995
TO: Wilbur J. Prezzano
Dear Bill:
This letter is intended to confirm the following:
1. As of the date set forth above, the letter agreement between you and Kodak dated September 3, 1993 remains in effect.
2. Any Kodak retirement benefits for which you would qualify if you had retired in 1994 will be provided to you if and when you retire from Kodak. However, with respect to your retiree health and dental benefits, specific provision must be made to protect such benefits in the event the coverage you would have received had you retired in 1994 is not being provided by the Company at the time of or during your retirement. In such event, you will receive that health and dental coverage that is then being provided by the Company which, in terms of both its benefits and required participant contributions, is most comparable to the company provided coverage you would have received had you retired in 1994.
3. With regards to your expenses while traveling for Kodak, you are authorized to incur reasonable travel and lodging expenses for yourself and, in those situations you deem appropriate, your wife for purposes of carrying out your duties and responsibilities for the Company. Kodak will reimburse you for such expenses, subject to documentation in accordance with Kodak policy.
Please indicate your acceptance of the terms set forth in this letter by signing the attached duplicate original and returning the same to my attention.
Eastman Kodak Company
Date 1/5/95 Michael P. Morley
Date 1/16/95 Wilbur J. Prezzano
Exhibit (10) T
EMPLOYMENT AGREEMENT
AGREEMENT, made and entered into as of the 11th day of February, 1994 by and between Eastman Kodak Company, a New Jersey corporation (together with its successors and assigns permitted under this Agreement, the "Company"), and Mr. Harry L. Kavetas (the "Executive").
W I T N E S S E T H
WHEREAS, the Company desires to employ the Executive and to enter into an agreement embodying the terms of such employment (this "Agreement") and the Executive desires to enter into this Agreement and to accept such employment, subject to the terms and provisions of this Agreement;
NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein and for other good and valuable consideration, the receipt of which is mutually acknowledged, the Company and the Executive (individually a "Party" and together the "Parties") agree as follows:
1. Definitions.
(a) "Base Salary" shall mean the salary provided for in Section 4 below or any increased salary granted to the Executive pursuant to Section 4.
(b) "Board" shall mean the Board of Directors of the Company.
(c) "Cause" shall mean:
(i) the Executive is convicted of a felony involving moral turpitude; or
(ii) the Executive engages in conduct that constitutes willful gross neglect or willful gross misconduct in carrying out his duties under this Agreement, resulting, in either case, in material economic harm to the Company, unless the Executive believed in good faith that such act or nonact was in the best interests of the Company; or
(iii) the Executive's unlawful possession, use or sale of narcotics or other controlled substances, or performing job duties while illegally used controlled substances are present in his system; or
(iv) a material violation by the Executive of any provision of Sections 12 (a) or (b); or
(vi) a violation by the Executive of the provisions of Section 12 (c).
(d) "Constructive Termination Without Cause" shall mean a termination of the Executive's employment at his initiative as provided in this Section 11(d) following the occurrence, without the Executive's written consent, of one or more of the following events (except in consequence of a prior termination):
(i) a reduction in the Executive's then current Base Salary or target award opportunity under the Company's Management Annual Performance Plan;
(ii) the removal of the Executive from any of the positions described in Section 3 below;
(iii) a material diminution in the Executive's duties;
(iv) the failure of the Company to obtain the assumption in writing of its obligation to perform this Agreement by any successor to all or substantially all of the assets of the Company within 15 days after a merger, consolidation, sale or similar transaction.
(e) "Disability" shall have the same meaning as under the Company's Long-Term Disability Plan, as such plan is amended from time to time.
(f) "Stock" shall mean the Common Stock of the Company.
(g) "Term of Employment" shall mean the period specified in Section 2 below.
2. Term of Employment.
The Company hereby employs the Executive, and the Executive hereby accepts such employment, for the period commencing February 11, 1994 and ending at the close of business on February 10, 1999, subject to earlier termination of the Term of Employment in accordance with the terms of this Agreement.
3. Position, Duties and Responsibilities.
(a) Commencing February 11, 1994 and continuing for the remainder of the Term of Employment, the Executive shall be employed as Senior Vice President and Chief Financial Officer of the Company. Executive shall be responsible for the duties and responsibilities normally associated with the position of Chief Financial Officer, together with such additional duties and responsibilities not inconsistent therewith as may be assigned by the Chief Executive Officer. The Executive, in carrying out his duties under this Agreement, shall report to the Chief Executive Officer.
(b) Anything herein to the contrary notwithstanding, nothing shall preclude the Executive from (i) serving on the boards of directors of a reasonable number of other corporations or the boards of a reasonable number of trade associations and/or charitable organizations, (ii) engaging in charitable activities and community affairs, and (iii) managing his personal investments and affairs, provided that such activities do not materially interfere with the proper performance of his duties and responsibilities as the Company's Chief Financial Officer or violate any other terms of this Agreement.
4. Base Salary.
The Executive shall be paid an annualized Base Salary, payable in accordance with the regular payroll practices of the Company, of $550,000. The Base Salary shall be reviewed no less frequently than annually for increase in the discretion of the Board and its Executive Compensation and Development Committee (the "Committee").
5. Annual Incentive Awards.
The Executive shall participate in all annual incentive award programs maintained by the Company for its senior level executives or its employees generally, including, without limitation, the following:
(a) The Company's Management Annual Performance Plan. The Executive shall have an annual target award opportunity under such plan of at least $330,000. With regard to the Award for 1994 performance, payable in April of 1995 (the "1994 Performance Award"), the Executive shall receive a minimum guaranteed payment of $330,000. In the event, however, that the 1994 Performance Award that the Executive is awarded exceeds $330,000, the Performance Award that will be paid to him shall be an amount equal to the sum of $330,000 plus an amount determined by multiplying the amount by which the Performance Award exceeds $330,000 by a fraction the numerator of which shall be the total number of days that the Executive is employed by the Company during 1994 and the denominator of which is 365.
(b) The Company's Wage Dividend. For the purposes of the Wage Dividend, he shall be deemed to have at least five years of service. However, for purposes of the 1994 Wage Dividend payable in March of 1995, the Executive's Wage Dividend Base shall not include his entire Base Salary, but only that portion of the Base Salary which is actually paid to him during 1994, regardless of whether he elects to receive or defer such amount or parts thereof.
Payment of annual incentive awards shall be made at the same time that other senior-level executives receive their annual incentive awards.
6. Long-Term Incentive Programs.
(a) General. Except as otherwise stated in this Section 6, the Executive shall be eligible to participate in the long-term incentive programs of the Company on the same basis as other senior-level executives of the Company.
(b) Restricted Stock Award. As soon as practicable after commencement of the Executive's employment, the Company shall grant the Executive restricted shares of Stock substantially in the form attached to the Agreement as Exhibit A, such shares of Stock to be subject to forfeiture in their entirety if the Executive's employment terminates pursuant to Section 11(c) or 11(e) below prior to the end of the Term of Employment. The number of shares of restricted Stock to be granted to the Executive shall be determined by dividing $550,000 by the fair market value of a share of Stock on the date the restricted stock is granted. Fair market value shall be determined by taking the mean between the high and low at which the Stock trades on the New York Stock Exchange on the date the restricted stock is granted.
(c) Stock Option Award. As soon as practicable after commencement of the Executive's employment, the Company shall grant the Executive a 10-year option, substantially in the form attached to this Agreement as Exhibit B, to purchase 200,000 shares of Stock (the "Option"), such option to become exercisable on February 10, 1999 and to be subject to forfeiture in its entirety if the Executive's employment terminates pursuant to Section 11(c) or 11(e) below prior to such date. The exercise price (per share) of the option shall be the fair market value of a share of Stock on the date of the option's grant. Fair market value shall be determined by taking the mean between the high and low at which the Stock trades on the New York Stock Exchange on the date of the option's grant.
(d) 1993-1995 Restricted Stock Subplan. As soon as practicable after the commencement of the Executive's employment, the Executive shall become a Participant of the Company's 1993-1995 Restricted Stock Subplan (the "Subplan"). The Award that the Executive shall be eligible to receive under the Subplan shall be calculated by multiplying the amount of the Award that the Executive would have been eligible to receive had he been a Participant in the Subplan since its establishment by a fraction the numerator of which shall be the number of days that the Executive is employed by the Company during the Subplan's Award Period and the denominator of which is the total number of days in the Award Period. To the extent the Committee elects to grant Awards under the Subplan, the Award that the Executive would otherwise receive under the Subplan shall be reduced by the number of shares of Stock granted to the Executive under Section 6(b) above.
(e) Spring, 1994 Stock Option Grant. The Executive will not receive an award under the Company's Spring 1994 grant of stock options under the Eastman Kodak Company 1990 Omnibus Long-Term Compensation Plan.
7. Employee Benefit Programs.
(a) In General. During the Term of Employment, the Executive shall be entitled to participate in all employee pension and welfare benefit plans and programs made available to the Company's senior level executives or to its employees generally, as such plans or programs may be in effect from time to time, including, without limitation, pension, profit sharing, savings and other retirement plans or programs, medical, dental, hospitalization, short-term and long-term disability and life insurance plans, accidental death and dismemberment protection, travel accident insurance, and any other pension or retirement plans or programs and any other employee welfare benefit plans or programs that may be sponsored by the Company from time to time, including any plans that supplement the above-listed types of plans or programs, whether funded or unfunded.
(b) Vacation. The Executive will be entitled to six weeks paid vacation per year. However, for purposes of calendar 1994, the six weeks of paid vacation will be prorated based on the number of days the Executive is employed by the Company during such year.
(c) Service. To the extent there is a period of employment required as a condition for full benefit coverage under any employee benefit program, the Executive shall be deemed to have met such requirement. For purposes of the Company's Short-Term Disability Plan, the Executive shall be deemed to have 15 years of service immediately upon his employment with the Company. For purposes of any retiree welfare benefits of the Company for which the Executive may become eligible, the Executive's actual years of service with the Company will be used to determine his entitlement to any such benefit and he shall not be deemed to have completed any years of service with the Company in addition to his actual years of service for this purpose.
8. Supplemental Pension.
(a) The Executive shall be eligible to receive a pension benefit to be determined in accordance with the terms of the Kodak Retirement Income Plan ("KRIP")and supplements thereto as in effect on the date of this Agreement, subject to the terms of this Section 8 and adjustment for any future enhancements to KRIP and supplements thereto. For purposes of this Section 8, "supplements thereto" shall include the Kodak Excess Retirement Income Plan.
(b) For purposes of establishing (i) the total amount of "Accrued Service" used to calculate the Executive's retirement and pre-retirement survivor income benefits under KRIP, (ii) the Executive's "Total Service" for purposes of determining the applicability of the early retirement reduction factor contained in Section 5.02(b)(2) of KRIP (i.e., the 75/85 rule), and (iii) the Executive's "Vesting Service" for purposes of Section 7.02 of KRIP, Executive shall be credited with six years of service (one year of actual service and five years of additional, deemed service) for each year of service earned under the terms of KRIP. (In the event of a sixth year of employment, the Executive should be credited with two more years of additional, deemed service, bringing the Executive's total years of service to 32.)
(c) The retirement and pre-retirement survivor income benefits provided under this Section 8 shall be reduced by any benefit for which the Executive or his survivors are eligible under any other Company pension plan or pension plan of a prior employer, whether or not qualified, providing deferred compensation or survivor benefits. For purposes of determining such deduction, the amount of any benefit payable under any plan shall be calculated using, to the extent applicable, the same assumptions used to calculate benefits for the Executive or his survivors under KRIP and supplements thereto (e.g., frequency of payment, form of benefit, commencement date of payment, and, in the event the form of distribution is a lump sum, discount rate).
(d) The amount of the benefit, if any, payable to the Executive under the terms of this Section 8 shall be: (i) paid in the same form and at the same time as the Executive's benefit under KRIP or, in the event the Executive is not entitled to any benefit under the terms of KRIP, as if the amount of the benefit under this Section 8 was payable under KRIP; and (ii) unless otherwise paid under KRIP, paid out of the Company's general assets and not funded in any manner, included in the Executive's gross income as ordinary income, subject to all income and payroll tax withholdings required to be made under applicable federal, state and local law or regulation, and not grossed up in order to keep the Executive whole.
9. Reimbursement of Business and Other Expenses.
(a) Business Expenses. The Executive is authorized to incur reasonable expenses in carrying out his duties and responsibilities under this Agreement and the Company shall promptly reimburse him for all business expenses incurred in connection with carrying out the business of the Company, subject to documentation in accordance with the Company's policy.
(b) Relocation Expenses. The Executive shall be eligible for the Company's relocation policy. In accordance with the terms of such policy, the following expenses shall be reimbursed, regardless of whether he elects to sell his present residence in New Canaan, Connecticut:
(i) the cost of temporary living expenses in the Rochester, New York area for a period of time ending (i) when the Executive moves into a permanent residence in the Rochester, New York area or (ii) September 30, 1994, whichever occurs first. The Executive shall make a good faith effort to find a satisfactory permanent residence in the Rochester, New York area as soon as he reasonably can after the commencement of his employment with the Company.
(ii) the expenses the Executive incurs in connection with the purchase of a permanent residence in the Rochester, New York area and any moving expenses he incurs in moving his household goods from his present residence to such residence in Rochester.
(c) It is the intention of the Company that the Executive shall, after taking into account any taxes on a reimbursement or other benefit under Section 9(b), be kept whole with respect to such reimbursement or other benefit. Accordingly, to the extent the Executive is taxable on any such reimbursement or benefit, the Company shall pay the Executive in connection therewith an amount which after all taxes incurred by the Executive on such amount shall equal the amount of the reimbursement or benefit being provided.
10. Perquisites.
(a) Fringe Benefits. During the Term of Employment, the Executive shall be entitled to participate in any of the Company's executive fringe benefits in accordance with the terms and conditions of such arrangements as are in effect from time to time for the Company's senior-level executives. In all events, the Executive shall be entitled to the following:
(i) The Executive shall participate in the transportation pool made available to senior executives in Rochester;
(ii) The Company shall provide the Executive with personal financial (including tax) counseling by a firm to be chosen by the Executive from one of three providers available through the Company; and
(iii) During the first year of the Executive's employment, the Company shall, at Company expense, make available to the Executive Company aircraft to travel, from time to time, between Westchester County Airport and Monroe County Airport, such use to be subject to income imputation rules pursuant to applicable Internal Revenue Service regulations.
(b) Initiation Fees. The Company shall promptly reimburse the Executive for the initiation fees he incurs in order to obtain membership in one country club and one luncheon club in the Rochester, New York area. It is the intention of the Company that the Executive shall, after taking into account any taxes on a reimbursement under this Section 10(b), be kept whole with respect to such reimbursement. Accordingly, to the extent the Executive is taxable on any such reimbursement, the Company shall pay the Executive in connection therewith an amount which after all taxes incurred by the Executive on such amount shall equal the amount of the reimbursement being provided.
11. Termination of Employment.
(a) Termination Due to Death. In the event the Executive's employment is terminated due to his death, his estate or his beneficiaries as the case may be, shall be entitled to:
(i) Base Salary for a period of 90 days following the date of death;
(ii) pro rata annual incentive award under the Management Annual Performance Plan or successor thereto for the year in which the Executive's death occurs based on 100% of his target award opportunity for such year, payable in a single installment promptly after his death;
(iii) pro rata long-term performance incentive for the performance period or periods in which the Executive was participating at the time of his death based on the target award opportunity for such period or periods, payable in accordance with the terms of the plan or program under which such long-term performance incentive is provided;
(iv) the right in the Executive's estate to exercise any stock option outstanding at the time of the Executive's death in accordance with its terms;
(v) vesting of any restricted stock award outstanding at the time of the Executive's death in accordance with its terms;
(vi) the expenses associated with the relocation of the Executive's family back to New Canaan, Connecticut;
(vii) the balance of any incentive awards earned (but not yet paid);
(viii) the amounts that become due pursuant to Section 8;
(ix) any amounts earned, accrued or owing (but not yet paid) under Sections 7, 9 and 10; and
(x) other benefits in accordance with applicable plans and programs of the Company.
(b) Termination Due to Disability. In the event the Executive's employment is terminated due to his disability, he shall be entitled in such case to the following:
(i) disability benefits provided in accordance with the long-term disability program as applicable to senior executives of the Company;
(ii) pro rata annual incentive award under the Management Annual Performance Plan or successor thereto for the year in which termination due to disability occurs based on 100% of his target award opportunity for such year, payable in a single installment promptly following termination;
(iii) pro rata long-term performance incentive for the performance period or periods in which Executive was participating at the time of his death based on the target award opportunity for such period or periods, payable in accordance with the terms of the plan or program under which such long-term performance incentive is provided;
(iv) the continued right to exercise any stock option outstanding at the time of termination in accordance with its terms;
(v) vesting of any restricted stock award outstanding at the time of termination in accordance with its terms;
(vi) the expenses associated with relocation of the Executive and his family back to New Canaan, Connecticut;
(vii) continued participation, at the Company's expense, for 36 months in medical, dental, hospitalization and life insurance coverage and in all other employee plans and programs in which he was participating on the date of termination;
(viii) the balance of any incentive awards earned (but not yet paid);
(ix) the amounts that become due pursuant to Section 8;
(x) any amounts earned, accrued or owing (but not yet paid) under Sections 7, 9 and 10; and
(xi) other benefits in accordance with applicable plans and programs of the Company.
(c) Termination by the Company for Cause.
(i) A termination for Cause shall not take effect unless the Executive is given written notice by the Chief Executive Officer of the intention to terminate him for Cause.
(ii) In the event the Company terminates the Executive's employment for Cause, he shall be entitled to:
(A) the Base Salary through the date of termination;
(B) the amounts that become due pursuant to Section 8;
(C) any amounts earned, accrued or owing (but not yet paid) under Sections 7, 9 and 10; and
(D) other benefits in accordance with applicable plans and programs of the Company.
(d) Termination Without Cause or Constructive Termination Without Cause. In the event the Executive's employment is terminated without Cause, other than due to Disability or death, or in the event there is a Constructive Termination Without Cause, the Executive shall be entitled to:
(i) the Base Salary through the date of termination;
(ii) the Base Salary, at the annualized rate in effect on the date of termination of the Executive's employment (or in the event a reduction in Base Salary is the basis for a Constructive Termination Without Cause, then the Base Salary in effect immediately prior to such reduction), for a period of 18 months following such termination provided that the salary continuation payment under this Section 11(d)(ii) shall be in lieu of any salary continuation arrangements under any other severance program of the Company;
(iii) the right to exercise any stock option outstanding at the time of termination in accordance with its terms;
(iv) vesting of any restricted stock award outstanding at the time of termination in accordance with its terms;
(v) the expenses associated with relocation of the Executive and his family back to New Canaan, Connecticut;
(vi) continued participation, at the same rate of contribution that the Executive was paying immediately prior to his termination of employment, in all medical, dental, hospitalization and life insurance coverage and in other employee benefit plans or programs in which he was participating on the date of the termination of his employment until the earlier of:
(A) 18 months following termination of employment; or
(B) the date, or dates, he receives equivalent coverage and benefits under the plans and programs of a subsequent employer;
(vii) the balance of any incentive awards earned (but not yet paid);
(viii) the amounts that become due pursuant to Section 8 except that for purposes of Section 8 the Executive shall be deemed to continue in employment for the 18 months during which he receives salary continuation payments pursuant to Section 11(d)(ii) and he shall receive service credits for such period on the same basis as if he had, in fact, continued in employment;
(ix) any amounts earned, accrued or owing (but not yet paid) under Sections 7, 9 and 10; and
(x) other benefits in accordance with applicable plans and programs of the Company.
(e) Voluntary Termination. In the event of a termination of employment by the Executive on his own initiative other than a termination due to death or Disability or a Constructive Termination without Cause, the Executive shall have the same entitlements as provided in Section 11(c)(ii) above for a termination for Cause. A voluntary termination under this Section 11(e) shall be effective upon 30 days prior written notice to the Company and shall not be deemed a breach of this Agreement.
(f) No Mitigation; No Offset. In the event of any termination of employment under this Section 11, the Executive shall be under no obligation to seek other employment and there shall be no offset against amounts due the Executive under this Agreement on account of any remuneration attributable to any subsequent employment that he may obtain except as specifically provided in this Section 11.
(g) Nature of Payments. Any amounts due under this Section 11 are in the nature of severance payments considered to be reasonable by the Company and are not in the nature of a penalty.
12. Confidentiality: Assignment of Rights and Non-Competition.
(a) Confidentiality. During the Term of Employment and thereafter, the Executive shall not disclose to anyone or make use of any trade secret or proprietary or confidential information of the Company, including such trade secret or proprietary or confidential information of any customer or other entity to which the Company owes an obligation not to disclose such information, which he acquires during the Term of Employment, including but not limited to records kept in the ordinary course of business, except (i) as such disclosure or use may be required or appropriate in connection with his work as an employee of the Company or (ii) when required to do so by a court of law, by any governmental agency having supervisory authority over the business of the Company or by any administrative or legislative body (including a committee thereof) with apparent jurisdiction to order him to divulge, disclose or make accessible such information.
(b) Assignment of Rights. The Executive hereby sells, assigns and transfers to the Company all of his right, title and interest in and to all inventions, discoveries, improvements and copyrightable subject matter (the "rights") which during the Term of Employment are made or conceived by him, alone or with others and which are within or arise out of any general field of the Company's business or arise out of any work he performs or information he receives regarding the business of the Company while employed by the Company. The Executive shall fully disclose to the Company as promptly as available all information known or possessed by him concerning the rights referred to in the preceding sentence, and upon request by the Company and without any further remuneration in any form to him by the Company, but at the expense of the Company, execute all applications for patents and for copyright registration, assignments thereof and other instruments and do all things which the Company may deem necessary to vest and maintain in it the entire right, title and interest in and to all such rights.
(c) Non-Competition. The Executive understands and agrees that by virtue of his employment by the Company as its Chief Financial Officer he must and will have complete and intimate knowledge of confidential and proprietary information about the Company's, including its subsidiaries and affiliated companies, current and future business policies, accounts, suppliers, customers, technology, procedures and methods of operation all of which the Executive agrees are confidential and the sole and exclusive property of the Company.
The Parties agree that the Company would suffer great loss and damage if either during the Term of Employment or the two year period immediately following the termination of the Executive's employment for whatever reason, the Executive were to become employed by, provide services to, serve a director, consultant, advisor or in any other capacity render advice or services to a competitor of the Company, including a competitor of a wholly-owned subsidiary of the Company or a competitor of any entity in which the Company holds a fifty percent or greater interest.
Competitor shall be defined by the Chief Executive Officer, acting in his sole discretion exercising reasonable judgment as to both the then current and future anticipated activities of the Company.
The provisions and limitation of this Section 12(c) shall apply on a worldwide basis.
13. Indemnification.
(a) The Company agrees that if the Executive is made a party, or is threatened to be made a party, to any action, suit or proceeding, whether civil, criminal, administrative or investigative (a "Proceeding"), by reason of the fact that he is or was a director, officer or employee of the Company or is or was serving at the request of the Company as a director, officer, member, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, whether or not the basis of such Proceeding is the Executive's alleged action in an official capacity while serving as a director, officer, member, employee or agent, the Executive shall be indemnified and held harmless by the Company to the fullest extent legally permitted or authorized by the Company's certificate of incorporation or bylaws or resolutions of the Company's Board of Directors or, if greater, by the laws of the State of New Jersey, against all cost, expense, liability and loss (including, without limitation, attorney's fees, judgments, fines, ERISA excise taxes or penalties and amounts paid or to be paid in settlement) reasonably incurred or suffered by the Executive in connection therewith, and such indemnification shall continue as to the Executive even if he has ceased to be a director, member, employee or agent of the Company or other entity and shall inure to the benefit of the Executive's heirs, executors and administrators. The Company shall advance to the Executive all reasonable costs and expenses incurred by him in connection with a Proceeding within 20 days after receipt by the Company of a written request for such advance and a reasonably detailed description of such costs and expenses. Such request shall include an undertaking by the Executive to repay the amount of such advance if it shall ultimately be determined that he is not entitled to be indemnified against such costs and expenses.
(b) The Company agrees to continue and maintain a directors and officers' liability insurance policy covering the Executive to the extent the Company provides such coverage for its other executive officers.
14. Effect of Agreement on Other Benefits.
Except as specifically provided in this Agreement, the existence of this Agreement shall not prohibit or restrict the Executive's entitlement to full participation in the employee benefit and other plans or programs in which senior executives of the Company are eligible to participate.
15. Assignability: Binding Nature.
This Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors, heirs (in the case of the Executive) and assigns. No rights or obligations of the Company under this Agreement may be assigned or transferred by the Company except that such rights or obligations may be assigned or transferred pursuant to a merger or consolidation in which the Company is not the continuing entity, or the sale or liquidation of all or substantially all of the assets of the Company, provided that the assignee or transferee is the successor to all or substantially all of the assets of the Company and such assignee or transferee assumes the liabilities, obligations and duties of the Company, as contained in this Agreement, either contractually or as a matter of law. The Company further agrees that, in the event of a sale of assets or liquidation as described in the preceding sentence, it shall take whatever action it legally can in order to cause such assignee or transferee to expressly assume the liabilities, obligations and duties of the Company hereunder. No rights or obligations of the Executive under this Agreement may be assigned or transferred by the Executive other than his rights to compensation and benefits, which may be transferred only by will or operation of law, except as provided in Section 21 below.
16. Representation.
The Company represents and warrants that it is fully authorized and empowered to enter into this Agreement and that the performance of its obligations under this Agreement will not violate any agreement between it or him and any other person, firm or organization. The Executive represents that he knows of no agreement between him and any other person, firm or organization that would be violated by the performance of his obligations under this Agreement.
17. Entire Agreement.
This Agreement contains the entire understanding and agreement between the Parties concerning the subject matter hereof and supersedes all prior agreements, understandings, discussions, negotiations and undertakings, whether written or oral, between the Parties with respect thereto.
18. Amendment or Waiver.
No provision in this Agreement may be amended unless such amendment is agreed to in writing and signed by the Executive and an authorized officer of the Company. No waiver by either Party of any breach by the other Party of any condition or provision contained in this Agreement to be performed by such other Party shall be deemed a waiver of a similar or dissimilar condition or provision at the same or any prior or subsequent time. Any waiver must be in writing and signed by the Executive or an authorized officer of the Company, as the case may be.
19. Severability.
In the event that any provision or portion of this Agreement shall be determined to be invalid or unenforceable for any reason, in whole or in part, the remaining provisions of this Agreement shall be unaffected thereby and shall remain in full force and effect to the fullest extent permitted by law.
20. Survivorship.
The respective rights and obligations of the Parties hereunder shall survive any termination of the Executive's employment to the extent necessary to the intended preservation of such rights and obligations.
21. Beneficiaries/References.
The Executive shall be entitled, to the extent permitted under any applicable law, to select and change a beneficiary or beneficiaries to receive any compensation or benefit payable hereunder following the Executive's death by giving the Company written notice thereof. In the event of the Executive's death or a judicial determination of his incompetence, reference in this Agreement to the Executive shall be deemed, where appropriate, to refer to his beneficiary, estate or other legal representative.
22. Governing Law/Jurisdiction.
This Agreement shall be governed by and construed and interpreted in accordance with the laws of New York without reference to principles of conflict of laws.
23. Resolution of Disputes.
Any disputes arising under or in connection with this Agreement shall, at the election of the Executive or the Company, be resolved by binding arbitration, to be held in Rochester, New York in accordance with the rules and procedures of the American Arbitration Association. Judgment upon the award rendered by the arbitrator(s) may be entered in any court having jurisdiction thereof. Costs of the arbitration or litigation, including, without limitation, reasonable attorneys' fees of both Parties, shall be borne by the Company. Pending the resolution of any arbitration or court proceeding, the Company shall continue payment of all amounts due the Executive under this Agreement and all benefits to which the Executive is entitled at the time the dispute arises.
24. Notices.
Any notice given to a Party shall be in writing and shall be deemed to have been given when delivered personally or sent by certified or registered mail, postage prepaid, return receipt requested, duly addressed to the Party concerned at the address indicated below or to such changed address as such Party may subsequently give such notice of:
If to the Company: Eastman Kodak Company 343 State Street Rochester, New York 14650
Attention: Senior Vice President and General Counsel
If to the Executive: Harry L. Kavetas 314 Brushy Ridge Rd. New Canaan, Connecticut 06840
25. Headings.
The headings of the sections contained in this Agreement are for convenience only and shall not be deemed to control or affect the meaning or construction of any provision of this Agreement.
26. Counterparts.
This Agreement may be executed in two or more counterparts.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first written above.
Eastman Kodak Company
By: Senior Vice President
Harry L. Kavetas
Exhibit A
NOTICE OF RESTRICTED STOCK GRANTED [date] PURSUANT TO EASTMAN KODAK COMPANY 1990 OMNIBUS LONG-TERM COMPENSATION PLAN ("Grant Notice")
To:
You are granted [ ] shares of Eastman Kodak Company Common Stock (the "Restricted Shares"). The Restricted Shares are granted under the Eastman Kodak Company 1990 Omnibus Long-Term Compensation Plan (the "Plan") and are subject to the terms of the Plan and the following conditions:
1. The Restricted Shares awarded hereunder shall be promptly issued and a certificate(s) for such shares shall be issued in your name. You shall thereupon be a shareholder of all the shares represented by the certificate(s). As such, you shall have all the rights of a shareholder with respect to such shares, including, but not limited to, the right to vote such shares and to receive all dividends and other distributions(subject to Paragraph 2 below) paid with respect to them, provided, however, that the shares shall be subject to the restrictions in Paragraph 4 below. The stock certificates representing such shares shall be imprinted with a legend stating that the shares represented thereby are Restricted Shares subject to the terms and conditions of this Grant Notice and, as such, may not be sold, exchanged, transferred, pledged, hypothecated or otherwise disposed of except in accordance with the terms of this Grant Notice. Each transfer agent for the Common Stock shall be instructed to like effect in respect of such shares. In aid of such restrictions, you shall immediately upon receipt of the certificate(s) therefor, deposit such certificate(s) together with a stock power or other like instrument of transfer, appropriately endorsed in blank, with an escrow agent designated by the Committee, which may be the Company, under a deposit agreement containing such terms and conditions as the Committee shall approve, the expenses of such escrow to be borne by the Company.
2. If under Section 18 of the Plan, entitled "Adjustment of Available Shares," you, as the owner of the Restricted Shares, shall be entitled to new, additional or different shares of stock or securities, the certificate or certificates for, or other evidences of, such new, additional or different shares or securities, together with a stock power or other instrument of transfer appropriately endorsed, shall be imprinted with a legend as provided in Paragraph 1 above, deposited by you under the deposit agreement provided for therein, and subject to the restrictions provided for in Paragraph 4 below.
3. The term "Restricted Period" with respect to the Restricted Shares shall mean the period beginning on February 11, 1994 and ending on February 10, 1999.
4. During the Restricted Period, none of the Restricted Shares shall be sold, exchanged, transferred, pledged, hypothecated or otherwise disposed of except by will or the laws of descent and distribution. Any attempt by you to dispose of your shares in any such manner shall result in the immediate forfeiture of such shares and any other shares then held by the designated escrow agent on your behalf.
5. If your employment is terminated pursuant to Section 11(c) or 11(e) of the Employment Agreement between you and the Company dated February 11, 1994 (the "Employment Agreement") at any time before the Restricted Period ends, you shall immediately forfeit all of the Restricted Shares then held on your behalf by the designated escrow agent.
6. If your employment is terminated pursuant to Section 11(a) or 11(b) of the Employment Agreement, at any time before the Restricted Period ends, the restrictions set forth in Paragraph 4 above shall lapse as to that number of shares determined by multiplying [ ] shares (subject to adjustment as provided in Section 18 of the Plan) by a fraction, the numerator of which shall be the number of months during the Restricted Period you have been employed (including the month of termination) and the denominator of which shall be 60 months. You shall immediately forfeit all remaining Restricted Shares.
7. If your employment is terminated pursuant to Section 11(d) of the Employment Agreement, at any time before the Restricted Period ends, the restriction set forth in Paragraph 4 above shall lapse as to that number of shares determined by multiplying [ ] shares (subject to adjustment as provided in Section 18 of the Plan) by a fraction, the numerator of which shall be the number of months during the Restricted Period you have been employed (including the month of termination) plus 18 months (but not to exceed 60 months) and the denominator of which shall be 60 months. You shall immediately forfeit all remaining Restricted Shares.
8. If your employment continues through the Restricted Period, the restrictions set forth in Paragraph 4 above, with respect to the Restricted Shares shall lapse.
9. Section 20 of the Plan (noncompetition) shall not apply to this grant.
10. The Company, or the designated escrow agent at the request of the Company, shall be entitled to deduct from the Restricted Shares the amount of all applicable income and employment taxes required to be withheld unless you make other arrangements with the Company for the timely payment of such taxes.
Exhibit B
NOTICE OF STOCK OPTION GRANTED [date]
PURSUANT TO EASTMAN KODAK COMPANY 1990 OMNIBUS LONG-TERM COMPENSATION PLAN ("Grant Notice")
To:
You are granted a Nonqualified Stock Option to purchase 200,000*1 shares of Eastman Kodak Company Common Stock at $ per share. This option is granted under the Eastman Kodak Company 1990 Omnibus Long-Term Compensation Plan (the "Plan") subject to the terms of this Grant Notice.
1. This option shall become exercisable (vested) on the fifth anniversary of this grant. The period between the date this option is granted and such fifth anniversary shall be the "Restricted Period".
2. This option, unless sooner terminated or exercised in full, shall expire on February 10 , 2004.
3. If your employment is terminated pursuant to Section 11(c) or 11(e) of the Employment Agreement between you and the Company dated February 11, 1994 (the "Employment Agreement") at any time before the Restricted Period ends, you shall immediately forfeit this option.
4. If your employment is terminated pursuant to Section 11(a) or 11(b) of the Employment Agreement, at any time before the Restricted Period ends, this option shall immediately become exercisable and vested as to all 200,000 shares (subject to adjustment as provided in Section 18 of the Plan) multiplied by a fraction, the numerator of which shall be the number of months during the Restricted Period you have been employed (including the month of termination) and the denominator of which shall be 60 months. You shall immediately forfeit your rights as to any shares subject to this option at the time of your termination that are not exercisable and vested after applying the fraction described in the preceding sentence. Your rights under this option as to any shares as to which it is or becomes exercisable and vested at the time of your termination of employment shall continue to be exercisable until the scheduled expiration date under Paragraph 2 above, or, if sooner, the exercise of this option in full.
- - --------------------------- *1 Actual grant shall be for 200,000 shares less the number of shares that shall be granted concurrently under a stock option intended to qualify as an incentive stock option under Section 422 of the Internal Revenue Code. Such option grant shall be in substantially the same form as this grant except to the extent necessary to constitute an incentive stock option under Section 422.
5. If your employment is terminated pursuant to Section 11(d) of the Employment Agreement, at any time before the Restricted Period ends, this option shall, to the extent not already exercisable, immediately become exercisable and vested as to 200,000 shares (subject to adjust as provided in Section 18 of the Plan) multiplied by a fraction, the numerator of which shall be the number of months during the Restricted Period you have been employed (including the month of termination) plus an additional 18 months (but not in the aggregate to exceed 60 months) and the denominator of which shall be 60 months. You shall immediately forfeit your rights as to any shares subject to this option at the time of your termination that are not exercisable and vested after applying the fraction described in the preceding sentence. Your rights under this option as to any shares as to which it is or becomes exercisable and vested at the time of your termination of employment shall continue to be exercisable until the scheduled expiration date under Paragraph 2 above, or, if sooner, the exercise of this option in full.
6. If your employment continues through the Restricted Period, this option shall become exercisable and vested in full and shall continue to be exercisable until its scheduled expiration date under Paragraph 2 above, or, if sooner, its exercise in full.
7. You shall not have any of the rights of a shareholder with respect to the shares of Common Stock covered by this option except to the extent one or more certificates for such shares shall be delivered to you upon the exercise of the option.
8. You may exercise this option by way of the Company's broker-assisted stock option exercise program, to the extent such program is available at the time of such exercise. Pursuant to the terms of such program, the amount of any taxes required to be withheld upon exercise of any options under the program shall be paid in cash directly to the Company.
9. Section 20 of the Plan (noncompetition) shall not apply to this grant.
NOTICE OF AWARD OF NON-QUALIFIED STOCK OPTIONS
GRANTED TO HARRY L. KAVETAS
FEBRUARY 15, 1994
PURSUANT TO THE
EASTMAN KODAK COMPANY 1990 OMNIBUS LONG-TERM
COMPENSATION PLAN
APPROVED BY:
Richard S. Braddock, Chairman of the Executive Compensation and Development Committee February 15, 1994
NOTICE OF AWARD OF NON-QUALIFIED STOCK OPTIONS GRANTED TO HARRY L. KAVETAS FEBRUARY 15, 1994 PURSUANT TO THE EASTMAN KODAK COMPANY 1990 OMNIBUS LONG-TERM COMPENSATION PLAN
Paragraph Title Page
1 Background 136
2 Award 136
3 Terms and Conditions of Non-Qualified Stock Options 136
(a) Option Price 136 (b) Duration of Option 136 (c) Vesting of an Option 136 (d) Payment of Option Price 136 (e) Withholding 136 (f) Rights as a Shareholder 136 (g) Broker Assisted Exercise 137 (h) Termination of Employment 137
4 Death/Disability 137
5 Termination without Cause or Constructive Termination 137
6 Definitions 137
7 Non-Assignability 137
8 Noncompetition 137
NOTICE OF AWARD OF NON-QUALIFIED STOCK OPTIONS GRANTED TO HARRY L. KAVETAS FEBRUARY 15, 1994 PURSUANT TO THE EASTMAN KODAK COMPANY 1990 OMNIBUS LONG-TERM COMPENSATION PLAN
1. Background. Under Sections 8 of the 1990 Omnibus Long-Term Compensation Plan (the "Plan"), the Compensation Committee may, among other things, award non-qualified stock options of the Company's Common Stock to those Key Employees as the Committee in its discretion may determine, subject to such terms, conditions and restrictions as it deems appropriate.
2. Award. On February 15, 1994, the Committee granted to Harry L. Kavetas (the "Participant") an Award of one hundred ninety seven thousand six hundred and seventy two (197,672) non-qualified stock options of Common Stock. One option provides for the ability to purchase a single share of Common Stock. This Award is granted under the Plan, subject to the terms and conditions of the Plan and those set forth in this Award Notice.
3. Terms and Conditions of Non-Qualified Stock Options. The following terms and conditions shall apply to the Award of Non-Qualified Stock Options:
(a) Option Price. The option price shall be Forty Two and 94/100 Dollars ($42.94).
(b) Duration of Option. Each option shall expire at the close of business on February 14, 2004, unless sooner terminated or exercised in full in accordance with the terms and conditions of this Award Notice and the Plan.
(c) Vesting of an Option. The options shall vest and, therefore, become exercisable on February 15, 1999. The period between February 15, 1994 and February 15, 1999 shall be the "Restricted Period."
Once vested, the options may be exercisable by the Participant regardless of whether any other options he has been granted by the Company remain exercisable. Options may be exercised by written notice to the Company stating the number of shares with respect to which the option is being exercised.
(d) Payment of Option Price. The option price for the shares for which an option is exercised by the Participant shall be paid by the Participant on the date the option is exercised in cash, in shares of Common Stock owned by the Participant, or a combination of the foregoing. Any share of Common Stock delivered in payment of the option price shall be valued at its "fair market value." For purposes of this subparagraph, "fair market value" shall mean the opening price of the Common Stock on the New York Stock Exchange on the date of exercise; provided, however, if the Common Stock is not traded on such date, then the opening price on the immediately preceding date on which Common Stock is traded shall be used.
(e) Withholding. The Participant may pay the amount of taxes required to be withheld upon exercise of his options by (i) delivering a check made payable to the Company; or (ii) delivering to the Company at the time of such exercise shares of Common Stock having a "fair market value," as determined in accordance with Paragraph "3(d)" above, equal to the amount of such withholding taxes.
(f) Rights as a Shareholder. The Participant shall not have any of the rights of a shareholder with respect to the shares of Common Stock covered by an option except to the extent one or more certificates for such shares shall be delivered to him upon the exercise of such option.
(g) Broker Assisted Exercise. Notwithstanding Paragraphs "3(d)" and "3(e)" above to the contrary, the Participant may exercise any option granted to him under this Award Notice by way of the Company's broker-assisted stock option exercise program, to the extent such program is available at the time of such exercise. Pursuant to the terms of such program, the amount of any taxes required to be withheld upon exercise of any options under the program shall be paid in cash directly to the Company.
(h) Termination of Employment. If the Participant's employment is terminated pursuant to Section 11(c) or 11(e) of the Employment Agreement between the Participant and the Company dated as of February 11, 1994 (the "Employment Agreement") at any time before the Restricted Period ends, the Participant shall immediately forfeit the entire Award.
4. Death/Disability. Notwithstanding Paragraph "3(c)" above to the contrary, if the Participant's employment is terminated pursuant to Section 11(a) or 11(b) of the Employment Agreement at any time before the Restricted Period ends, the Award shall, to the extent not already exercisable, immediately become exercisable and vested as to that number of non-qualified stock options determined by multiplying 197,672 options (subject to adjustment as provided in Section 18 of the Plan) by a fraction, the numerator of which shall be the number of months during the Restricted Period that the Participant was employed (including the month of termination) and the denominator of which shall be 60 months. The Participant shall immediately forfeit his rights as to any options that are not exercisable and vested after applying the fraction described in the immediately preceding sentence. The Participant's rights as to any options which are or become exercisable and vested at the time of his termination of employment shall continue to be exercisable until the scheduled expiration date under Paragraph "3(b)" above, or, if sooner, the exercise of the option in full.
5. Termination Without Cause or Constructive Termination. Notwithstanding Paragraph "3(c)" above to the contrary, if the Participant's employment is terminated pursuant to Section 11(d) of the Employment Agreement at any time before the Restricted Period ends, the Award shall, to the extent not already exercisable, immediately become exercisable and vested as to that number of non-qualified stock options determined by multiplying 197,672 options (subject to adjustment as provided in Section 18 of the Plan) by a fraction, the numerator of which shall be the number of months during the Restricted Period that the Participant was employed (including the month of termination) plus an additional 18 months (but not in the aggregate to exceed 60 months) and the denominator of which shall be 60 months. The Participant shall immediately forfeit his rights as to any options that are not exercisable and vested after applying the fraction described in the immediately preceding sentence. The Participant's rights as to any options which are or become exercisable and vested at the time of his termination of employment shall continue to be exercisable until the scheduled expiration date under Paragraph "3(b)" above, or, if sooner, the exercise of the option in full.
6. Definitions. Any defined term used in this Award Notice shall have the same meaning for purposes of this document as that ascribed to it under the terms of the Plan.
7. Non-Assignability. The Awards shall not in any manner be subject to alienation, anticipation, sale, transfer (except by will or the laws of descent and distribution), assignment, pledge or encumbrance.
8. Noncompetition. Section 20 of the Plan, entitled "Noncompetition Provision," shall not apply to this Award.
NOTICE OF AWARD OF INCENTIVE STOCK OPTIONS
GRANTED TO HARRY L. KAVETAS
FEBRUARY 15, 1994
PURSUANT TO THE
EASTMAN KODAK COMPANY 1990 OMNIBUS LONG-TERM
COMPENSATION PLAN
APPROVED BY:
Richard S. Braddock, Chairman of the Executive Compensation and Development Committee February 15, 1994
NOTICE OF AWARD OF INCENTIVE STOCK OPTIONS GRANTED TO HARRY L. KAVETAS FEBRUARY 15, 1994 PURSUANT TO THE EASTMAN KODAK COMPANY 1990 OMNIBUS LONG-TERM COMPENSATION PLAN
Paragraph Title Page
1 Background 140
2 Award 140
3 Terms and Conditions of Incentive Stock Options 140
(a) Option Price 140 (b) Duration of Option 140 (c) Vesting of an Option 140 (d) Payment of Option Price 140 (e) Withholding 141 (f) Rights as a Shareholder 141 (g) Termination of Employment 141
4 Death/Disability 141
5 Termination without Cause or Constructive Termination 141
6 Definitions 141
7 Non-Assignability 142
8 Noncompetition 142
9 Compliance with Code Section 422. 142
NOTICE OF AWARD OF INCENTIVE STOCK OPTIONS GRANTED TO HARRY L. KAVETAS FEBRUARY 15, 1994 PURSUANT TO THE EASTMAN KODAK COMPANY 1990 OMNIBUS LONG-TERM COMPENSATION PLAN
1. Background. Under Sections 8 of the 1990 Omnibus Long-Term Compensation Plan (the "Plan"), the Compensation Committee may, among other things, award Incentive Stock Options, within the meaning of Section 422 of the Internal Revenue Code of 1986, of the Company's Common Stock to those Key Employees as the Committee in its discretion may determine, subject to such terms, conditions and restrictions as it deems appropriate.
2. Award. On February 15, 1994, the Committee granted to Harry L. Kavetas (the "Participant") an Award of two thousand three hundred and twenty eight (2,328) incentive stock options of Common Stock. One option provides for the ability to purchase a single share of Common Stock. This Award is granted under the Plan, subject to the terms and conditions of the Plan and those set forth in this Award Notice.
3. Terms and Conditions of Incentive Stock Options. The following terms and conditions shall apply to the Award of Incentive Stock Options:
(a) Option Price. The option price shall be Forty Two and 94/100 Dollars ($42.94).
(b) Duration of Option. Each option shall expire at the close of business on February 14, 2004, unless sooner terminated or exercised in full in accordance with the terms and conditions of this Award Notice and the Plan.
(c) Vesting of an Option. The options shall vest and, therefore, become exercisable on February 15, 1999. The period between February 15, 1994 and February 15, 1999 shall be the "Restricted Period".
Once vested, the options may be exercisable by the Participant regardless of whether any other options he has been granted by the Company remain exercisable. Options may be exercised by written notice to the Company stating the number of shares with respect to which the option is being exercised.
(d) Payment of Option Price. The option price for the shares for which an option is exercised by the Participant shall be paid by the Participant on the date the option is exercised in cash, in shares of Common Stock owned by the Participant, or a combination of the foregoing. Any share of Common Stock delivered in payment of the option price shall be valued at its "fair market value". For purposes of this subparagraph, "fair market value" shall mean the opening price of the Common Stock on the New York Stock Exchange on the date of exercise; provided, however, if the Common Stock is not traded on such date, then the opening price on the immediately preceding date on which Common Stock is traded shall be used.
(e) Withholding. The Participant may pay the amount of taxes required to be withheld upon exercise of his options by (i) delivering a check made payable to the Company; or (ii) delivering to the Company at the time of such exercise shares of Common Stock having a "fair market value", as determined in accordance with Paragraph "3(d)" above, equal to the amount of such withholding taxes.
(f) Rights as a Shareholder. The Participant shall not have any of the rights of a shareholder with respect to the shares of Common Stock covered by an option except to the extent one or more certificates for such shares shall be delivered to him upon the exercise of such option.
(g) Termination of Employment. If the Participant's employment is terminated pursuant to Section 11(c) or 11(e) of the Employment Agreement between the Participant and the Company dated as of February 11, 1994 (the "Employment Agreement") at any time before the Restricted Period ends, the Participant shall immediately forfeit the entire Award.
4. Death/Disability. Notwithstanding Paragraph "3(c)" above to the contrary, if the Participant's employment is terminated pursuant to Section 11(a) or 11(b) of the Employment Agreement at any time before the Restricted Period ends, the Award shall, to the extent not already exercisable, immediately become exercisable and vested as to that number of incentive stock options determined by multiplying 2,328 options (subject to adjustment as provided in Section 18 of the Plan) by a fraction, the numerator of which shall be the number of months during the Restricted Period that the Participant was employed (including the month of termination) and the denominator of which shall be 60 months. The Participant shall immediately forfeit his rights as to any options that are not exercisable and vested after applying the fraction described in the immediately preceding sentence. The Participant's rights as to any options which are or become exercisable and vested at the time of his termination of employment shall continue to be exercisable until the scheduled expiration date under Paragraph "3(b)" above, or, if sooner, the exercise of the option in full.
5. Termination Without Cause or Constructive Termination. Notwithstanding Paragraph "3(c)" above to the contrary, if the Participant's employment is terminated pursuant to Section 11(d) of the Employment Agreement at any time before the Restricted Period ends, the Award shall, to the extent not already exercisable, immediately become exercisable and vested as to that number of incentive stock options determined by multiplying 2,328 options (subject to adjustment as provided in Section 18 of the Plan) by a fraction, the numerator of which shall be the number of months during the Restricted Period that the Participant was employed (including the month of termination) plus an additional 18 months (but not in the aggregate to exceed 60 months) and the denominator of which shall be 60 months. The Participant shall immediately forfeit his rights as to any options that are not exercisable and vested after applying the fraction described in the immediately preceding sentence. The Participant's rights as to any options which are or become exercisable and vested at the time of his termination of employment shall continue to be exercisable until the scheduled expiration date under Paragraph "3(b)" above, or, if sooner, the exercise of the option in full.
6. Definitions. Any defined term used in this Award Notice shall have the same meaning for purposes of this document as that ascribed to it under the terms of the Plan.
7. Non-Assignability. The Awards shall not in any manner be subject to alienation, anticipation, sale, transfer (except by will or the laws of descent and distribution), assignment, pledge or encumbrance.
8. Noncompetition. Section 20 of the Plan, entitled "Noncompetition Provision", shall not apply to this Award.
9. Compliance with Code Section 422. The options granted by way of this Award Notice are intended to qualify as Incentive Stock Options under Section 422 of the Internal Revenue Code of 1986. To the extent any provision of this Award Notice is determined to be inconsistent or contrary to Section 422, such provision shall be automatically changed, effective as of the date of the options' grant, so as to be consistent and in compliance with such section.
NOTICE OF AWARD OF RESTRICTED STOCK
GRANTED TO HARRY L. KAVETAS
FEBRUARY 15, 1994
PURSUANT TO THE
EASTMAN KODAK COMPANY 1990 OMNIBUS LONG-TERM
COMPENSATION PLAN
APPROVED BY:
Richard S. Braddock, Chairman of the Executive Compensation and Development Committee February 15, 1994
NOTICE OF AWARD OF RESTRICTED STOCK GRANTED TO HARRY L. KAVETAS FEBRUARY 15, 1994 PURSUANT TO THE EASTMAN KODAK COMPANY 1990 OMNIBUS LONG-TERM COMPENSATION PLAN
Paragraph Title Page
1 Background 145
2 Award 145
3 Terms and Conditions of Restricted Shares 145
(a) Issuance 145 (b) Stock Splits, Dividends, etc. 146 (c) Restricted Period 146 (d) Restrictions on Restricted Shares 146 (e) Lapse of Restrictions 146
4 Disability/Death 146
5 Termination without Cause or Constructive Termination 146
6 Noncompetition 146
7 Withholding 146
8 Definitions 146
NOTICE OF AWARD OF RESTRICTED STOCK GRANTED TO HARRY L. KAVETAS EFFECTIVE FEBRUARY 15, 1994 PURSUANT TO THE EASTMAN KODAK COMPANY 1990 OMNIBUS LONG-TERM COMPENSATION PLAN
1. Background. Under Section 10 of the 1990 Omnibus Long-Term Compensation Plan (the "Plan"), the Compensation Committee may, among other things, award restricted shares of the Company's Common Stock to those Key Employees as the Committee in its discretion may determine, subject to such terms, conditions and restrictions as it deems appropriate.
2. Award. On February 15, 1994, the Committee granted, to Harry L. Kavetas (the "Participant") an Award of twelve thousand eight hundred and ten (12,810) restricted shares of Common Stock ("Restricted Shares"). This Award is granted under the Plan, subject to the terms and conditions of the Plan and those set forth in this Award Notice.
3. Terms and Conditions of Restricted Shares. The following terms and conditions shall apply to Restricted Shares:
(a) Issuance. The Restricted Shares awarded hereunder to the Participant shall be promptly issued and a certificate(s) for such shares shall be issued in the Participant's name. The Participant shall thereupon be a shareowner of all the shares represented by the certificate(s). As such, the Participant shall have all the rights of a shareowner with respect to such shares, including but not limited to, the right to vote such shares and to receive all dividends and other distributions (subject to Paragraph " 3(b)") paid with respect to them, provided, however, that the shares shall be subject to the restrictions in Paragraph "3(d)". The stock certificates representing the Restricted Shares shall be imprinted with a legend stating that the shares represented thereby are restricted shares subject to the terms and conditions of this Award Notice and, as such, may not be sold, exchanged, transferred, pledged, hypothecated, or otherwise disposed of except in accordance with this Award Notice. Each transfer agent for the Common Stock shall be instructed to like effect in respect of such shares. In aid of such restrictions, the Participant shall immediately upon receipt of the certificate(s) therefor, deposit such certificate(s) together with a stock power or other like instrument of transfer, appropriately endorsed in blank, with an escrow agent designated by the Committee, which may be the Company, under a deposit agreement containing such terms and conditions as the Committee shall approve, the expenses of such escrow to be borne by the Company.
(b) Stock Splits, Dividends, etc. If under Section "18" of the Plan, entitled "Adjustment of Available Shares", the Participant, as the owner of the Restricted Shares, shall be entitled to new, additional, or different shares of stock or securities, the certificate or certificates for, or other evidences of, such new, additional, or different shares or securities, together with a stock power or other instrument of transfer appropriately endorsed, shall be imprinted with a legend as provided in Paragraph "3(a)" above, deposited by the Participant under the deposit agreement provided for therein, and subject to the restrictions provided for in Paragraph "3(d)" below.
(c) Restricted Period. The term "Restricted Period" with respect to the Restricted Shares shall mean the period beginning on February 15, 1994 and ending on February 14, 1999.
(d) Restriction on Restricted Shares. The restrictions to which the Restricted Shares are subject are:
(i) Nonalienation. During the Restricted Period, none of the Restricted Shares shall be sold, exchanged, transferred, pledged, hypothecated, or otherwise disposed of except by will or the laws of descent and distribution. Any attempt by the Participant to dispose of his shares in any such manner shall result in the immediate forfeiture of such shares and any other shares then held by the designated escrow agent on the Participant's behalf.
(ii) Continuous Employment. If the Participant's employment is terminated pursuant to Section 11(c) or 11(e) of the Employment Agreement between the Participant and the Company dated as of February 11, 1994 (the "Employment Agreement") at any time before the Restriction Period ends, he shall immediately forfeit all of the Restricted Shares then held on his behalf by the designated escrow agent.
(e) Lapse of Restrictions. The restrictions set forth in Paragraph "3(d)" above, with respect to the Restricted Shares held by the designated escrow agent on behalf of the Participant, will lapse upon the expiration of the Restriction Period.
4. Death/Disability. Notwithstanding Paragraph "3(e)" above to the contrary, if the Participant's employment is terminated pursuant to Section 11(a) or 11(b) of the Employment Agreement at any time before the Restricted Period ends, the restrictions set forth in Paragraph "3(d)" above shall lapse as to that number of shares determined by multiplying 12,810 shares (subject to adjustment as provided in Section 18 of the Plan) by a fraction, the numerator of which shall be the number of months during the Restricted Period that the Participant was employed (including the month of termination) and the denominator of which shall be 60 months. The Participant shall immediately forfeit all remaining Restricted Shares.
5. Termination Without Cause or Constructive Termination. Notwithstanding Paragraph "3(e)" above to the contrary, if the Participant's employment is terminated pursuant to Section 11(d) of the Employment Agreement at any time before the Restriction Period ends, the restrictions set forth in Paragraph "3(d)" shall lapse as to that number of shares determined by multiplying 12,810 shares (subject to adjustment as provided in Section 18 of the Plan) by a fraction, the numerator of which shall be the number of months during the Restricted Period that the Participant was employed (including the month of termination) plus 18 months and the denominator of which shall be 60 months. The Participant shall immediately forfeit all remaining Restricted Shares.
6. Noncompetition. Section 20 of the Plan, entitled "Noncompetition Provision", shall not apply to the grant of the Restricted Shares.
7. Withholding. The Company, or the designated escrow agent at the request of the Company, shall be entitled to deduct from the Restricted Shares the amount of all applicable income and employment taxes required to be withheld unless the Participant makes other arrangements with the Company for the timely payment of such taxes.
8. Definitions. Any defined term used in this Award Notice shall have the same meaning for purposes of this document as that ascribed to it under the terms of the Plan.
Exhibit (22) Subsidiaries of Eastman Kodak Company
Organized Companies Consolidated Under Laws of
Eastman Kodak Company New Jersey Eastman Kodak International Finance B.V. Netherlands Eastman Kodak International Sales Corporation Barbados Eastman Technology, Inc. New York Torrey Pines Realty Company, Inc. Delaware The Image Bank, Inc. New York Northfield Pharmaceuticals Limited Delaware Kodak Health Imaging Systems, Inc. Delaware Qualex Inc. Delaware Jamieson Film Company Delaware Eastman Gelatine Corporation Massachusetts Eastman Canada, Inc. Canada Kodak Canada, Inc. Canada Kodak (Export Sales) Ltd. Hong Kong Kodak Argentina, Ltd. New York Kodak Brasileira C.I.L. Brazil Kodak Chilena S.A.F. Chile Kodak Colombiana, Ltd. New York Kodak Panama, Ltd. New York Foto Interamericana de Peru, Ltd. New York Kodak Caribbean, Limited New York Kodak Uruguaya, Ltd. New York Kodak Venezuela, S.A. Venezuela Kodak (Near East), Inc. New York Kodak (Singapore) Pte. Limited Singapore Kodak Philippines, Ltd. New York Kodak Limited England Kodak Ireland Limited Ireland Kodak-Pathe France Kodak A.G. Germany Kodak Korea Ltd. South Korea Kodak Far East Purchasing, Inc. New York Kodak New Zealand Limited New Zealand Kodak (Australasia) Proprietary Limited Australia Kodak (Kenya) Limited Kenya Kodak (Egypt) S.A. Egypt Kodak (Malaysia) S.B. Malaysia Kodak Taiwan Limited Taiwan Eastman Kodak International Capital Company, Inc. Delaware Kodak de Mexico S.A. de C.V. Mexico N.V. Kodak S.A. Belgium Kodak a.s. Denmark Kodak Norge A/S Norway Kodak SA Switzerland Kodak (Far East) Limited Hong Kong Kodak (Thailand) Limited Thailand Eastman Kodak De Mexico, S.A. de C.V. Mexico Kodak Mexicana S.A. de C.V. Mexico Industria Mexicana de Foto Copiadoras, S.A. de C.V. Mexico Kodak G.m.b.H. Austria Kodak G.m.b.H. Germany Kodak Oy Finland Kodak Nederland B.V. Netherlands
Exhibit (22) (Continued) Organized Companies Consolidated Under Laws of
Kodak S.p.A. Italy Kodak Portuguesa Limited New York Kodak S.A. Spain Kodak AB Sweden Eastman Kodak (Japan) Ltd. Japan K.K. Kodak Information Systems Japan Kodak Japan Ltd. Japan Kodak Imagica K.K. Japan Kodak Japan Industries Ltd. Japan
Note: Subsidiary Company names are indented under the name of the parent company.